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Abstract
Tauopathies  are  a  group  of  neurodegenerative  diseases  defined  by  the  aggregation  of 
abnormally  phosphorylated  protein  tau.  The  cause  for  neurodegeneration  observed  in 
tauopathies is not known. The discovery of mutations in the gene encoding for tau in familial 
cases  of  FTDP-17,  a  hereditary  tauopathy,  emphasized  the  importance  of  tau  in  these 
diseases.  This  led  to  the  creation  of  animal  models  expressing  human  tau  containing 
mutations found in FTDP-17, recapitulating some of the aspects of the disease, including 
neurodegeneration  and  tau  aggregation.  Reports  on  the  consequences  of  human  tau 
expression in the neurons of C. elegans are partially contradictory, especially with regard to 
their locomotor phenotype. In this work, we replicated C. elegans models of tauopathies and 
performed immunohistochemical and locomotion assessments. We created 23 genomically 
integrated  strains  pan-neuronally  expressing  either  wild  type  or  mutated  human  tau.  In 
agreement with published reports,  immunohistochemistry revealed no difference between 
wild type or mutated human tau with regard to phosphorylation status. To obtain lifelong, 
longitudinal  recordings  of  several  hundred  worms,  we  developed a  novel  worm tracking 
system which we termed Robot-Assisted Plate Imaging Device (RAPID). Using RAPID, we 
recorded the stimulated locomotor performance of human tau-expressing worms, exceeding 
the number of all  reported observations combined by two orders of magnitude. Our data 
indicate no pronounced locomotor phenotype in those transgenic worms, arguing against the 
reported neurotoxic effect of tau in C. elegans.
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1 Introduction
1.1 Alzheimer’s Disease and Tauopathies
1.1.1 Alzheimer’s Disease
Alzheimer’s disease (AD) is characterized by a progressive, irreversible cognitive decline 
which ultimately results in severe dementia  (Burns and Iliffe, 2009). The clinical symptoms 
are accompanied by prominent neuropathological hallmarks: brain atrophy, extracellular 
deposits of amyloid β (Aβ) in the form of amyloid plaques, neurofibrillary tangles (NFTs) and 
neuropil threads (NTs) made up of intraneuronal inclusions of tau protein, as well as synaptic 
and neuronal loss. Aβ deposits can also be found in walls of arteries and arterioles where 
they cause cerebral amyloid angiopathy (CAA). Other morphological changes associated 
with AD are an increased number of neurons with granulovacuolar degeneration, i.e. Hirano 
bodies, and increased accumulation of lipofuscin as well as a larger number of corpora 
amylacea (Ellison et al., 2012). 
The biggest risk factor for developing AD is age (Kawas et al., 2000). The incidence rate of 
AD increases by 0.08 % per year in the age group of 60 - 65 and raises to 6.48 % increase 
in incidence rate per year in age group 85+. Even though most patients suffer from sporadic 
AD (sAD) with unclear cause, carriers of the type 4 allele of the apolipoprotein E (APOE-ε4) 
have a higher risk of developing AD and a decreased age of onset (Corder et al., 1993). A 
small proportion of AD cases are caused by mutations in either the amyloid precursor protein 
(APP) from which Aβ is cleaved, or mutations in presenilin 1 (PS1) or presenilin 2 (PS2) 
which are part of the secretases that process APP. These autosomal dominant mutations 
cause familial/hereditary forms of AD (fAD) and lead to early onset of the disease, usually 
before the age of 65 (Van Cauwenberghe et al., 2016). These findings have resulted in the 
formulation of the so-called amyloid cascade hypothesis, which will be outlined in the next 
section.
1.1.2 Amyloid Cascade Hypothesis
Most mutations in APP, PS1, and PS2 discovered in fAD correlates with overproduction of 
Aβ,  amyloid plaques, and CAA. As patients suffering from fAD will develop all other 
pathological changes of sAD, including NFTs, Aβ was thought to be the initiator of these 
changes and much research was directed towards understanding the so-called amyloid 
cascade (Musiek and Holtzman, 2015). However, the occurrence and distribution of amyloid 
plaques neither correlates well with the progression of AD nor with neuronal loss. It has been 
observed that the distribution of NFTs and neuronal loss correlates with the severity of 
clinical AD symptoms. Hence, it was postulated that Aβ aggregation triggers the aggregation 
of tau into NFTs which are hypothesized to ultimately lead to neurodegeneration (Braak and 
Braak, 1991). Conversely, it  is not understood whether tau exerts direct neurotoxicity nor 
how Aβ mediates a toxic effect. Ultimately, the amyloid cascade hypothesis has therefore not 
led to deeper insight into the pathomechanisms underlying AD. The link between Aβ 
overproduction and its accumulation in fAD and sAD remains enigmatic.
Amyloid plaques as well as NFTs can be found in young patients in absence of any clinical 
symptoms, therefore it has been speculated that there is a long-lasting “preclinical” phase of 
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AD (Braak and Braak, 1997). More recently, the development of PET tracers for Aβ (Klunk et 
al.,  2004) have allowed longitudinal studies of amyloid plaques. The resulting data from 
human subjects support this hypothesis, since cognitively normal subjects with Aβ deposits 
are more likely to develop symptoms of AD later on (Morris et al., 2009) and higher amounts 
of Aβ deposits in healthy adults increase the risk of decline in episodic memory and 
language functions (Ellis et al., 2013).
1.1.3 Tauopathies
There are a number of neurodegenerative diseases, collectively termed tauopathies, that 
feature accumulation of insoluble tau protein. AD is the most frequent form among them. 
Other entities are parkinsonism-dementia complex of Guam, postencephalitic parkinsonism, 
dementia pugilistica, familial British dementia, progressive supranuclear palsy, corticobasal 
degeneration, argyrophilic grain disease, Pick’s disease and frontotemporal lobar 
degeneration with parkinsonism linked to chromosome 17 (FTDP-17). Most of them occur in 
a sporadic manner (Ellison  et  al.,  2012). The clinical symptoms vary depending on the 
affected brain regions, and the role of tau accumulation in these diseases is not understood 
(Williams, 2006). Similar to fAD, a number of mutations were found in the gene coding for 
tau (MAPT: microtubule-associated protein tau) which cause FTDP-17 (Rademakers et al., 
2004).
1.2 Microtubule-Associated Protein Tau (MAPT)
1.2.1 MAPT Gene and Tau Isoforms
Human tau is encoded by the MAPT gene on chromosome 17q21 (Neve et al., 1986) and 
expressed in neurons, astrocytes and oligodendrocytes (Shin et al.,  1991), as well as in 
neurons of the the peripheral nervous system and in skeletal and heart muscle (Trojanowski 
et al., 1989). In the adult human brain, six tau isoforms are primarily expressed which are 
generated through complex, tightly regulated alternative splicing reviewed in (Andreadis, 
2012). The isoforms are generated by combinations of exon 2 and 3 with exon 10. Exon 3 
only occurs in combination with exon 2, hence producing the six isoforms (Figure 1). The 
isoforms are differentially expressed with a higher expression of the shorter, 3R isoforms 
during development (Kosik et al., 1989). Furthermore, intron 9 of MAPT contains the gene 
for Saitohin (STH), which shares much of the expression pattern of tau and is of  unknown 
function (Conrad and Vianna, 2002).
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Splicing of the tau isoforms, domains, mutations and some phosphorylation sites. 
Human MAPT is spliced to generate the six tau isoforms of the adult brain (a). From 
top to bottom: 2N4R (441 AA), 1N4R (412 AA), 0N4R (383 AA), 2N3R (410 AA), 
1N3R (381 AA), and 0N3R (352 AA). Tau is organized into different domains 
consisting of the N-terminal projection domain, the proline rich domain, MT assembly 
or MT binding domain containing the 3 or 4 MT binding repeats, and the C-terminal 
domain (b). The location of some of the exonic mutations found in FTDP-17 are 
shown as well as some anti-tau antibody epitopes (AT8, AT100, AT180, 12E8, and 
PHF1). Not shown are the intronic mutations following exon 10. Adapted from (Wang 
and Mandelkow, 2015). 
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1.2.2 Functions of Tau
The different domains of tau have multiple functions which are reviewed in (Guo et al., 2017), 
and summarized below. The N-terminal domain changes the spacing between microtubules 
(MTs), inhibits axonal transport, is involved in the subcellular localisation and binds to the 
plasma membrane as well as membrane proteins. It is thought to interact with the C-terminal 
domain and fold the protein into the so-called “paperclip” conformation in which tau is not 
bound to MTs (Jeganathan et al., 2006). The proline-rich domain is thought to be involved in 
signalling function, possibly through binding of several protein kinases; it might additionally 
interact with DNA and RNA. Tau is well known to bind to MTs through the microtubule 
binding repeats. In addition, these repeats can also interact with F-actin, thereby tethering 
MTs and actin together. Other proteins known to be bound by tau include α-synuclein, 
histone deacetylase 6, APOE, and PS1. Functions of the C-terminal region are not known. 
Tau is found in all compartments of neurons, however it is enriched in the axons 
(Schoenfeld and Obart, 1994). 
Besides tau, there are a number of MT  associated proteins or  MAPs  (Mandelkow and 
Mandelkow,  1995), with structural and functional similarities, such as MAP2 and MAP4 
(Dehmelt et al., 2004). MAP1 family members share some functional similarities, but differ in 
the MT binding structures (Halpain and Dehmelt, 2006). 
1.2.3 MAPT Mutations
So far, 44 mutations in MAPT are described to be clinically relevant in FTDP-17 (Cruts et al., 
2012). The majority of mutations were found in the MT binding domain between exon 9 and 
exon 13, as well as in intron 10 (Rademakers et al., 2004). The effects of these mutations 
are diverse; mutations in the binding domain may change the affinity towards MTs or make it 
more prone to self-aggregate, while mutations in intron 10 as well as some mutations in exon 
10 interfere with physiological splicing and thereby change the ratio between tau isoforms 
(i.e. 3R and 4R). Functional changes beyond MT binding are not yet understood, but are 
likely to play a role given the many functions and potential binding partners of tau. 
1.2.4 Post-Translational Modifications of Tau
To orchestrate the many functions of tau,  the protein can undergo a number of post-
translational modifications (PTMs). The most prominent and extensively investigated is 
phosphorylation since aggregated tau in NFTs is found to be highly phosphorylated (Goedert 
et  al.,  1992). Therefore, phosphorylation is thought to play a role in aggregation and 
neurodegeneration. There are 85 potential phosphorylation sites of which 71 are found to be 
phosphorylated under physiological and/or pathological circumstances, summarized in 
(Sergeant  et  al.,  2008). Phosphorylation is carried out by at least 20 different kinases 
belonging to four different groups: proline-dependent protein kinases (PDPK), non-PDPK, 
glycogen protein kinases and tyrosine protein kinases. Glycogen synthase kinase-3 (GSK-3), 
cyclin-dependent kinase-5 (cdk5), casein kinase 1 (CK1), and cyclic AMP-dependent protein 
kinase (PKA), were identified as major tau kinases and are intensively studied as potential 
drug targets in AD (Hanger et al., 2009). The physiological phosphorylation state of tau is 
kept in balance by the activity of kinases and phosphatases alike. The mechanism of tau 
hyperphosphorylation remains unclear. It has been suggested that hyperphosphorylation is 
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caused by downregulation of protein phosphatase 2 (PP2A), the major tau phosphatase (Liu 
et al., 2005).
 
Phosphorylation in the MT binding repeats is considered an important physiological 
mechanism to fine tune the MT affinity of tau. In addition, phosphorylation outside of the MT 
binding repeats can also alter the MT binding properties through intramolecular interactions 
(Goode et al., 1997). Aberrant phosphorylation is thought to release tau molecules from MTs 
which then may oligomerize and form aggregates. 
Consequences of phosphorylation on functions of tau beyond MT binding are not well 
understood.  Phosphorylation could lead to missorting, alter degradation, truncation, and 
change the interactions with many of its binding partners (Wang and Mandelkow, 2015). 
Furthermore, phosphorylation influences tau aggregation directly with some sites increasing 
the  propensity  (Haase  et  al.,  2004), while others decrease the fibrillization propensity 
(Schneider et al., 1999). 
Which sites are phosphorylated under physiological conditions and which are characteristic 
for aggregated tau remains a matter of debate. It was suggested that all sites 
phosphorylated in aggregated tau are also phosphorylated under physiological conditions 
(Matsuo et  al.,  1994), and that soluble tau would become rapidly dephosphorylated post 
mortem while aggregated tau was inaccessible to phosphatases, hence remaining 
phosphorylated. Nonetheless, tau molecules extracted from aggregates seem to contain 
more phosphate groups per molecule than soluble tau extracted from biopsies. Furthermore, 
a substantial  amount  of  experimental  evidence on the effect  of  tau phosphorylation was 
obtained  in  model  systems  overexpressing  human  tau  (Götz  et  al.,  2010).  Tau 
phosphorylation and dephosphorylation in those models may not underlie the same carefully 
balanced control mechanisms as in human and therefore must be interpreted cautiously. 
Apart from phosphorylation, many more PTMs were described (Martin  et  al.,  2011), and 
include glycosylation, glycation, prolyl-isomerization, truncation, nitration, polyamination, 
ubiquitination, sumoylation, oxidation, and, more recently, acetylation (Min  et  al.,  2010). 
Again, the relevance of those PTMs for tau aggregation or toxicity is not well understood.
1.2.5 Tau Aggregation
As discussed previously, intracellular inclusions of tau protein are the key pathological 
hallmark of tauopathies, including AD. The correlation between NFT distribution and 
progression of AD symptoms has lead to the hypothesis that tau aggregates are central to 
the disease and are the direct cause for neurodegeneration (Arriagada et al., 1992).
NFTs and NTs can be demonstrated histologically using various silver stains (Uchihara, 
2007), most notably the Gallyas silver impregnation method (Gallyas,  1971). Apart from 
intracellular NFTs and NTs, Gallyas silver impregnation also stains extracellular tangles, 
which feature a less dense staining and yet outline the shapes of neurons which are 
themselves no longer recognizable. Hence, they are believed to be the remnants of a tangle-
bearing neuron, which had died and thus left behind an extracellular “ghost tangle”. These 
ghost tangles are resistant to degradation, probably due to cross-linking of the proteins and 
are thought to remain for an extended period (Smith et al., 1994). Interestingly, the number of 
ghost tangles found in the hippocampus is far lower than the number of neurons that must 
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have died, and therefore NFTs may not be the sole reason for neuronal death (Kril et al., 
2002). Furthermore, it was estimated that tangle-bearing neurons can survive up to 20 years 
in humans (Morsch et al., 1999). A more recent study in mice has shown that tangle-bearing 
neurons are able to process sensory inputs and are functional within neural circuits 
(Kuchibhotla et al., 2014). 
Despite these findings, tau aggregates have been extensively studied biochemically and 
ultrastructurally, in vivo as well as in vitro. NFTs in AD were first described in 1963 as thick 
bundles of parallel filaments which appeared to be helical and were aptly termed paired 
helical filaments (PHFs) (Kidd, 1963). PHFs can be extracted from AD brains as well as 
assembled in vitro and have been studied in great detail. The core of the fibres are made up 
of cross-β-sheet structures (Barghorn et al., 2004) and the hexapeptide motifs (VQIXXK) of 
the MT binding repeats R2 and R3 are essential for the assembly into PHFs (Barghorn and 
Mandelkow,  2002). Recently, the structure of PHFs extracted from an AD patient was 
resolved with cryo-electron microscopy (Fitzpatrick  et  al.,  2017). The core of the 
protofilaments are made up of the MT binding repeats 3 and 4 plus 10 amino acids following 
R4 (V306 - F378) which form 8 β-sheets and arrange in a C-shaped manner. Nonetheless, the 
exact mechanism of how PHFs form in vivo is still to be elucidated.
It is thought that the assembly of PHFs in vitro  follows a nucleated polymerization process 
where monomeric tau starts to form dimers, assembles into oligomers and eventually 
filaments which comprise the PHFs (Friedhoff et al., 1998). Tau aggregation can be induced 
in vitro and in vivo by “seeding” with preformed filaments.
Because of the filamentous character of NFTs in AD, Prusiner  already speculated in 1984 
that AD may be a prion disease with a very long incubation time (Prusiner, 1984). 30 years 
later, this hypothesis gained a lot of attention when the experiments outlined in the next 
section were performed. 
1.3 Prion-Like Properties of Tau in Animal Models for 
Tauopathies
1.3.1 Induction of Tau Aggregation by Injection
The formation of NFTs in mice can be induced by intracerebrally injecting a host mouse 
expressing wild type (wt) human tau (hTau)  with brain homogenates from mice expressing 
hTau carrying the P301S mutation (Clavaguera et al., 2009). Upon injection, the host mice 
progressively  develop hyperphosphorylated hTau, Gallyas-positive inclusions, resembling 
NFTs, NTs, and coiled-bodies. Homogenates depleted of hTau did not induce such changes. 
The inclusions were not limited to the injection sites but also appeared in anatomically 
connected, yet remote brain regions in a time-dependent manner. Importantly, such injected 
wt hTau transgenic mice do not show any signs of  additional  neurodegeneration despite 
overt neuronal inclusions of hTau protein.
Many more aggregation inducing injection models have since been reported. Brain 
homogenates from mice expressing mutated hTau were injected into presymptomatic, 2 
month old mice of the same genotype which then developed tangle pathology spreading 
from the injection sites to anatomically connected areas within 2 month, increasing in density 
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over time (Ahmed et al., 2014). Apart from mouse-derived inoculants, filaments generated in 
vitro from different recombinant hTau isoforms or fragments have also been successfully 
used to induce aggregation of tau in injected host mice (Guo et al., 2016; Iba et al., 2013; 
Peeraer et al., 2015).
Tau oligomers extracted from AD patients injected into wt mice caused widespread 
aggregation and hyperphosphorylation of endogenous murine tau (mTau)  at the site of 
injection as well as in adjacent brain regions while PHFs did not lead to the same pathology 
(Lasagna-Reeves  et  al.,  2012). However, Sarkosyl-insoluble extracts containing high 
molecular PHFs  (Audouard et al.,  2016) injected into the brain of wt and double mutant 
hTau-expressing mice induced Gallyas-positive inclusions. Furthermore, brain extracts from 
various sporadic tauopathies are able to cause Gallyas-positive deposits when injected 
intracerebrally in wt hTau-expressing mice, and to a lesser extent, in injected wt mice 
expressing only endogenous mTau (Clavaguera et al., 2013).
Lastly, we  have  shown that brain homogenates from symptomatic P301S mutant hTau 
expressing mice is able to increase Gallyas-positive deposits in the brainstem and neocortex 
9 months after intraperitoneal injections into asymptomatic heterozygous mice of the same 
genotype, albeit to a lesser extent than injections into the hippocampus (Clavaguera et al., 
2014). As with intracerebral injections, the mechanism of spreading remains to be 
elucidated.
1.3.2 Induction of Tau Aggregation by Expression of Mutated Tau
To study tau pathology, several mouse lines were generated expressing hTau carrying MAPT 
mutations that are associated with FTDP-17 such as G272V, P301L, P301S, V337M and 
R406W (Frank et al., 2008). In contrast to mice expressing wt hTau constructs, most of these 
mutant hTau-expressing lines spontaneously develop NFTs and NTs, and show neuronal cell 
loss which functionally manifests as motor and/or cognitive impairment. One mouse line that 
has been extensively studied in our group and was pivotal to the findings of Clavaguera et al. 
(Clavaguera et al., 2009) is the P301S hTau mouse model (Allen et al., 2002). These mice 
express the shortest 4R hTau isoform (0N4R, 383 aa) harboring the P301S mutation. The 
transgene expression is driven by the thy-1.2 promoter which is particularly active in the 
neurons  of  the  brainstem and spinal cord. Overexpressed P301S mutant hTau is 
hyperphosphorylated and localized in neuronal somata as well as in neurites. Silver-positive 
filamentous inclusions are found which ultrastructurally resemble PHFs of AD. Homozygous 
animals show a 49 % reduction of motor neurons in the spinal cord, leading to paraparesis, 
muscle weakness and tremor at 6 month of age. 
To recapitulate the distribution and appearance of tau aggregates in AD, several mouse 
models were generated with mutated hTau expression restricted to the entorhinal cortex 
(EC) (de Calignon et  al.,  2012;  Harris  et  al.,  2012;  Liu  et  al.,  2012). The degree of tau 
pathology, spreading, and neurodegeneration observed was highly variable. Gallyas-positive 
inclusions, neuronal and synaptic loss was observed by de Calignon et al. in the EC as well 
as hTau in the hippocampus in the absence of hTau mRNA, indicating a transport of hTau 
between neurons (de Calignon et al., 2012). Liu et al. reported silver-positive inclusions in 
EC and hTau and silver-positive inclusions in the hippocampus of aged mice without 
neuronal loss (Liu et  al.,  2012). Harris et al. stated expression of mutated hTau caused 
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Gallyas-positive inclusions in neurons of the hippocampus, and loss of presynaptic markers 
in aged mice in absence of cognitive impairment (Harris et al., 2012). The differences have in 
part been attributed to different genetic backgrounds of the mouse strains used and 
spreading of hTau was ascribed to leaky expression in regions other than EC. 
1.3.3 Templated Misfolding and Prion-like Properties of Tau
Human brain homogenate from various sporadic tauopathies including AD are also able to 
induce the aggregation of wt hTau expressed in mice (Clavaguera  et  al.,  2013). The 
aggregates that are formed in the injected mice resemble the disease specific aggregates 
and hence the existence of tau “conformers” or tau “strains” has been proposed to give rise 
to the clinical phenotype. The same study showed that the aggregation inducing seeds are 
stably transmitted over two generations. Wild type hTau-expressing mice developed Gallyas-
positive inclusions after injections with brain homogenates from either wt hTau-expressing 
mice injected with brain  homogenates  from  P301S hTau-expressing mice, or brain 
homogenates from wt mice, injected with brain homogenates from sporadic tauopathies. 
Different tau aggregation patterns or “conformations” were generated in vitro. HEK293 cells 
expressing hTau fragments consisting of the MT binding repeats develop aggregates after 
exposure to preformed fibrils. Distinct aggregation patterns can then be derived by clonal 
expansion (Sanders et al., 2014). Extracts from different clones were serially injected into the 
brain of mutant hTau-expressing mice for three generations and extracts from the last 
generation were incubated with naive cells. Remarkably, the biochemical and histological 
properties were conserved throughout all passages indicating these properties can be 
transmitted in a prion-like fashion. In addition, they used brain homogenates of human 
patients with various tauopathies and used them as seeds on naive cells. These seeds led to 
a variety of biochemical and morphological phenotypes that were distinct between the 
different tauopathies suggesting that each tauopathy harbours specific tau “strains” or 
“conformers”. Later, the same group generated even more distinct tau aggregating clones by 
seeding them with various preformed fibrils and used extracts from these distinct clones to 
inject them into the brain of mutant hTau-expressing mice (Kaufman et al.,  2016). These 
mice developed distinct tau pathology and most notably, show different rates of progression 
and regions affected as defined by abnormal phosphorylation.  However,  no 
neurodegeneration nor bona fide NFTs were reported. Lastly, fibrils form recombinant hTau 
induced by AD extracts are more potent to cause abnormal tau phosphorylation when 
injected in wt mice, compared to fibrils generated using heparin to induce aggregation again, 
arguing for distinct properties of tau “strains” (Guo et al., 2016).
1.3.4 Murine Tau
Apart from a delayed maturation of neurons in primary cell culture, mTau knockout mice do 
not show an obvious phenotype, possibly due to compensatory mechanisms and 
upregulation of MAP1A expression (Dawson et  al.,  2001;  Harada et  al.,  1994). There is 
considerable homology in the C-terminal half following exon 2 between mTau and hTau 
including the MT binding repeats which only differ by three amino acids. Murine tau is also 
able to form filaments in vitro (Kampers et al.,  1999). Filament assembly is promoted by 
hyperphosphorylation and the filaments resemble filaments composed of hTau (Chohan et 
al.,  2005). Nonetheless, mTau-expressing mice do not develop NFTs, not even under 
overexpression of endogenous mTau (Adams et al., 2009). 
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1.3.5 Surrogate Markers for Neurodegeneration
Since  the  discovery  of  hyperphosphorylated  tau  as  major  constituent  of  NFTs,  many 
phosphorylation dependent anti-tau antibodies were developed to study tau phosphorylation 
in situ, some of which are summarized in Table 1 and shown in Figure 1.
Antibody Epitope Reference Phosphorylation 
Dependent
Conformational
AT8 pSer202, pThr205 Goedert, 1995 yes no
AT100 pThr212, pSer214 Zheng-
Fischhoefer, 1998
yes induced by heparin
AT180 pThr231 Goedert, 1994 yes no
12E8 pSer262, pSer356 Seubert,  1995  & 
Litersky, 1996
yes no
Alz50 AA 7-9, 312–342 Jicha, 1997 NA yes
MC1 AA 7-9, 312–342 Jicha, 1997 NA yes
PHF-1 pSer396, pSer404 Otvos, 1994 yes no
Some anti-tau antibodies and their epitopes. Alz50 was raised against forebrain 
homogenate of human AD patients and MC1 was raised against PHFs immuno-
affinity purified using Alz50. Epitopes are numbered according to the longest hTau 
isoform 2N4R, NA: not assessed.
Although tau in NFTs is hyperphosphorylated and recognized by phosphorylation-dependent 
antibodies, presence of phosphorylated tau is neither sufficient to assume tau aggregation 
nor neurodegeneration. Aggregation of tau protein can only be demonstrated by biophysical 
means such as sequential extraction, Gallyas silver impregnation, and electron microscopy. 
Most tauopathy models expressing hTau lack essential regulatory elements which balance 
the  phosphorylation/dephosphorylation  in  the  human  brain.  In  absence  of  significant 
neurodegeneration  in  the  majority  of  wt  hTau  models,  authors  often  use  the  term  "tau 
pathology"  which  typically  refers  to  a  labelling  with  one  or  more  of  phosphorylation-
dependent antibodies. The effect of NFTs on neuronal function is not well understood, but 
NFTs  can  at  least  be  unambiguously  demonstrated  using  various  silver  impregnation 
methods  (Uchihara,  2007).  There  is  currently  no  consensus  on  the  definition  of 
neurodegeneration: some authors describe synaptic loss, while others use the term when 
potentially reversible functional impairments are observed. 
Instead of focusing on mimicking the biochemical or histological properties of tauopathies as 
surrogate markers for neurodegeneration, it may be more fertile to focus on the functional 
implications of tau expression in model systems.
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Table 1: Anti-Tau Antibodies and Epitopes
1.4 C. elegans as Model System for Tauopathies
1.4.1 Protein with Tau-like Repeats
So far, only one gene of C. elegans, is known which is similar to mammalian MAPT, and thus 
was named protein with tau-like repeats 1 (ptl-1) (Goedert et al., 1996). This gene is spliced 
to generate two isoforms, PTL-1A and PTL-1B, containing either  four or five repeats. The 
repeat domains of ptl-1 roughly share 50 % sequence homology with the repeat domains of 
human MAPT, but regions outside the repeats are unrelated. Both ptl-1 isoforms are 
expressed in five of the six touch neurons (ALML/R, AVM, PLML/R) and their neurites during 
larval stages as well as in adults. Null-mutants and deletion of the binding repeats of ptl-1 
show an accelerated appearance of structural abnormalities in the touch neurons, decreased 
drug sensitivity and a reduced lifespan (Chew et al.,  2013). Re-expression of wt hTau in 
these ptl-1 mutants does not rescue these phenotypes, suggesting hTau does not 
compensate for PTL-1's functions in worms. The overall MT structure in touch neurons is not 
disturbed in ptl-1 knock-out worms (Gordon et al., 2008), furthermore, touch response and 
habituation are similar to wt worms (Swierczek et al., 2011). PTL-1 was implicated in axonal 
transport through an interaction with UNC-104  since ptl-1 knock-outs show a more 
pronounced retrograde movement of UNC-104 (Tien et al., 2011). In summary, despite some 
similarities, ptl-1 and hTau may be considered distantly related proteins only.
1.4.2 C. elegans Models of Tauopathies
C. elegans does not express a protein with close homology to mammalian tau. Together with 
the relative simplicity of the worm's nervous system, consisting of only 302 neurons in adult 
hermaphrodites (White et  al.,  1986), compensatory effects are  less likely  than in  mouse 
models. This makes the nematode an ideal model to study potential toxic effects of tau and 
its mutant forms independently of its function in the nervous system. 
This section reviews a number of  hTau-expressing C. elegans strains with regard to the 
reported locomotion phenotype, structural appearance of hTau-expressing neurons, as well 
as biochemical properties. These aspects,  summarized in Table 2, have been addressed 
independently of the particular aims of the respective studies, facilitating comparison.
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The phenotypes are summarized with regard to locomotion, structural alterations and 
biochemical properties. Pan = pan-neuronal expression, Unc = uncoordinated 
locomotion, Gaps = discontinuities in neurites, PHP: pseudo hyperphosphorylated tau 
(Ser/Thr > Glu), NP: non-phosphorylated tau (Ser/Thr > Ala).
The first C. elegans model expressing hTau constructs was reported by Kraemer et al. in 
2003 (Kraemer et al., 2003). Three hTau constructs with different isoforms were generated: 
hTau (1N4R, wt), hTau (1N4R, P301L) and hTau (1N4R, V337M), all driven by the pan-
neuronal promoter of aex-3. Pharyngeal GFP expression, driven by myo-2p, was used as a 
selection marker and transgenes were genomically integrated.  All strains were reported to 
exhibit uncoordinated locomotion (unc), which increased over time until worms were almost 
paralyzed by day 9. These observations were made on small cohorts by manual scoring of a 
thrashing assay, counting the number of body bends in liquid over a defined period of time. 
The  data  demonstrate  a  lower  performance  of  all  transgenic  worms  relative  to  non-
transgenic wt controls. The thrashing rates for strains expressing hTau (1N4R, V337M) and 
hTau (1N4R, P301L) were lower than hTau (1N4R, wt). Sequential extraction (Ishihara et al., 
1999) of homogenized worms leads to high salt soluble, detergent soluble and detergent 
insoluble fractions. In 1-day old worms, hTau was only detectable in the high salt soluble 
fraction but high levels of detergent soluble and detergent insoluble hTau were detected in 
mixed age populations, indicating an increase of insoluble hTau over time. Furthermore, 
hTau was phosphorylated on seven probed sites, including AT8, 12E8, and PHF-1, most of 
which were found in high salt soluble and detergent soluble fractions. Using fluorescence 
microscopy, GABAergic neurons and their processes were examined and found to display 
gaps in the ventral and dorsal nerve cord as well as neuronal loss, both increasing with age. 
Axonal degeneration was also visible ultrastructurally and non-filamentous, tau-positive 
accumulations were observed. 
In 2005, Miyasaka et al. (Miyasaka et al., 2005) reported findings on a set of hTau lines with 
expression restricted to the touch neurons, driven by the promoter of  mec-7. The isoforms 
used  were:  hTau (0N3R, wt), hTau (0N4R, wt), hTau (0N4R, P301L), and  hTau (0N4R, 
R406W). A dominant behavioral marker,  rol-6(su1006) (Mello et al., 1991), was used as a 
selection marker leading to helically twisted bodies which precludes the study of locomotion. 
Despite this impairment, animals were scored for touch response and touch sensitivity was 
reported to be progressively declining in all hTau lines, with hTau (0N4R, P301L) and hTau 
(0N4R, R406W) lines performing worst: 20 - 40  % of all  assessed worms showed no 
response on day 5 after hatching. Immunohistochemistry (IHC) on freeze-cracked worms 
revealed loss of acetylated α-tubulin in PLMs with fewer tubulin positive PLMs detected with 
increasing age in hTau (0N4R, P301L) and hTau (0N4R, R406W), but not in hTau (0N4R, wt) 
expressing line. These neurons additionally  displayed abnormal morphologies in all  hTau 
lines, such as multiple processes emerging from a cell bodies as well as curvy and branched 
processes, again mutated hTau-expressing lines being more severely affected than wt hTau 
lines. Tau accumulation was reported based on IHC in freeze-cracked worms, and abnormal 
processes were also observed in absence of hTau labelling. Ultrastructurally, hTau-
expressing worms showed thinner or missing MTs in PLMs but no sign of filamentous tau. 
Solubility was not assessed, as the amount of hTau that is expressed by the touch neurons 
would probably lie below the detection level in whole worm protein extracts.
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Brandt et al. generated hTau constructs based on an  N-terminally FLAG-tagged 0N3R 
isoform with the wt sequence or as pseudo hyperphosphorylated tau (PHP) in which some of 
the Ser/Thr residues (S198, S199, S202, T231, S235, S396, S404, S409, and S413)  are 
substituted with Glu to reflect the charge distribution that would be carried by the phosphate 
groups (Brandt  et al.,  2009). These constructs were pan-neuronally expressed under the 
rgef-1 promoter. Transgenes were expressed in pha-1(e2123) mutants, along with a wt copy 
of  PHA-1 to rescue the otherwise embryonic  lethal  mutation at  25 °C. Hence,  the hTau 
expression  in  individual  worms  of  the  same  genotype  can  vary  due  to  non-mendelian 
inheritance of the extrachromosomal transgene. A cohort of worms was scored daily for the 
unc  phenotype. Locomotion became increasingly uncoordinated with 50  % of the non-
transgenic population becoming uncoordinated by adult day 10 with day 0 defined as larval 
stage L4, while both hTau (0N3R, PHP) and hTau (0N3R, wt) expressing lines became unc 
on day 8. In a thrashing assay, worms performed progressively worse, with the hTau-
expressing lines showing a decreased thrashing rate compared to non-transgenic worms. 
Furthermore, inhibitory motoneurons of living, anaesthetized animals were analysed using 
GFP expression driven by the  unc-47 promoter.  The number of motoneurons on day 1, 3, 
and 6 of old worms did not differ between hTau and non-transgenic worms but the number of 
worms with at least one gap in the dorsal nerve cord was between 60-80 % in hTau (0N3R, 
PHP)  expressing worms whereas less than 20 % of the hTau (0N3R, wt) and non-transgenic 
worms showed any gaps. Similarly, broadening of axons of motoneurons was more frequent 
in the hTau (0N3R, PHP) line compared to hTau (0N3R, wt) or non-transgenic worms. With 
age, hTau (0N3R, PHP) expressing worms accumulated more hTau in the detergent soluble 
fraction compared to hTau (0N3R, wt) line as demonstrated by sequential  extraction and 
western  blotting. Lastly, they repeated their experiments with a another hTau construct 
where the same Ser/Thr residues as in hTau (0N3R, PHP) are replaced with Ala, mimicking 
a non-phosphorylated (NP) hTau protein. This line performed worse than hTau (0N3R,  wt) 
and hTau  (0N3R,  PHP)  expressing worms in the thrashing assay, but showed fewer 
morphological neuronal alterations. There was no detergent insoluble nor Sarkosyl insoluble 
hTau detectable in any of the lines.
Fatouros et al. (Fatouros et al., 2012) expressed a fragment of hTau containing the four MT 
binding repeats (fragment F3, AA 258-360) and incorporated the deletion mutation ΔK280, 
yielding the F3(ΔK280) pro-aggregating construct. A second construct was created with the 
F3 fragment containing two additional mutations (I277P, I308P) which results in the 
F3(ΔK280,  277P,  I308P) anti-aggregating construct.  Both constructs were  genomically 
integrated and are pan-neuronally expressed under the rab-3 promoter. Since pro- and anti-
aggregating lines were similar in their locomotion phenotype, all lines were crossed with 
CK10, a strain previously created  (Kraemer et al., 2003), pan-neuronally expressing hTau 
(1N4R, V337M). The crossed pro-aggregating lines exhibit a strong unc phenotype and a 
more reduced locomotion speed while the anti-aggregating lines showed no unc phenotype 
and  a less reduced locomotion speed on adult day 1. The morphology of GABAergic 
neurons was followed throughout development and adulthood and the number of gaps 
counted in analogy to earlier reports  (Kraemer et al., 2003). For each line, the number of 
gaps decreased during larval development and increased during adulthood. The pro-
aggregating line shows significantly more gaps than the control and the anti-aggregating 
lines. Three times more worms of the pro-aggregating lines showed gaps in cholinergic 
neurites  compared to the reporter and anti-aggregating line. Thioflavin-S-positive speckles 
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were observed around the nerve ring in pro-aggregating, but not in the anti-aggregating 
lines. In 1 day old adults, only the pro-aggregating lines showed detergent soluble and 
detergent insoluble hTau in sequential extracts, whereas CK10 and anti-aggregating lines 
only showed hTau bands in the high salt soluble fractions. In 7 day old adults, all lines 
showed detergent soluble and insoluble hTau, but the amount was increased in the pro-
aggregating lines by 4- and 8-fold compared to CK10. 
Xie et al. (Xie et al., 2014) published work on lines expressing full length hTau (0N4R, wt), 
hTau (0N3R, wt) and fragments consisting of the N-terminal half without MT binding repeats 
hTau (0N AA 1-192, wt) and the carboxyl terminally half containing 3 or 4 MT binding 
repeats, hTau (3R AA 193-352 , wt) and hTau (4R AA 193-383, wt), all of which were N-
terminally tagged with a fragment of UNC-119 and pan-neuronally expressed under the unc-
119 promoter. Day 1 adults of each lines were scored for unc phenotype. High expression of 
hTau (0N4R, wt) leads to ~76 % of the worm population being unc, but low expression only 
cause ~6  % unc worms. Furthermore, hTau  (0N3R,  wt) expression did not cause unc 
although expression levels were comparable to hTau  (0N4R,  wt). Almost all worms 
expressing hTau (4R, wt) fragments at low levels were unc, while hTau (0N, wt) and hTau 
(3R,  wt)  fragment expression did not lead to an unc phenotype. Morphologically, hTau 
(0N3R,  wt)   and hTau  (0N4R,  wt) expressing worms did not show any gaps but their 
processes appeared kinked. The number of kinks per unit length increased with age and was 
always higher in hTau  (0N4R,  wt) worms. The hTau expressed in the worms was 
phosphorylated as detected by size difference on western blots after phosphatase treatment.
In 2016, Miyasaka et al. (Miyasaka et al., 2016) used the strains listed above (Xie et al., 
2014), namely N-terminally UNC-119-tagged hTau (0N4R, wt), hTau (0N3R, wt), and the 
carboxyl terminal fragment containing 4 MT binding repeats hTau (4R AA 193-383, wt). In 
addition, they generated lines with FTDP-17 mutations, hTau (0N4R, R406W) and hTau 
(0N4R, P301L). All constructs were expressed pan-neuronally under the unc-119 promoter. 
Again, these worm lines were subjected to a behavioral analysis by scoring them for unc 
phenotype according to the motion pattern by an observer and more quantitatively by a 
thrashing assay. The lines with high expression of hTau (0N4R, wt) and hTau (0N4R, P301L) 
were most affected while the appearance of unc phenotype was moderate in hTau (0N3R, 
wt) and hTau (0N4R, R406W) on day 2 after hatching. The number of worms affected by the 
unc phenotype increased on day 5 after hatching, and remained most severe in the high 
expressing hTau (0N4R, wt) line. The thrashing assay was performed two and five days after 
hatching and the performance significantly decreased between the two timepoints in high 
expressing hTau (0N4R, wt), hTau (0N4R, R406W) and hTau (0N4R, P301L) lines. Neuritic 
abnormalities were observed in all hTau-expressing lines with neurites showing kinks and 
protrusions. The number of worms affected by abnormalities increased with age from 80 % 
to almost 100 % in the hTau (0N4R, wt) high expressing line, and it increased in all lines 
between day 5 and day 10 after hatching and further increased in all lines except in hTau 
(0N4R, R406W), where the number of worms affected by kinks decreased between day 10 
and day 20. The authors report that kinking and protrusions increase in individual worms 
leading to fragmentation. Unfortunately, this data is not shown in the publication. IHC on 
paraffin sections revealed more intense labelling for hTau at the bends of the kinks but no 
NFTs and a loss of microtubules in the kinked neurites. All phosphorylation dependent 
antibodies (including AT8 and AT100) were positive in all hTau-expressing lines and an 
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improved protocol of sequential extraction revealed high salt soluble and traces of detergent 
soluble, but no detergent insoluble hTau 18 days after hatching. 
Lastly in 2016, Pir et al. (Pir et al., 2016) published findings on constructs hTau (2N4R, wt) 
and hTau (2N4R, A152T), pan-neuronally expressed under the  snb-1 promoter. While the 
expression of hTau (2N4R, wt) led to a mild, dose-dependent unc phenotype, day 1 adults of 
hTau (2N4R, A152T) expressing lines were strongly paralytic and were not able to propel 
their bodies. This was reflected in a thrashing assay, were day 1 adults of hTau (2N4R, wt) 
lines showed 30 and 20 thrashes in 30s, while the hTau (2N4R, A152T) lines only showed 2 
thrashes in the same period of time.
GFP expression in the GABAergic neurons of day 1 adults revealed gaps in the ventral 
nerve cord of hTau (2N4R, wt) lines, which were more severe in the high expressing line. 
hTau (2N4R, A152T) lines showed more severe gaps in the ventral and dorsal nerve cord, 
with longer stretches of either cord missing. More gross morphological abnormalities were 
reported in touch neurons. Branching and bending of the neural processes was prevalent in 
hTau (2N4R, A152T) expressing lines and less frequent in hTau (2N4R, wt) expressing lines, 
the proportion of animals affected by these aberrations increases between 1 day and 5 day 
old adults. Interestingly, the most severely affected line was the low expressing hTau (2N4R, 
A152T) line. High salt soluble, and detergent soluble, but no detergent insoluble hTau could 
be detected by sequential extraction and western blotting in all lines except the control line 
CK10 by Kraemer et al. which also showed a detergent insoluble hTau band on a population 
of mixed stage animals. Additional experiments were performed with non-integrated 
constructs of full-length hTau harbouring A152T mutation as well as the “anti-aggregation” 
mutations I277P and I308P used by Fatouros et al. and described above. These worms 
showed the same unc phenotype and a poor performance in the thrashing assay, 
comparable with the non-integrated worms solely harbouring the A152T mutation and 
significantly worse than the wt hTau-expressing worms. Tau fragments of the N-terminal half 
without the MT binding repeats (AA 1-243) harbouring the A152T or as wt construct did not 
cause an obvious phenotype and performed equally well. 
1.4.3 Quantifying Locomotion
Since the phenotype “uncoordinated locomotion” is not well defined, observer independent 
methods of locomotion quantification should be employed. While thrashing assays (Keith et 
al.,  2014) are more objective, they are nonetheless carried out by an experimenter.  This 
makes observations on a large number of  worms tedious and error  prone.  To overcome 
observer  bias,  automated  systems  were  developed  to  analyse  thrashing  assays  using 
computer-vision based approaches  (Buckingham and Sattelle,  2009; Restif  and Metaxas, 
2008; Tsechpenakis et al., 2008) or using spectroscopic systems (Simonetta and Golombek, 
2007).
To study the locomotion on solid media, many (semi-)automated systems were developed, 
known  as  worm  trackers  (Husson,  2012).  Worm  trackers  can  be  grouped  into  three 
categories:  (1)  differentiation  of  worm  behaviour  and  measuring  the  duration  of  each 
behaviour, such as crawling, egg laying or resting, (2) analysis of a specific behaviour such 
as  locomotion  and  e.g.  measuring  velocity,  bending  angles,  and  reversals  or  (3)  a 
combination  of  (1)  and  (2)  to  parametrize  the  entire  worm behaviour  (Buckingham and 
Sattelle,  2008). To measure the locomotor performance of an individual worm over time, 
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some requirements have to be met: worms need to be identifiable throughout the assay and 
the method should allow for a reasonable number of worms to be assessed per experiment. 
The first requirement excludes all methods which gain their throughput by having multiple 
worms per plate, since the individual worms can not be labelled. The need for a reasonable 
throughput implies no manual interventions between measurements. Hence, worms need to 
be kept and imaged on seeded plates, and the tracking algorithm is required to work robustly 
under  variable  imaging  conditions.  Since  more  advanced  worm  trackers  analyse  worm 
behaviour  by  segmenting  the  worm  from the  background,  these  algorithms can  not  be 
employed using seeded plates, where illumination changes with the location of the worm, 
such as within and outside the of bacterial lawn, or, at its edge. To fit all those needs, we 
developed a novel type of worm tracker. This system, termed RAPID, is discussed in the 
next  sectionManuscript:  RAPID  -  High-throughput  standardized  health  modelling  in  C.
elegans. 
1.5 Summary
Much effort has been put into research of tau and tauopathies, since tau was discovered to 
be the main constituent of paired helical filaments of Alzheimer’s disease more than 30 years 
ago. A clear link between tau and neurodegeneration was established with the discovery of 
MAPT mutations in FTDP-17. This has enabled the creation of model systems recapitulating 
some of the histological hallmarks of tauopathies including NFTs and neurodegeneration. Yet 
the fundamental questions remain: How does tau form aggregates? How does tau mediate 
neurodegeneration  and  are  these  two  processes  causally  linked?  Moreover,  is 
neurodegeneration caused by a loss of function of tau or does tau exert a direct toxic effect? 
If so, what is the neurotoxic species and how does it arise? All these questions are a matter  
of  debate  and  no  pathomechanism  for  tau-mediated  neurodegeneration  has  been 
established.  C. elegans has been used to study the effects of wild type and mutated hTau 
expression  in  neurons  by  several  groups.  The  reported phenotypes  vary regarding 
locomotion, structural aberrations and biochemical properties of tau. Some of the 
discrepancies may be attributed to the different hTau isoforms,  promoters and expression 
levels. Unfortunately, most of the locomotion phenotypes and the classification of unc were 
based on arbitrary definitions and scored by an observer.
1.6 Aim of this Work
In  this  work,  we  intended  to  replicate  a  reported  model  of  tauopathy  and  assess  the 
immunohistochemical  and  functional  changes  induced  by  expression  of  wild  type  and 
mutated hTau in neurons of C. elegans using histology and worm-tracking.
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2 Material and Methods
2.1 Plasmid Construction and Generation of Transgenic Worm 
Lines
Constructs were created by fusion PCR (Hobert, 2002), all primers (Microsynth AG, Balgach, 
Switzerland) and primer pairs used are listed in Table 22 and Table 23. Genomic C. elegans 
DNA was  extracted  by  single  worm  lysis  using  proteinase  K  digestion  as  described  in 
(Ahringer, 2006). Genomic DNA from N2 was used as template to amplify 1.3 kb upstream of 
aex-3,  0.7 kb upstream of  mec-7 and 2.2 kb downstream of  unc-86.  Genomic DNA from 
OH4134 was used to amplify gfp and dsRed2. cDNA of wild type hTau (isoform 1N4R) was 
amplified from pRK172 1N4R plasmid (generous gift  from M. Goedert,  MRC Cambridge, 
UK). Tau harbouring the V337M mutation was generated from the same plasmid using two 
sets of primers containing the mutated sequence. All fragments were amplified using a taq 
polymerase (PCR Extender  System, 5 Prime GmbH, Hilden,  Germany)  according to the 
manufacturer's protocol. After each amplification, PCR fragments were separated on an 0.8 
% (w/v) agarose gel, corresponding band excised and extracted (QIAquick Gel Extraction 
Kit,  QIAGEN  Inc.,  CA,  USA).  Once  the  individual  fragments  were  combined  into  full 
transgenes, the PCR products were ligated into the pCR 2.1-TOPO TA vector (TOPO® TA 
Cloning® Kit,  Thermo Fisher  Scientific  Schweiz AG,  Reinach,  Switzerland) and plasmids 
transformed into  chemically  competent  E.  coli (One  Shot® Mach1™-T1,  Thermo Fisher 
Scientific Schweiz AG, Reinach, Switzerland).
aex-3p::hTau(1N4R, V337)::unc-86UTR and  aex-3p::hTau(1N4R, P301S)::unc-86UTR were 
created  by  mutation  PCR  from  aex-3p::hTau(1N4R,  wt)::unc-86UTR by  site-directed 
mutagenesis  following  the  Stratagene's  Quick-Change™  protocol 
(http://sevierlab.vet.cornell.edu/resources/Stratagene-QuikchangeManual.pdf)  using  a 
Phusion DNA polymerase (Phusion High-Fidelity PCR Kit, Thermo Fisher Scientific Schweiz 
AG,  Reinach,  Switzerland)  and  Dpn  I (Thermo  Fisher  Scientific  Schweiz  AG,  Reinach, 
Switzerland). Plasmids were transformed in chemically competetent E. coli Dh5  (generousɑ  
gift from Johannes Thoma, D-BSSE ETH Zürich, Switzerland).
Transformed E. coli were plated onto LB agar plates containing 50 µg/ml (w/v) ampicillin, as 
well as IPTG and X-Gal and grown at 37 °C overnight. The next day, 10-15 white colonies 
were picked from each transformed construct and PCR reactions were performed to check 
for the presence of the desired construct. Several clones were selected, grown in 10 ml LB, 
plasmids  extracted  using  alkaline  lysis  as  described  here: 
https://msu.edu/course/css/451/LabProtocols/Plasmid%20Isolation%20Using%20Alkaline
%20Lysis%20%28Exp%203,%20CSS451%29.pdf. All plasmids were sanger sequenced and 
checked for unintended alterations before they were injected.
Plasmids  were  co-injected  into  N2  young  adults  as  described  in  (Evans,  2006) in  the 
following  combinations  mec-7p::hTau(1N4R,  V337)::unc-86UTR +  mec-7p::dsRed2::unc-
86UTR and  aex-3p::hTau(1N4R,  wt)::unc-86UTR +  aex-3p::gfp::unc-86UTR at 
concentrations of 80-100 ng/µl in dH2O each. DsRed2/GFP served as injection marker and 
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positive F1 were isolated, cultivated and kept once transmission of injection marker to F2 
was observed. Non-integrated transgenic lines were synchronized by hypochlorite treatment 
as described in section “Paraffin Embedding and Histology” and then subjected to 40 Gy 
irradiation from a Cs 137 gamma ray source (IBL 437C, Cisbio Bioassays, Codolet, France) 
once the majority has reached the L4 stage. 5 irradiated L4 were picked on each of 20 100 
mm NGM plates seeded with OP50 and grown at 20 °C for 14 days. A small chunk of each 
plate was then transferred to a 60 mm seeded NGM plate and grown another 5 days. 20 
worms of  each of  the 20 60 mm plates were then picked and put  on individual  35 mm 
seeded  NGM  plates  resulting  in  400  individual  worms.  After  1  week,  the  plates  were 
screened for fluorescent protein expression, in case of 100 % penetrance in progeny, the 
transgene has integrated into the genome. Stable lines were crossed 5 x with N2 males.
Outcrossed  lines  were  then  crossed  with  SS104  males  at  15  °C.  Heterozygous  F1 
hermaphrodites  were  singled,  and  homozygous  F2  were  then  singles  once  again.  After 
singled F2 started to lay eggs, the plate was cut in two parts and one part was shifted to 25 
°C while the remaining part was kept at 15 °C. In case of 100 % sterile F3 on the plates at 25 
°C, the cross was complete and the line was continued from the corresponding plate kept at 
15 °C.
2.2 Worm Line Maintenance and Preparation for RAPID Assay
2.2.1 Worm Line Maintenance
The following worm strains were provided by the Caenorhabditis Genetics Center (CGC, 
funded by NIH Office of Research Infrastructure Programs P40 OD010440):
N2, OH4134, SS104, and the E. coli strain OP50.
Worms were cultivated as described in (Stiernagle, 2006) with the following exceptions: M9 
buffer  was prepared  using  2  g  instead  of  6  g  Na2HPO4 and worms were frozen  in  M9 
containing 15 % (v/v) of 87 % glycerol which was sterilized by autoclaving.
Worms were grown on 35 mm NGM agar plates filled with 3.5 ml NGM agar without additives 
and  seeded  the  next  day  with  150  µl  overnight  culture  of  OP50  grown  in  LB  without 
antibiotics. Furthermore, OP50 cultures were grown in 1 L LB overnight at room temperature 
by adding 200 µl starter culture from an overnight culture grown in LB containing 50 µg/ml 
ampicillin. OP50 were then pelleted by centrifugation at 2’500 rcf for 30 min and kept at -20 
°C until use. To add additional OP50 to worm cultures, pellets were thawed, resuspended in 
equal amounts M9 and distributed in drops of 200 µl onto the plates. All  chemicals were 
obtained from Sigma-Aldrich (Sigma-Aldrich Chemie GmbH Buchs, Switzerland).
Lines harbouring the glp-4(bn2) allele were kept in temperature controlled incubators at 15 
°C for cultivation or at room temperature to induce sterility. Other lines were grown at 20 °C 
in temperature controlled incubators.
2.2.2 Preparation of Worms for RAPID Assay
Before an assay was run, worm strains were grown as described above at 15 °C on 35 mm 
NGM plates seeded with OP50. To synchronize worms, 10 - 15 gravid hermaphrodites were 
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picked on seeded NGM plates and allowed to lay eggs for 4 - 8 h at RT, after which the 
adults were removed. The next day, hatched larvae (L1/L2) were singled on individual 35 
mm NGM agar plates, seeded with 15 µL overnight culture of OP50 seeded the day before. 
Then the plates were labelled, sealed and put on the RAPID assay as described in  Worm
strain maintenance and preparation for RAPID assay. The time of the egg lay plus half the 
time of the egg lay duration was defined as date of birth for a given strain. Usually, four 
strains were prepared in parallel with 70 worms per strain and a total of 280 worms per run. 
2.3 Paraffin Embedding and Histology
2.3.1 Generation of Worm Blocks
A large number of synchronized worms was obtained by hypochlorite treatment, modified 
from  http://groups.molbiosci.northwestern.edu/morimoto/research/Protocols/IX.%20C.
%20elegans/A.%20General/3.%20Bleaching%20Protocol.pdf.
A starter culture of worms were washed off of a single plate with ~0.5 ml M9 using a plastic  
pasteur pipette and distributed on 14 35 mm NGM plates seeded with OP50. The worms 
were grown either at 20 °C or in case of glp-4(bn2) carrying strains at 15 °C. If the bacteria 
were depleted before the majority of worms contained eggs, concentrated OP50 was added. 
Once the majority of worms developed into gravid hermaphrodites, worms were collected in 
a 15 ml conical tube by washing off the plates with M9.
Worms  were  pelleted  for  5  min  at  1.5  rcf  and  supernatant  discarded.  The  pellet  was 
resuspended in 7.5 ml  of  hypochlorite  solution (8.25 ml dH2O, 3.75 ml 1M NaOH, 3 ml 
sodium  hypochlorite  6-14  %  active  chlorine,  Sigma-Aldrich  Chemie  GmbH  Buchs, 
Switzerland) through vortexing. As soon as most of the worms dissolved or cracked open, 
the  suspension  was  gravity  filtered  through  a  100  µm mesh (CELLSTAR EASYstrainer, 
Greiner Bio-One GmbH, Frickenhausen, Germany) into a 50 ml conical tube filled with 35 ml 
M9. The tube was topped up with M9 and spun down 5 min at 1.5 rcf. The pellet was then 
resuspended in M9 and transferred to a 15 ml conical tube and spun down 5 min at 1.5 rcf,  
this step was repeated 2 more times. The embryos were incubated for 24 h on a rotating 
wheel in the dark at room temperature. Afterwards, the hatched worms were centrifuged 5 
min at 1.5 rcf and supernatant was removed leaving 0.5 ml M9 and the worms in the tube. 
The worms were resuspended in the remaining liquid and evenly dispensed on 21 35mm 
OP50 seeded NGM plates. 72 h after transfer, the worms were collected in a 15 ml conical 
tube in M9 and pelleted 5 min at 1.5 rcf. The pellet was resuspended in 10 ml 10 % (v/v)  
histological  grade  formaldehyde  in  phosphate  buffer  pH 7.4  (Spitalpharmazie,  University 
Hospital Basel), transferred to 15 ml glass centrifuge tubes and fixed for 1h at 60 °C. The 
fixed worms were spun down 3 min at 3 rcf and resuspended in M9, 3 times to wash off any 
formaldehyde. If the pellet was larger than 300 µl in volume, the pellet was resuspended and 
half of it was put in a second tube, then spun down 3 min at 3 rcf. 200 µl of human blood 
plasma  (donor  plasma  after  expiration  date  from  the  Blutspendezentrum  Basel,  also 
available from Sigma-Aldrich Chemie GmbH Buchs, Switzerland). 50 µm of thrombin from 
bovine plasma (T4648, Sigma-Aldrich Chemie GmbH Buchs, Switzerland) was added using 
a cut off pipette tip to decrease shearing and well mixed by pipetting up and down. After 30 s, 
when the coagulation was complete, 10 ml of 10 % (v/v) histological grade formaldehyde in 
phosphate  buffer  pH  7.4  (Spitalpharmazie,  University  Hospital  Basel)  was  added  and 
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incubated for 1h at 60 °C. Fixed thrombi were then placed in histology cassettes (Tissue-
Loc™  HistoScreen™  Cassettes,  Thermo  Fisher  Scientific  Schweiz  AG,  Reinach, 
Switzerland), dehydrated in an ascending series of EtOH/water solutions, followed by xylene 
and paraffin (Surgipath Paraplast®, Leica Biosystems Nussloch GmbH, Nussloch, Germany) 
embedded in an automated tissue processor (TPC 15 Duo, Medite Service AG, Dietikon, 
Switzerland) according to surgical pathology procedures. Finally, the worm block was taken 
from the molten paraffin, transferred to an embedding mold and embedded in paraffin. 4 µm 
sections  of  these  worm  blocks  were  cut  using  a  microtome  (Leica  SM2000R,  Leica 
Biosystems Nussloch GmbH, Nussloch, Germany), stretched on a hot water bath (Tissue 
Flotation Bath TFB 45,  Medite Service  AG,  Dietikon,  Switzerland)  mounted on positively 
charged microscopy glass slides (SuperFrost® Plus, Thermo Fisher Scientific Schweiz AG, 
Reinach,  Switzerland)  and  dried  overnight  at  37  °C  and  stored  for  later  use  in 
immunohistochemistry.
2.3.2 Hematoxylin and Eosin Staining
Paraffin  sections  were  deparaffinized  in  xylene  and  rehydrated  through  a  series  of 
EtOH/water  solutions  from  100  %,  96  %,  80  %,  and  70  %  (v/v),  followed  by  dH2O, 
submerging the sections for 5 min each step. Rehydrated sections are stained with Harris’ 
hematoxylin  (J.T.  Baker,  Biosystems  Switzerland  AG,  Muttenz,  Switzerland),  for  5  min, 
washed twice in dH2O and differentiated in 0.2 % HCl in (v/v) diluted in 70 % ethanol (v/v). 
Sections are stained in 1 % (w/v) Erythrosin B (RAL DIAGNOSTICS, Biosystems Switzerland 
AG,  Muttenz,  Switzerland),  a  stain  closely  resembling  eosin  Y,  washed  in  dH2O  and 
dehydrated through an ascending series of EtOH water solutions, form 70 %, 80 %, 100 % 
(v/v),  followed  by  xylene.  Sections  are  mounted  using  Pertex  (Histolab  Products  AB, 
Biosystems Switzerland AG, Muttenz, Switzerland). 
2.3.3 Gallyas Silver Impregnation
Sections are deparaffinized and rehydrated as described above. Sections are incubated in 3 
% periodic acid (w/v) for 30 min, rinsed in dH2O, followed by alkaline silver solution (1 M 
NaOH, 0.6 M KI, 2 mM AgNO3) for 10 min. Sections are developed by mixing developer 
solution  1  (0.5  M  Na2CO3),  solution  2  (24  mM  NH4NO3,  12  mM  AgNO3,  3.5  mM 
H4[Si(W3O10)4]), and solution 3 (24 mM NH4NO3, 12 mM AgNO3, 3.5 mM H4[Si(W3O10)4], 3 % 
formaldehyde) in a ratio of  30:9:21 immediately before use,  for  5-10 min (depending on 
desired staining intensity). Developing is stopped using 0.5 % acetic acid (v/v) for 30 min and 
fixed using 5 % Na2S2O3 (w/v) for 3 min. The sections are rinsed in dH2O, counterstained 
using  hematoxylin,  differentiated,  dehydrated,  and  embedded  as  described  above.  The 
Gallyas silver impregnation was automated using a modified rotary autostainer (Shandon 
Varistain  24-3,  discontinued)  equipped  with  three  bottles  and  three  pumps  to  mix  the 
developer solutions right before use, see Figure 2.
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Figure  2:  Modified  Autostainer  for  Gallyas  Silver  
Impregnation
Modified autostainer used to perform Gallyas silver impregnation for optimal 
reproducibility. A basket holding the slides is attached to the lid, which can be raised 
and rotated to transfer the slides from one container to the next. The developer 
solutions are stored separately and pumped in one of the containers to mix them right 
before immersion of the slides (bottles on the left).
2.3.4 Immunohistochemistry
All immunohistochemical labellings were performed using an automated IHC slide staining 
system (Ventana, BenchMark XT, Ventana Medical Systems, USA) using the manufacturer's 
protocol and reagents. Antibodies, dilutions and pretreatments used are listed in Table 3. 
Antibody Clone Source Retrieval Dilution
HT7 MN1000 Invitrogen CC1 24 1:500
AT8 MN1020 Invitrogen CC1 24 1:4'000
AT100 MN1060 Invitrogen CC1 24 1:800
anti-GFP
ab290 
(polyclonal) Abcam CC1 24 1:16'000
Antibodies and dilutions used throughout this work. Heat-mediated antigen retrieval 
was performed according to the manufacturer’s protocol for 24 min using “Cell 
Conditioning 1” solution (Ventana, Ventana Medical Systems, USA). 
All labellings were carried out in duplicate, each time using appropriate positive and negative 
controls. IHC labelling were assessed by two researchers in a blinded fashion to genotype 
and strain. Tau expression was compared to the positive control which served as a reference 
for labelling intensities. Images were recorded using a digital camera mounted to an upright 
microscope  (Olympus  DP73  +  Olympus  BX43,  Olympus  Schweiz  AG,  Volketswil, 
Switzerland) using fixed exposure and fixed illumination settings  for  images that  are 
shown in the same panel. 
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Table 3: Antibodies and Protocols
2.3.5 Resin Embedding
1 mm3 cubes of tissue or a pellet of worms were fixed in 3 % glutaraldehyde in PBS (v/v) for 
2 h at 4 °C, rinsed two time in PBS and postfixed in 1 % OsO4 in PBS (w/v) for 2 h at 4 °C. 
OsO4 was removed and the tissue was dehydrated in an ascending series of EtOH of 70 %, 
80 %, 96 % and 100 % for two times 15 min each and finally 100 % acetone two times for 30 
min. The acetone was removed and the tissue was incubated in a 1:1 mix of acetone and 
Durcupan™ (44610-1EA, Sigma-Aldrich Chemie GmbH Buchs, Switzerland) for 3 h followed 
by a 1:3 mix of acetone and Durcupan™ overnight. The next day, the tissue was embedded 
in  Durcupan™ and cured at  60 °C for  two days.  The blocks  were trimmed to size and 
sectioned on an ultramicrotome (Reichert Ultracut S, Leica Wien, Austria) using a glass knife 
for sections between 0.5 - 1 µm or using a diamond knife for ultrathin sections between 100 - 
200 nm. Ultrathin sections were negatively stained in 4 % uranyl acetate (w/v) in 50 % EtOH 
(v/v).  The resin of semithin sections can be removed by immersion of sections in a saturated 
solution of KOH in EtOH for 15 min washed in absolute EtOH, hydrated in a descending 
series of EtOH and processed the same way as paraffin sections. 
2.3.6 Statistical Evaluation of RAPID Data
RAPID data was evaluated as described in  Modelling and statistical tests including model 
selection. Data from 8 runs were combined and compared against the reference (SS104 
pooled from run 2 and 9). The follwing formulae were used in R to fit the models with the lme 
function of the nlme package:
model1 <- lme(afterArea ~ days*genotype + I(days^2) + temperatureTable, 
random=~days|setID/groupID/sampleID, data = trackDataCollector_day3, 
corCAR1(form = ~days|setID/groupID/sampleID), method = "REML", na.action = 
na.omit)
model2 <- lme(afterArea ~ days*HT7 + I(days^2) + genotype + temperatureTable, 
random=~days|setID/groupID/sampleID, data = trackDataCollector_day3, 
correlation = corCAR1(form = ~days|setID/groupID/sampleID), method = "REML", 
na.action = na.omit)
The structure of the R data frame trackDataCollector_day3 is shown in Table 25. 
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3 Results
As  discussed  in  section  “C.  elegans  Models  of  Tauopathies“,  the  phenotypes  of  hTau 
expression  in  C.  elegans neurons  were  often  qualitatively  described  as  uncoordinated 
locomotion and only  a small  number of  animals were assessed by conducting thrashing 
assays. To study the progression rate of a phenotype, longitudinal measurements would be 
preferable over cross-sectional measurements.  Since existing worm-tracking solutions do 
not pair high throughput with longitudinal data acquisition, we developed the Robot-Assisted 
Plate Imaging Device (RAPID).  As a proof  of  principle experiment for  the capabilities of 
RAPID,  we  assessed  the  stimulated  locomotor  performance  of  10  different  C.  elegans 
strains, some of which were reported to have locomotor phenotypes. Since RAPID is not 
limited to the study of neurodegeneration, we evaluated our novel method with focus on 
quantitative and qualitative assessment of physiological and pathological ageing, a topic of 
particular impact when studying effects of life-prolonging interventions in  C. elegans.  The 
results from this set of experiments and a detailed description of the hard- and software 
components of RAPID were compiled in a manuscript which was submitted to Neurobiology 
of Aging on 17.07.2017 and a request for revisions was received on 21.10.2017. Hence, the 
manuscript is included in this work in its originally submitted form and the major points to be 
revised are discussed in section “Reviewer Comments on RAPID Manuscript“. 
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3.1.3 Abstract
As one of  the  most  widely  used animal  models  of  ageing,  the nematode  C. elegans is 
increasingly employed to differentiate “healthy ageing” from chronological lifespan extension. 
However, most worm tracker-based ageing assays are unsuited to assess health. Here, we 
report  on the development of  RAPID, an automated high-throughput  platform for  lifelong 
individual  worm  recordings,  which  allows  to  assay  responses  to  standardized,  non-
destructive vibratory stimuli as health readout. Significantly, a comparative analysis of wild 
type and nine genetically modified C. elegans strains revealed superior overall health of wild 
type  worms,  even  when  compared  to  long-lived  strains.  Thus,  implying  that  lifespan 
extension may not be of advantage when occurring at the expense of decreased overall 
health, our observation is highly relevant to animal model-based gerontology research.
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3.1.4 Introduction
C. elegans lifespan has long been known to be influenced by environmental factors such as 
temperature and food availability (Klass, 1977). In addition, single gene mutations in age-1 
(Friedman and Johnson, 1988) and  daf-2  (Kenyon et al., 1993) drastically extend lifespan 
under laboratory conditions. With the realisation that lifespan can be actively modulated, C. 
elegans has  become  an  important  model  system  to  dissect  the  genetics  of  longevity 
(Kenyon, 2010). However, the parameter “lifespan” does not qualitatively describe the ageing 
process. In particular, in many instances, extending lifespan does not increase healthspan, 
i.e. the amount of time spent in good health, prior to the onset of age-associated decline in 
bodily functions. Therefore, increasing lifespan per se is not necessarily useful if ultimately 
intended  to  extend  healthspan  in  humans.  Currently,  there  are  no  widely  accepted 
healthspan-defining  parameters  in  model  systems,  as  it  has  been  difficult  to  identify 
appropriate biomarkers which could translate to humans (Tatar, 2009). Decline in human gait 
speed is a robust predictor of human mortality (White et al.,  2012). Likewise,  C. elegans 
exhibits decreased motility with age (Croll et al., 1977; Bolanowski et al., 1981) possibly due 
to muscle frailty (Glenn et al., 2004) and functional decline in motoneuron activity (Liu et al., 
2013). Whereas early work measuring motility to predict lifespan had led to inconclusive data 
(Bolanowski et al., 1981; Johnson et al., 1988), later studies showed a correlation between 
the number of days with fast movement, pharyngeal pumping rates (Huang et al., 2004), and 
lifespan, as well as a correlation between the rate of motor activity decline and lifespan (Hsu 
et  al.,  2009).  Furthermore,  motor  activity  has  been  used  to  define  healthspan  and  to 
compare long-lived worm mutants with wild type in a cross-sectional study (Bansal et al., 
2015): of note, long-lived mutants showed an increased healthspan, but when normalized to 
lifespan,  their  healthspan  was  shorter  than  in  wild  type.  A similar  study  concluded  that 
relative  healthspan,  normalized  to  lifespan,  was  comparable  between  short-lived  daf-16 
mutants,  long-lived  daf-2 mutants,  and  wild  type (Hahm  et  al.,  2015).  Moreover,  within 
isogenic  C. elegans cultures, there seems to be not only variability regarding the ageing 
process  itself  but  also  within  the  healthspan  of  individual  worms, whereby  long-lived 
individuals  do  not  have  a  longer  healthspan  if  this  parameter  is  normalized  to  lifespan 
(Zhang et al., 2016). In addition to these fundamental physiological insights, these studies 
emphasize  the  importance  of  automated,  longitudinal  recording  systems  to  objectively 
determine the intra- and inter-individual variation of the ageing process.
To overcome observer bias and to increase throughput as well as detection sensitivity, many 
automated  systems,  generically  termed  worm  trackers,  have  been  developed  (Husson, 
2012).  Whereas  single  worm trackers  record  the  behavior  of  individual  animals  at  high 
resolution,  multi  worm  trackers  simultaneously  assay  up  to  120  nematodes  at  lower 
resolutions (Swierczek et al.,  2011). Some trackers are able to extract a broad range of 
locomotion parameters such as velocity, bending angles and frequencies, and can detect 
complex patterns such as movement reversals  or  omega turns.  As individual  worms are 
typically  not  labelled,  multi  worm  trackers  are  not  suitable  for  longitudinal  studies. 
Furthermore, most trackers observe a baseline activity over several minutes under different 
conditions  such  as  genetic  backgrounds  or  compounds,  which  allows  for  detailed 
quantitative and qualitative descriptions of locomotion at single timepoints only. Alternatively, 
microfluidic devices have been employed for lifelong longitudinal studies (Hulme et al., 2011; 
Cornaglia et al., 2016). In such devices, where a steady liquid flow delivers food and soluble 
compounds, and constantly removes waste and progeny, individual animals are confined to 
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micro-cultivation chambers to repeatedly assess swimming capability and gross morphology. 
Recently, a high-density vermiculture slide has been introduced in which individual worms 
are  confined  to  a  small  patch  of  bacteria  and  sandwiched  in  between  a  hydrogel  and 
polydimethylsiloxane (Zhang et al., 2016). While these sophisticated microfluidic approaches 
are appealing, their fabrication, setup, and readout are beyond the technical (and financial) 
capabilities of most C. elegans laboratories (Ng et al., 2002; Friend and Yeo, 2010).
In  contrast  to  the  above-mentioned  options,  scanner-based  worm  trackers  replace 
microscopic lens systems and cameras with modified consumer-grade flatbed scanners to 
continuously record worm motions on NGM plates (Peliti et al., 2013; Stroustrup et al., 2013). 
Using an array of several scanners, these setups can achieve considerable throughput and 
offer the potential of studying single worms on smaller plates over extended periods of time. 
However,  temporal  resolutions  achieved  so  far  were  1  image /  20s  and  1  image /  2h,  
respectively.  As  scanning  time  increases  with  spatial  resolution,  the  latter  can  not  be 
arbitrarily decreased since worms that leave their initial position during imaging will not be 
detected  (Stroustrup  et  al.,  2013).  Likewise,  the  fixed  focal  length  of  flatbed  scanners 
necessitates highly uniform agar plate thickness to avoid the animals leaving the optical focal 
plane; in addition, there is currently no option to deliver stimuli to single plates on a flatbed 
scanner. Whereas, in theory, a battery of lens-based single worm trackers could be used to 
record longitudinal data, such a space-consuming approach would (1) still provide only low 
throughput, (2) be hard to calibrate given the large number of individual imaging platforms, 
and (3) remain costly. 
To overcome these limitations in obtaining high-throughput longitudinal, lifelong recordings of 
individual worms under standard laboratory conditions, we have developed RAPID (Robot-
Assisted Plate Imaging Device). Here we report on the capabilities of our recording system 
using a  set  of  well-characterized,  genetically  modified  C.  elegans strains.  In  addition  to 
efficiently  replicating  previous  findings  in  the  field,  our  easy-to-standardize  approach 
demonstrates that none of the examined long-lived or hyperactive mutant C. elegans strains 
has a healthspan or motility performance superior over wild type.
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3.1.5 Materials and Methods
RAPID control software and robotic setup:
All software source code, circuit schematics, and 3D printable parts developed by us are 
made available on github (https://github.com/gabe0815/RAPID), a copy of which is part of 
the  supplementary  material.  The  assay  is  coordinated  through  an  ImageJ 
(https://imagej.nih.gov/ij/) macro, where robot and cameras are operated through a series of 
BASH scripts on a x86_64 machine running GNU/Linux. The macro loops through a sample 
lookup table in which all plates are registered with a unique sample ID and the time of birth.  
Each stack of four is processed top down by putting each plate on its designated imaging 
platform, simultaneously starting the image acquisition/assay. As soon as the recording of 
the first  plate has finished,  the robot  puts the plate back on its original position thereby 
reversing the order of  plates in  the stack.  Images of  each recording are downloaded to 
individual folders along with metadata (sample ID, time of birth, time of recording, camera 
serial number, imaging platform and temperature) as text files. After all plates have been 
moved back to storage, the next stack of plates is processed. The temperatures next to the 
plates  and  next  to  the  imaging  platforms  are  measured  every  5  min  using  a  digital 
thermometer  (DS18S20B,  Maxim  Integrated,  San  Jose,  USA)  through  a  microcontroller 
board (Atmel ATMega328p, arduino nano, www.arduino.cc). The NGM plates are stored on a 
table in a laser cut cardboard grid with 10 x 7 slots. Four layers of NGM plates are stacked 
upside down on top of each other resulting in 280 plates in total. Each position in the grid is 
forming a stack which is processed in parallel on 4 imaging platforms. A 6-joint robotic arm 
(M-430iA 2PH + R-30iA, FANUC Switzerland GmbH, Biel, Switzerland) equipped with a 10 x 
15  mm  silicone  vacuum  cup  (Amico  No.  a12122700ux0033,  purchased  through 
www.amazon.de), a diaphragm air pump (TOPSFLO TZ712/P12-15040, TOPS INDUSTRY & 
TECHNOLOGY CO. LTD., China) and a solenoid valve (Pneutronics 11-12-5-BV-12P77) to 
break the vacuum, is used to transfer plates between the imaging platform and the table. The 
vacuum pump is controlled via a relay connected to the robot controller  (R-30iA).  Robot 
motion programs were written in the FANUC TP language and are solely based on taught 
coordinates. Execution of robot subroutines is initiated via communication variables through 
an ethernet (TCP/IP, R-30iA built-in web server) connection.
Image acquisition and imaging platform
Images are  recorded using Canon Digital  IXUS 70 cameras (Canon Inc.,  Tokyo,  Japan) 
equipped with CHDK v1.3 (http://chdk.wikia.com/wiki/CHDK, build 4296), an open source 
firmware addition, enabling camera control with lua scripts executed on the camera, and 
through ptpcam (http://chdk.wikia.com/wiki/PTP_EXTENSION). The cameras are operated 
using battery adapters and run off a 4.2V power supply which can be interrupted through the 
controller of the robotic arm. The power button of each camera is constantly pressed down 
using a 3D-printed (polylactic acid) clamp to allow for a hard reset by switching off the power. 
A phototransistor is mounted to the auto focus LED, triggering the vibration motor once the 
LED is turned on through a second transistor. The execution of lua scripts, downloading and 
deletion of images is performed through ptpcam with CHDK extensions added. Producing 
high  quality  images,  unmodified  consumer-grade  cameras  offer  several  advantages.  In 
contrast  to  most  scientific  imaging  sensors,  they  are  equipped  with  fast  algorithms  to 
automatically adjust focus, exposure time, and gain. For RAPID, we chose a point-and-shoot 
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camera model that offers execution of user-written scripts directly on the camera, minimizing 
communication with the host computer and facilitating parallelization. Our analysis algorithm 
is independent of specific camera models since consumer-grade cameras generally deliver 
data in common image file formats (e.g. JPEG) through USB/PTP, eliminating the need of 
device-specific  drivers  or  hardware  extensions  to  the  host  PC  (Figure  9).  There  is  no 
restriction in resolution or number of images processed, as the analysis is performed post  
hoc and no active  feedback to  the imaging platform is  required during data  acquisition. 
Compressed raw image data including meta information are preserved so that  additional 
parameters  such  as  velocity,  track  wavelength,  and  body  bending  frequency  could  be 
extracted.
The imaging platform is set  up as a simplified inverted microscope (Figure 8).  The light 
source is a 12V 35W halogen spot (DECOSTAR 51 SST 4000, OSRAM GmbH, Munich, 
Germany) powered by a standard ATX PC power supply (2 spots/power supply), followed by 
a diffuser foil  (salvaged from a computer LCD display). The uppermost part of the stage 
consists of a large glass slide with a 3D-printed (polylactic acid) conical plate holder and a 
motor holder, equipped with a small vibration motor (salvaged from cordless phones, 12 x 
6mm,  3V  DC)  attached  to  the  slide  with  epoxy  resin.  A  set  of  magnifying  lenses 
(PLFILDCCL55, Polaroid 55mm 4-Piece Close Up Camera Lens Filter Kit, purchased from 
www.amazon.de) projects an image of the plate onto the camera resting on the bottom of the 
assembly, facing upwards. The frame is made of medium-dense fibreboard, threaded iron 
rod, and screw nuts, allowing for tuning the alignment of camera, lens assembly, and plate 
holder. Each imaging platform forms an independent unit, which performs the vibration assay 
autonomously  once  the  script  on  the  camera  has  been  started.  Four  of  those  imaging 
platforms are mounted on a wooden rack, with diffuser and light source mounted above each 
unit.
The  lua  script  on  the  cameras  performs  the  following  actions:  (1)  setup  of  imaging 
parameters: setting a predefined optical zoom, automatically adjusting and locking exposure, 
signal gain, and focus; (2) imaging for 30 s, resulting in 27 images on average, depending on 
exposure time; (3) turning on autofocus LED for 5 s, triggering the vibrational stimulus; (4) 
imaging for further 30 s after re-adjustment/re-locking of focus and exposure time (Figure 8). 
After script execution, the plate is transferred back to its stack. Meanwhile, the images are 
copied from the camera to the PC and subsequently deleted on the camera. Then, image 
analysis is performed. After 10 rounds of recording, all  cameras are rebooted to prevent 
random crashes due to memory leaks. If a camera is not responding, an error routine forces 
a reboot of all cameras and then deletes any images which have been left on their SD cards.
The optical zoom of the camera combined with the lens set results in a pixel length of 6.5 
µm. The field of view is ranging from 230 - 250 mm2 of 870 mm2 total plate area. Due to 
chromatic aberration of the lens kit and varying agar thickness near the edge of the plate, the 
image quality is anisotropic with highest resolution at the center of the image. Worms moving 
close to the edge of the image tend to be slightly out of focus resulting in blurred tracks, 
which are detectable nonetheless. As the seeded OP50 spot is in the center of the plate, 
worms tend to stay closer to the middle of the image rather than the edge, allowing for better 
detection.
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Image compression and analysis
The  image  download  directory  is  scanned  regularly  for  unprocessed  images  and 
compression/analysis is performed as needed. First, the image files (jpeg-compressed RGB, 
8 bit/channel) from the camera are combined into a movie (libx264, AVI container) using 
avconv (Libav 9.18, Libav developers 2016) while the metadata of the images are extracted 
using exiv2 (Andreas Huggel, The Exiv2 Project) and saved in a text file. A second script 
finds  the  compressed  videos  and  extracts  motion  from  before  and  after  the  vibrational 
stimulus using python 2.7 (Python Software Foundation) and the python bindings for the 
open  source  computer  vision  library  (openCV  2.4.8,  Itseez).  A  minimum  projection  of 
sequential images is performed and the first frame of each series is subtracted from the final 
projection.  The resulting image summarizes all  changes in  intensity during the recording 
series, i.e. the track of a moving worm and noise. This image is then smoothed, converted to 
a binary  image using adaptive  mean thresholding and the number  of  non-zero  pixels  is 
counted and saved to a file, reflecting the total area the worm has crawled over during the 
recording. The extraction of worm tracks is performed for the interval before and after the 
vibrational stimulus separately. The compression and analysis are run in parallel using GNU 
Parallel (https://www.gnu.org/software/parallel) allowing fast processing of the acquired data 
on a multiprocessor (x86_64, AMD Opteron, 16 cores, 75 GB RAM) computer.
The  thresholded  track,  number  of  pixels  and  the  first  image  of  each  data  point  are 
superimposed and all superimposed images of a given worm are compiled into one mosaic 
bitmap. This mosaic is then visually inspected for plate contamination, thresholding errors, 
and other  artifacts.  Specific  time points  are  excluded from the analysis  using an image 
browser macro written in ImageJ macro language.
Worm strain maintenance and preparation for RAPID assay
The following worm strains were provided by the C. elegans Genetics Center (CGC, funded 
by NIH Office of Research Infrastructure Programs P40 OD010440): 
CB120  [unc-4(e120) II.,  daf-2(sa875) III.] (Brenner,  1974),  CB246  [unc-64(e246) III.] 
(Brenner,  1974),  CB306  [unc-50(e306) III.]  (Brenner,  1974),  CB1072  [unc-29(e1072) I.] 
(Brenner,  1974;  Lewis  et  al.,  1980),  CL2355  [smg-1(cc546),  dvIs50[pCL45 (snb-1::aβ(1-
42)::3' UTR(long) + mtl-2::gfp] I.] (Dosanjh et al., 2010), LS292 [dys-1(cx18) I.] (Gieseler et 
al., 1999), MT2426 [goa-1(n1134) I.] (Segalat et al., 1995; Van Swinderen et al., 2001), N2, 
TJ1052 [age-1(hx546) II.] (Friedman and Johnson, 1988), ZZ17 [lev-10(x17) I.] (Lewis et al., 
1980). Worms were cultivated on 3.5 cm NGM plates seeded with E. coli OP50 (Stiernagle, 
2006) at 20 °C. For the assay, worms were synchronized by picking 10-15 gravid adults in a 
100 µl  droplet  of  hypochlorite  solution  (8.25 ml dH2O, 3.75 ml 1M NaOH, 3 ml  Sodium 
hypochlorite  6-14% active chlorine, Sigma-Aldrich Chemie GmbH Buchs, Switzerland) on 
seeded NGM plates, which were kept at room temperature. Worms were singled on assay 
plates two days later, at L3/L4 stage. Plates were labelled with a unique identifier, time of 
birth, and array coordinates and sealed with a 10 x 1 cm strip of Parafilm M® (Bemis, USA). 
The sealed plates, in stacks of four, were placed upside down onto the storage grid (Figure 3 
c). At the same time, each plate's position was entered into the sample lookup table file. 
Once all plates were placed onto the grid, the assay was started. 
Assay  plates:  3.5  ml  of  NGM agar  containing  10 µg/ml  2′-Deoxy-5-fluorouridine  (FUdR, 
Sigma-Aldrich  Chemie  GmbH Buchs,  Switzerland)  were  poured  in  3.5  cm  Petri  dishes. 
Plates were stored in  closed containers for  up to one week,  prior  seeding.  Plates  were 
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seeded the day before the assay was started with 15 µl OP50 cultured in LB broth overnight, 
carefully placing the drop in the center of the plate. Hands-on times are summarized in Table
9.
Modelling and statistical tests
We used the lme function of the nlme package (https://cran.r-project.org/web/package=nlme) 
in R (https://www.r-project.org, version 3.2.3) to fit linear mixed-effect models to our assay 
data.  We  predicted  track  area  by  genotype  or  condition,  time,  temperature,  and  the 
interaction of genotype with time. Slopes and intercepts were allowed to vary for a given 
subject as random effects. For linear versus quadratic comparisons, a fixed effect for time2 
was added to the model, without including additional higher-order interactions. Correlation of 
the data was modeled using the corCAR1 function. For model comparison, models were fit 
by  maximizing  the  log-likelihood;  final  models  were  fit  by  maximizing  the  restricted  log-
likelihood.  Model  selection  was performed in  a  bottom-up approach,  sequentially  adding 
fixed effects and interactions.  If  a fixed effect significantly improved the model,  the fixed 
effect was included.
Intercept  and slope parameters for each condition/genotype were compared to reference 
parameters  (Table  4 and  Table  5).  p-values  indicate  the  probability  of  observing  these 
coefficients under the assumption of each condition/genotype having the same coefficients 
as the reference.  
Normal distribution of residuals was checked using diagnostic plots (Figure 10,  Figure 11). 
Population predictions were computed using the predict function with the mean temperature 
of each set as temperature level. Timepoints after day 3 were included in the analysis to 
ensure  we  only  consider  tracks  from adults  and  worms have  fully  adjusted to  the new 
environment after initial transfer. Lifespan data was extracted from the same data set, by 
determining the time point at which a worm produced at least two track areas > 0 within 3 
recordings, to filter for noise. Lifespan analysis was performed using the survfit function from 
the  survival  package  (https://cran.r-project.org/web/packages/survival/)  and  Kaplan-Meier 
plots  were  generated  using  the  survminer  package  (https://cran.r-
project.org/web/packages/survminer/).
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3.1.6 Results
RAPID setup
RAPID consists of four individual optical imaging platforms, a storage array of NGM Petri  
dishes  each  containing  a  single  worm,  and  a  robotic  arm  (Figure  3).  The  robotic  arm 
transfers the plates from the storage array to the imaging platforms and back, recording 280 
worms over several weeks without experimenter intervention. The imaging platforms feed 
raw data into an automatic image processing pipeline (Figure 8, Figure 9). 
The  vibration  stimulus  applied  during  the  assay  causes  the  plates  to  slightly  bounce, 
constantly tapping against the plate holder.  In wild type worms, tapping usually results in 
reversal of direction, or accelerated forward movement (Wicks and Rankin, 1995). Tap and 
touch response have been studied in great detail,  revealing the underlying neural circuits 
(Wicks and Rankin, 1995; Chalfie et al., 1985; Rose, 2001). As the plates move during the 
vibratory  stimulus,  the  system  does  not  detect  the  initial  response  to  the  first  tap  and 
therefore  relies  on the increased locomotor  activity  during 30 s after  stimulus  cessation 
(Figure  8 b).  Unmodified  consumer-grade  cameras  were  used  for  image  acquisition.  In 
summary,  RAPID  performs  repetitive,  standardized,  non-destructive  neurological 
examinations of individual worms.
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Four individual imaging platforms (a), see also Figure 8, are continuously loaded with 
plates containing single worms, using a robotic arm (b). Up to 280 plates are stored in 
an array (c) which are sequentially cycled and imaged for 1 min every 6.2 h. A 
vibrational stimulus is applied during recording to provoke motion of the worms. After 
the imaging is complete, plates are put back to the array and the images are 
downloaded and processed (d). Note: The camera model IXUS 70 comes in different 
exterior designs, hence the different chassis colours.
RAPID provides unbiased lifelong longitudinal data allowing modeling of functional 
decline during ageing
As a proof-of-principle experiment, we first performed lifelong recordings of 10 different  C. 
elegans strains  in  a  single  run,  to  test  whether  standardized  stimulus  application  and 
automated  track  quantification  would  allow  the  unbiased  comparison  of  different  worm 
strains.  Tested strains included wild  type (N2),  four  uncoordinated,  one hyperactive,  one 
progressively paralysed, one long-lived, and two levamisole-resistant strains. Worms were 
censored if they failed to produce a single track due to damage during their initial manual 
transfer to the plates, or due to crawling off the plate. The median number of worms included 
in the analysis were 23.5 from the initial 28 worms per strain or 239 out of 280 worms in  
total. All worms were associated with a unique identifier, enabling per worm motility vs. age 
plots. Worms of the same genotype or treatment were plotted in groups, revealing distinct 
decline patterns (Figure 4,  Figure 11). The rate of decline was quantified by fitting a linear 
mixed-effect model to the raw data to compare the rate of decline in relation to a reference 
strain. The fitted parameters of the worm strains plotted in Figure 4 are summarized in Table
4. All strains tested had a lower intercept, i.e. theoretical track area at time 0 h, compared to 
wild type with the exception of the hyperactive strain LS292 [dys-1(cx18) I.]. Motility profiles 
were all  significantly different  from wild type (Table 4).  The lowest  intercept  values were 
recorded for  the  uncoordinated strain  CB306 [unc-50(e306) III.].  The  rates  of  locomotor 
decline for  all  strains tested were lower  than wild  type except  for  the hyperactive strain 
LS292  [dys-1(cx18) I.].  With  the  exception  of  the  levamisole-resistant  strain  ZZ17  [lev-
10(x17) I.] in absence of levamisole, all examined parameters significantly differed from the 
respective wild type values. Thus, measuring the track area every 6.2 h directly quantified 
stimulus response and motility decline in the ageing worm.
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Track area vs. days in wild type (N2) and nine mutant strains as indicated below 
graphs. Day 0 indicates date of birth, the assay was started at day 3. Colour indicates 
temperature at the time the assay was performed, blue lines indicate the predicted 
values of the fitted model. Number of worms per group are indicated in Table 7.
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Value Std Error DF t value p value
N2
(Intercept)
23735.66 1259.40 6064 18.85 <0.001
days -2348.94 93.36 6064 -25.16 <0.001
CB1072 -18191.13 1095.56 229 -16.60 <0.001
CB120 -22051.65 1168.54 229 -18.87 <0.001
CB246 -15689.26 1061.47 229 -14.78 <0.001
CB306 -21272.04 1094.93 229 -19.43 <0.001
CL2355 -17627.05 1131.97 229 -15.57 <0.001
LS292 3895.36 1218.70 229 3.20 <0.002
MT2426 -4439.58 1157.50 229 -3.84 <0.002
TJ1052 -11171.86 1072.66 229 -10.42 <0.001
ZZ17 -4296.05 1158.84 229 -3.71 <0.001
temperature 144.82 37.53 6064 3.86 <0.001
days:CB1072 1512.70 133.65 6064 11.32 <0.001
days:CB120 2084.91 133.07 6064 15.67 <0.001
days:CB246 1425.61 123.67 6064 11.53 <0.001
days:CB306 1989.59 126.80 6064 15.69 <0.001
days:CL2355 1294.03 140.06 6064 9.24 <0.001
days:LS292 -1134.61 160.22 6064 -7.08 <0.001
days:MT2426 538.20 137.04 6064 3.93 <0.001
days:TJ1052 1364.06 123.00 6064 11.09 <0.001
days:ZZ17 48.84 144.55 6064 0.34 0.74
Intercepts and slopes of strains are relative to the reference strain (N2), p-values 
indicate probability of observing these coefficients under the assumption, each strain 
having the same coefficients as N2.
52
Table 4: Fitted Coefficients of the Different C. elegans Mutants
Models for age-related motility decline
For wild type worms, a linear decline (Bolanowski et al., 1981; Johnson et al., 1988; Duhon 
and Johnson, 1995) (by measuring wave frequency while moving forward), an exponential 
decline  (Liu  et  al.,  2013;  Hsu  et  al.,  2009),  and  a  quartic  decline  with  higher  order 
interactions (Bansal et al., 2015) have been proposed to model the rate of change in motility 
over time. We have tested these models on our data and find that wild type data is best  
represented by a quadratic function (Figure 12, Table 8). However, linear decline models fit 
to our data almost equally well (Figure 13), in particular if mutant and transgenic strains are 
considered as well.
Effects of 5-fluoro-2'-deoxyuridine on wild type motility
As NGM plates seeded with single fertile C. elegans hermaphrodites will become populated 
with hundreds of progeny, precluding any type of individual worm examination, some sort of 
sterility  is  required.  To ensure high-throughput  with  assays like  RAPID,  absence of  vital 
offspring is a prerequisite, as even larvae would be detected by the currently implemented 
image processing, causing erroneous track detection. 5-fluoro-2′-deoxyuridine (FUdR) is an 
inhibitor of thymidylate synthetase (Santi and Mchenry, 1972; Esposito and Holliday, 1964), 
widely used for its sterilizing effect on C. elegans  (Hosono, 1978) by blocking DNA synthesis 
and decreasing germ cell proliferation. When provided to C. elegans larvae before most cells 
are postmitotic, FUdR leads to a decreased body size (Hosono, 1978). Therefore, FUdR is 
usually applied to later larval stages or adults.
When applied later in adult life, FUdR has been shown to dramatically increase the lifespan 
of some mutants, but not of wild type, in a dose-dependent manner  (Hosono, 1978; Aitlhadj 
and  Stürzenbaum,  2010;  Van  Raamsdonk  and  Hekimi,  2011;  Gandhi  et  al.,  1980). 
Furthermore, FUdR increases resistance to proteotoxic stress  (Angeli et al., 2013; Feldman 
et al., 2014) and prolongs survival under osmotic stress (Anderson et al., 2016). There is 
evidence for deleterious effects on motility with FUdR use (Bolanowski et al., 1981; Glenn et 
al., 2004). As our assay does not allow to directly compare wild type worms with and without 
FUdR, we applied three different FUdR concentrations to wild type worms and compared 
their decline in motility against the lowest concentration (Figure 5, Table 5, Figure 10). The 
parameter for intercept and slope of 20 µg/ml and 40 µg/ml FUdR treated animals are not 
significantly  different  from 10 µg/ml  FUdR,  suggesting  any effects  FUdR might  have on 
motility are not dose-dependent in wild type C. elegans. 
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(a) Track area throughout life, day 0 indicates date of birth. The assay was started at 
day 3. Colour indicates temperature at the time each assay was performed. Three 
concentrations of FUdR were tested, 10 µg/ml (n = 21), 20 µg/ml (n = 24), and 40 
µg/ml (n = 24). Blue lines indicate the predicted values of the fitted model. (b) Same 
datasets summarized in one plot. Dots represent individual measurements, lines are 
predicted values from the fitted model. Colours indicate different FUdR 
concentrations.
Lifespan determination from RAPID data
Since each RAPID examination starts with a cohort of young adult worms and is terminated 
after the last individual has died, high-resolution lifespan data can be extracted from our 
datasets.  Traditionally,  lifespan is  assessed by  inspecting  worm cohorts  on NGM plates 
every day or every other day (Wilkinson et al., 2012). Worms which do not move and which 
do not respond to prodding with a worm pick are defined as dead. Thus,  except for the 
mechanical  vibratory  stimulus  which  replaces  individual  prodding,  RAPID  conditions  are 
identical to the classical lifespan assay. We defined the time of death as the last time point at 
which a worm showed a response to the vibrational stimulus, and had at least one valid track 
in the previous two rounds, in order to filter out noise (as detailed in the methods section). 
Thus, given its imaging cycle, RAPID allowed lifespan determination with an accuracy of 6.2 
hours. FUdR concentration does only have minimal effects on wild type lifespan (Figure 6 a, 
Table 6) which is in concordance with the overall motility decline that is only insignificantly 
influenced by FUdR concentration. Lifespan of certain mutants significantly differs from wild 
type (Figure 6 b, Table 7). To demonstrate age-related functional decline, we used individual 
lifespan to normalize the corresponding motility dataset and plotted these data in a group-
wise manner (Figure 7). Our data show that none of the mutant/transgenic strains tested 
performs better than wild type.
(a) Survival data from wild type at various FuDR concentrations: Kaplan-Meier 
survival curves generated from the FUdR data set (Figure 5). Day 0 indicates time of 
birth, the assay was started on day 2. Median survival and number of worms are 
indicated in Table 6. (b) Survival differences between wild type and mutants: Kaplan-
Meier survival curves generated from the same data set as in Figure 4. Median 
survival and number of worms are indicated in Table 7.
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Lifespan data (Figure 4, Figure 6 b) is normalized per worm. No mutant or transgenic 
strain in our series performs better than wild type. In contrast, the long-lived strains 
(TJ1052 [age-1(hx546) II.] and CB120 [unc-4(e120) II., daf-2(sa875) III.]) all perform 
worse than wild type.
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3.1.7 Discussion
The need for  inter-laboratory  standardization  of  lifespan assessments has recently  been 
addressed  by  the  formation  of  the  Caenorhabditis Intervention  Testing  Program  (CITP) 
(Lucanic et al.,  2017). The aim of CITP is to identify and test compounds which prolong 
lifespan and have a positive  effect  on health.  We believe that  RAPID complements  the 
standardization efforts of CITP by contributing valuable quantitative health and lifespan data, 
allowing a more rigorous compound evaluation.
Combining longitudinal  single  worm tracking with  an automated,  high-throughput  system 
offers many possibilities for future research, in particular to study health during the ageing 
process. Other appealing phenomena to be quantified include response to external physical 
and chemical conditions, potentially in combination with large numbers of well-characterized 
genetic  mutants.  In  particular,  long-term  toxicity  studies  and  drug  discovery  would  be 
applications where effects are not  expected to occur  instantaneously.  Since response to 
stimuli with motor output involves portions of the C. elegans nervous system responsible for 
sensing,  signal  processing,  and  muscle  activity,  our  assay  is  furthermore  suitable  to 
quantitatively  assess  neurodegeneration.  With  RAPID,  we  developed  such  a  screening 
system which enables simultaneous, lifelong longitudinal recordings of 280 single worms on 
standard NGM plates. A vibratory stimulus ensures the observation of worms in an active 
state, allowing full assessment of motion capabilities within 30 s. This decreases the time 
required for evaluation compared to worms that are in a dwelling state, and increases assay 
sensitivity. Due to the latency of several hours between the measurements, habituation and 
fatigue  are  unlikely,  and  repeated  stimuli  will  provoke  comparable  responses  (Beck and 
Rankin,  1997;  Rankin  and  Broster,  1992).  Compared  to  existing  longitudinal  recording 
assays  (Zhang et al., 2016; Hulme et al., 2011; Cornaglia et al., 2016), RAPID uses NGM 
plates which do not require special fabrication techniques, and which are compatible with 
standard  C. elegans laboratory culture conditions. Single plates enable the combination of 
motility  assessment using RAPID with other non-invasive assays such as high-resolution 
microscopy. 
If unperturbed and on NGM, seeded with the E. coli strain OP50, C. elegans spends about 
78% in a state of dwelling with little displacement and low velocities, and 22% in a state of 
roaming (Ryan et al., 2014; Fujiwara et al., 2002; Ben Arous et al., 2009). The preferences 
for dwelling and roaming depend on food quality (Shtonda, 2006). We chose vibration as 
stimulus  to  provoke  dwelling  and  roaming  worms  to  move  faster,  as  it  can  be  applied 
repeatedly and reproducibly invokes a reaction. In theory, any other non-invasive stimulus 
that  acts  on  a  sealed  plate  could  be  used,  such  as  single  taps (Rankin,  1991),  heat 
(Wittenburg and Baumeister, 1999), light of short wavelength (Edwards et al., 2008), or light 
in  combination  with  optogenetics (Stirman  et  al.,  2011).  The  only  limitation  in  terms  of 
longitudinal recording is restriction to non-permanent and non-destructive stimuli.
Identification  of  lifespan  phenotypes  induced  by  mutations,  dietary  restrictions,  or  other 
interventions has led to major insights into the physiology and genetics of ageing  (Kenyon, 
2010).  It  has  been  noted,  that  lifespan  increase  per  se is  not  necessarily  meaningful, 
especially  if  the  ultimate  goal  is  to  translate  findings  from  C.  elegans  research  to  life-
extending interventions in humans (Bansal et al.,  2015). The term "healthspan" has been 
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coined to describe the period of time an individual spends in good health, before the onset of 
age-related decline, whereas "gerospan" denotes the time spent in poor health until death. 
Consequently,  the  goal  of  any  ageing-modifying  intervention  should  be  to  increase 
healthspan without  prolonging gerospan.  As health is  not  a static  condition but  rather  a 
continuum, dividing the life of a worm into healthspan and gerospan by a fixed threshold is 
arbitrary.  Instead of  measuring the number  of  days spent  above a certain threshold,  we 
propose to model the decline of motility over time using linear mixed-effect models. Such 
models  allow any function  to  be  fit  to  a  given dataset.  The selection  of  an  appropriate 
function  involves  checking the goodness of  fit  with the observed values.  By choosing a 
reference strain in a reference condition, the function of healthy ageing is defined. Strains or 
conditions are directly compared to the reference, and the relative capabilities are indicators 
for  an improved  or  decreased overall  health  rather  than  healthspan.  Through their  high 
temporal resolution, RAPID data enable full use of the powerful linear-mixed effect models to 
accurately describe the decline in motility over time. When considering our dataset of nine 
mutant worm strains and wild type, a linear model of decline is preferable (Figure 13), as the 
data from the mutant  strains CB120 [unc-4(e120) II.,  daf-2(sa875) III.]  and CB306 [unc-
50(e306) III.] are in disagreement with a quadratic function. By fitting our RAPID data with a 
linear function to compare all strains in an unbiased fashion, we find our system capable of 
differentiating  physiological  ageing,  i.e.  healthspan (Bansal  et  al.,  2015),  from  simple 
extension of life, a phenomenon not necessarily aimed for in human medicine. Therefore, we 
propose to use RAPID as a platform to screen for ageing modifying compounds, mutations, 
or transgenes.
Higher performance than a reference strain would require to present with either a higher 
starting value, i.e. intercept β0, or a slower motility decline rate β1 (decline in area per day) 
with none of either parameter indicating worse performance than the reference:
β0strain ≥ β0reference ∧ β1strain ≤ β1reference
None of the tested strains matches these criteria (Table 4). Hence, we conclude, that wild 
type has the best motility capabilities, which is particularly highlighted upon normalization of 
motility decline over individual lifespan (Figure 7). The hyperactive strain LS292 [dys-1(cx18) 
I.] shows a normalized decline rate similar to wild type, but has a shorter lifespan, and hence 
worse capabilities. This normalization furthermore reveals that lifespan extension in the long-
lived strains TJ1052 [age-1(hx546) II.] and CB120 [unc-4(e120) II.,  daf-2(sa875) III.] does 
not extend healthspan.
As shown in Figure 4, a linear model is in agreement with 9/10 strains tested in our assay, 
with the exception of the long-lived mutant TJ1052 [age-1(hx546) II.]. TJ1052 [age-1(hx546) 
II.]  was previously assessed (Duhon and Johnson, 1995) by measuring the spontaneous 
wave frequency during swimming in liquid at 20 °C. The authors reported the decline of 
motility to decrease linearly over time. Our experiment shows a faster decline during the first  
8 days,  followed by a slower decrease rate until  death.  This two-phase decline is not  a 
group-derived effect but is also observed in individual worms of this genotype (Figure 14). 
Hence, a linear function does not accurately describe the decline over time in TJ1052 [age-
1(hx546) II.].  The  negative  deviation  from the predicted linear  decline  indicates  that  the 
ageing  process  does  not  scale  with  lifespan,  and  that  TJ1052  [age-1(hx546) II.]  shows 
decreased motion capabilities later in life. 
58
This suggests that the ageing process of TJ1052 [age-1(hx546) II.] functionally differs from 
wild  type.  The lifespan extension in  TJ1052 [age-1(hx546) II.]  does not  increase overall 
health,  and  therefore  does  not  increase  any  arbitrarily  defined  healthspan.  Similar 
observations have been made on daf-2 mutants: One study reported a shorter healthspan in 
daf-2 mutants normalized for lifespan by measuring total distance covered during 5 min on 
seeded plates (Bansal et al., 2015) while another research team concluded that normalized 
healthspan was equal to wild type based on measuring the maximum velocity crawled in 30 
s on unseeded plates (Hahm et  al.,  2015).  Interestingly,  the uncoordinated strain CB120 
[unc-4(e120) II.,  daf-2(sa875) III.]  showed a dramatically  increased lifespan,  even longer 
than the lifespan of TJ1052 [age-1[hx546) II]. The median lifespan for unc-4(e120) carrying 
hermaphrodites was previously reported to be 12.4 ± 2 days at 20 °C  (Gems and Riddle, 
2000). As CB120 [unc-4(e120) II.,  daf-2(sa875) III.], was reported to contain the additional 
daf-2(sa875) mutation (Ailion and Thomas, 2003), this might explain the overall decreased 
motility, inferred by unc-4(e120) combined with longevity due to daf-2(sa875) in CB120.
In summary, RAPID is a high-throughput, fully automated C. elegans recording system that 
employs standard vermiculture conditions. By utilizing linear mixed-effect models that reflect 
the age-dependent decline in motor performance (rather than arbitrary thresholds that divide 
adult life into healthspan and gerospan), RAPID enables objective quantification of the health 
impact of genetic and environmental factors throughout worm life. Thus, our system, which is 
easy to implement on a comparably small budget, should allow for robust inter-laboratory 
reproducibility  of  worm  experiments.  Finally,  we  propose  that  the  standardized  RAPID 
assays will be instrumental for ageing research on C. elegans, being particularly useful for 
health assessment and modelling of physiological ageing.
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Each worm is imaged for 1 min every 6.2 h. Pixel size is 6.5 µm with an effective field 
of view ranging from 230 to 250 mm2. Imaging frequency is ~1 s-1. As the robotic plate 
transfer to the imaging platform variably excites the worms due to an ambient light 
change and slight vibration, we added a vibration motor to the plate holder to apply a 
more vigorous stimulus for 5 s. (a) The imaging platform consists of the following 
components: plate holder with vibration motor (top), lens assembly (middle), and a 
consumer-grade camera (bottom). A diffusor and incandescent halogen light bulb are 
used for illumination (not shown). (b) After image transfer to the host computer, the 
worm track is extracted: A minimum intensity projection is calculated (top). Adaptive 
thresholding binarizes the track (middle) which is superimposed onto a grey copy of 
the first image (bottom). The number of track pixels is counted and written to a file 
along with other assay parameters. (c) Manual inspection and statistical analysis. All 
track overlays of a single worm are compiled into a mosaic (top), used for 
identification of falsely thresholded tracks and other artifacts, which are manually 
annotated to be excluded from statistical analysis. Annotated data is used to extract 
lifespan data (middle) and to model the decline of motility during ageing using linear-
mixed effect models (bottom).
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A PC is used to control and coordinate the entire assay through an ImageJ script. The 
script cycles through a sample lookup table in which all plates are entered before the 
assay is started containing a unique identifier and the date of birth of the given worm. 
Plates are processed in stacks of four. The ImageJ script initiates macros on the robot 
controller to pick up a plate from a specified array position and put it on one of the 
four imaging platforms. A script on the camera is initiated which sets up the imaging 
parameters, starts taking pictures and switches the vibrational motor at a specific time 
to deliver a stimulus. After the assay is completed, the images are transferred from 
camera storage to the host PC to be stored in a directory together with text files 
containing worm id, date of birth, current time stamp, ambient temperature, and 
additional parameters of hard- and software. Meanwhile, the robotic arm takes the 
plate off the imaging platform and puts it back onto the array. Once all four imaging 
platforms have been cleared, the next stack of plates is processed. A script 
continuously runs in the background, converting downloaded image series to more 
compressed movies, while preserving image metadata provided by the camera. 
Another script extracts track information from compressed movies (Figure 8).
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 Wild type worms at different FUdR concentrations. (a) Normal Q-Q plot of residuals. 
(b) Tukey-Anscombe plot. (c) Histogram of residuals. (d) Fitted vs measured.
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Wild type worms at different FUdR concentrations. (a) Normal Q-Q plot of residuals. 
(b) Tukey-Anscombe plot. (c) Histogram of residuals. (d) Fitted vs measured.
Pooled area vs. days data from Figure 5. (a) A linear and a quadratic function have 
been used in a linear-mixed effect model to fit the data. (b-e) Diagnostic plots indicate 
that a quadratic function (a,d) fits the data better than a linear function (c,e).
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(a) RAPID data fit with a linear-mixed effect model with a linear (red line) and a 
quadratic term for time without higher-order interactions (blue line). Quadratic terms 
appear to be in discordance for the strains CB120 [unc-4(e120) II.] and CB306 [unc-
50(e306) III.]. Hence, we fitted a linear function to all strains. (b,c) Diagnostic plots for 
the linear and quadratic functions.
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A rapid decline between day 2 and day 8 is followed by a slow decline in the 
remaining lifetime.
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Temperature is continuously recorded during the assay (blue dots). (a) FUdR in wild 
type experiment. (b) Various worm strains experiment. The plots show fluctuations 
due to reduced ventilation/air conditioning at night and on weekends (yellow overlay). 
Mean temperature during the assay was 26.46 °C (black horizontal line).
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Value Std Error DF t value p value
N2, 10 µM FUdR
(Intercept)
12470.38 1621.59 2545 7.69 <0.001
days -1480.67 63.97 2545 -23.15 <0.002
N2, 20 µM FUdR 451.27 1057.88 65 0.43 0.67
N2, 40 µM FUdR -242.71 1068.10 65 -0.23 0.82
temperature 383.43 56.11 2545 6.83 <0.001
days:N2, 20 µM FUdR 62.93 86.96 2545 0.72 0.47
days:N2, 40 µM FUdR 94.37 87.73 2545 1.08 0.28
A linear mixed-effect model has been fitted. Pair-wise comparison of 20/40 µg/ml to 
10 µg/ml FUdR. The interaction term is not significant, indicating no effect of FUdR 
concentration on motility over time.
Condition animals *rmean *se(rmean) median 0.95LCL 0.95UCL
10 µg/ml 21 14.34 0.43 14.83 13.52 15.73
20 µg/ml 24 15.13 0.37 15.25 14.85 16.28
40 µg/ml 24 14.74 0.82 15.07 14.36 17.35
Median survival is altered by less than a day by different FUdR concentrations. 
Compare with Kaplan-Meier plots (Fig. 3 a).
strain animals *rmean *se(rmean) median 0.95LCL 0.95UCL
N2 22 11.47 0.39 11.10 10.32 12.40
CB1072 28 9.14 0.34 9.04 8.53 10.34
CB120 17 14.16 0.25 19.39 17.59 21.97
CB246 28 12.19 0.37 12.45 11.69 13.49
CB306 23 13.05 0.41 13.76 12.48 15.58
CL2355 26 8.81 0.42 8.78 7.87 9.96
LS292 23 7.69 0.18 7.89 7.39 8.16
MT2426 22 10.77 0.37 10.58 9.94 12.00
TJ1052 25 13.63 0.42 19.06 14.94 21.12
ZZ17 24 8.57 0.29 8.37 8.23 9.03
   
TJ1052 [age-1(hx546) II.] and CB120 [unc-4(e120) II., daf-2(sa875) III.] show an 
increased lifespan. This is unexpected for unc-4(e120) II., see discussion. The 
mutants CB1072 [unc-29(e1072) I.], CL2355 [smg-1(cc546) dvIs50 I.], LS292 [dys-
1(cx18) I.], MT2426 [goa-1(n1134) I.] and the transgenic strain ZZ17 [lev-10(x17) I.] 
are short-lived.
72
Table 5: Linear Mixed-Effect Model Describes FUdR Effect on Motility
Table 6: Statistical Analysis of Wild Type Survival Data at Different FUdR  
Concentrations
Table 7: Summary Statistics of Strain-Specific Lifespan Data
a 
Value Std Error DF t value p value
N2, 10 µM FUdR
(Intercept)
12470.38 1621.59 2545 7.69 <0.001
days -1480.67 63.97 2545 -23.15 <0.002
N2, 20 µM FUdR 451.27 1057.88 65 0.43 0.67
N2, 40 µM FUdR -242.71 1068.09 65 -0.23 0.82
temperature 383.43 56.11 2545 6.83 <0.001
days:N2, 20 µM FUdR 62.93 86.96 2545 0.72 0.47
days:N2, 40 µM FUdR 94.37 87.72 2545 1.08 0.28
b  
Value Std Error DF t value p value
N2, 10 µM FUdR
(Intercept)
18670.61 1563.18 2544 11.94 <0.001
days -2612.58 77.47 2544 -33.72 <0.001
N2, 20 µM FUdR 704.26 1044.71 65 0.67 0.5
N2, 40 µM FUdR 575.97 1055.48 65 0.55 0.59
days^2 62.52 3.09 2544 20.25 <0.001
temperature 314.22 52.45 2544 5.99 <0.001
days:N2, 20 µM FUdR 24.47 72.40 2544 0.34 0.74
days:N2, 40 µM FUdR -18.05 73.07 2544 -0.25 0.8
(a) Linear mixed-effect model fitted with linear function. (b) Linear mixed-effect model 
fitted with quadratic function without higher order interactions. Both models show no 
significant difference in pair-wise comparison of 20/40 µg/ml with 10 µg/ml FUdR, 
indicating no effect of FUdR concentration on motility over time.
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Table 8: Statistical Comparison Between Linear and Quadratic Functions for  
RAPID Wild Type Data
Task Est'd. Time Comment
synchronize worms with drop bleach, 
depends  on  number  of  different 
strains
5 min per strain
pour plates 20 min
seed plates 30 min drop has to be placed carefully in the 
centre
single worms 1 h
label and seal plates 1 h
setup RAPID 10 min upload sample table, check cameras, 
robot, and analysis daemons
place plates on assay table 30 min
inspect  data  sets  for  thresholding 
artifacts
5 h
This table illustrates the "hands on" time for a single lab worker performing a RAPID 
assay with 280 individual worms.
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Table 9: Time Required For RAPID Experiment 
3.2 Establishing Histology for C. elegans
Histology and immunohistological examination has a long-standing and successful history in 
many  fields  of  biomedical  science  and  most  notably  in  contemporary  routine 
histopathological  diagnostics.  IHC  visualizes  epitopes  of  gene  products  in  situ,  thereby 
allowing to detect the presence of a particular epitope in the context of cellular compartments 
and surrounding tissue.
The use of conventional histopathological procedures on  C. elegans is hampered by the 
small size of the organism. Nonetheless, our laboratory introduced robust protocols for  C. 
elegans histology  on  cryostat  sections  (Hench  et  al.,  2011).  To  further  standardize  and 
facilitate histology and IHC for  C. elegans, we now successfully adapted a cytological cell 
block technique (Jain et al., 2014) to worm embedding. Using blood plasma and recombinant 
thrombin to enmesh the animals in an artificial clot, we create a pseudo-tissue containing 
1000s of animals which can subsequently be formalin-fixed and paraffin-embedded (FFPE) 
using standard procedures,  creating so-called worm blocks (Figure 16).  Such embedded 
specimens allow storage at room temperature for years without significant loss of antigenicity 
(Kokkat  et  al.,  2013),  enabling  retrospective  histochemical  comparative  evaluation,  most 
prominently  by  IHC.  Morphological  details  are  better  preserved  in  FFPE  compared  to 
cryostat  sections.  Since the worms in a worm block  form a pseudo-tissue,  they can be 
handled  in  the  same  way  as  e.g.  biopsy  tissue,  making  use  of  highly  automated  and 
standardized histopathology infrastructure. 
The  use  of  conventional  light  absorbing  chromogens  as  well  as  a  permanent  mounting 
medium furthermore allows re-evaluation of archived stained slides. Worms within a worm 
block  are  randomly  oriented  yielding  sections  through  all  possible  planes  at  once.
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Generation of worm blocks starts by collecting a large number of synchronized 
worms, formalin fixation, and enmeshing the worms in a blood clot generated from 
blood plasma and thrombin, which is then fixed in formalin once again. From this point 
onwards, the specimen is treated like regular, macroscopic tissue, dehydrated and 
paraffin embedded (a). Once FFPE worm blocks are made, a large number of 
sections can be cut for histological examinations and stored for years (b). This format 
is suitable for the vast majority of histopathological labelings, in particular 
immunohistochemistry as indicated by the stylized antibody. Low magnification 
overview of an H&E stained paraffin section is shown in (c), scale bar = 1 mm. 
Figure 17 shows sections of such a worm block made from wild type (N2) worms three days 
after  synchronization,  stained with  hematoxylin  and eosin.  Sections  through the pharynx 
inside the head of the worms as an anatomical landmark were chosen to unambiguously 
visualize some of the major anatomical structures of the nematode.
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Hematoxylin and eosin stained sections of a worm block made from adult N2 worms, 
three days after synchronization. Gross anatomy of an adult hermaphrodite (a), P: 
pharynx (green), N: location of nerve ring and head neurons (not shown), I: intestine 
(purple), PG: proximal gonad (blue), U: uterus (light blue), DG: distal gonad (blue), A: 
anus. Not shown are the body wall muscles and the nervous system, modified from 
http://wormatlas.org. Schematic representation of the 302 neurons and their neurites 
(b) rendered with neuroConstruct using data from the openWorm project. N: nerve 
ring and head neurons, VC: ventral nerve cord, DC: dorsal nerve cord. Selected 
sections through the longitudinal axis including the head (c). Pharynx, head neurons, 
intestine, and gonads can be readily identified. This orientation will be shown 
throughout this work. Scale bar = 50 µm. 
To establish  IHC with  anti-hTau  antibodies,  we  generated  worm blocks  of  synchronized 
cultures  of  previously  published  hTau-expressing  transgenic  worm strains  (Table  11 and 
Figure 18). The antibodies used, their epitope, dilutions and antigen retrieval protocols are 
listed in Table 10.
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Antibody Clone Epitope (AA) Phos. Retrieval Dilution
HT7 MN1000 159 - 163 no CC1 24 1:500
AT8 MN1020 202/205 yes CC1 24 1:4'000
AT100 MN1060 212/214 yes CC1 24 1:800
Anti-hTau antibodies and dilutions used in this work unless otherwise indicated. All 
labellings were performed on an automated IHC slide staining system (Ventana 
Benchmark XT, Roche, Switzerland). Epitopes are listed in amino acid positions 
according to hTau (2N4R, wt) as indicated in the manufacturer's data sheets, Phos.: 
phosphorylation-dependent epitope, Retrieval: antigen retrieval according to the 
manufacturer's protocol for 24 min using “Cell Conditioning 1” solution (Ventana, 
Roche, Switzerland).
Antibodies
Publication Strain Tau Isoform HT7 AT8 AT100
Kraemer et al. CK10 hTau(1N4R, V337M) pan++ pan++ cords+
Miyasaka et al. FX10646 hTau(0N3R, wt) single cells - -
FX10519 hTau(0N4R, wt) single cells single cells -
FX11152 hTau(0N4R, P301L) single cells - -
FX12012 hTau(0N4R, R406W) single cells - -
Brandt et al. VH255 hTau(0N3R, wt) pan++ pan+ cords+
VH254 hTau(0N3R, PHP) pan+ - cords+
VH420 hTau(0N3R, NP) - - -
Tau IHC of some of the published strains discussed in section “C. elegans as Model 
System for Tauopathies”. Worm blocks of all strains were generated three days after 
synchronization (1 day old adults). The strains by Kraemer et al. and Brandt et al. 
express hTau pan-neuronally (Brandt et al., 2009; Kraemer et al., 2003), while strains 
of Miyasaka et al. express hTau primarily in the six touch neurons (Miyasaka et al., 
2005). The transgenes created by Brandt et al. are not genomically integrated (Brandt 
et al., 2009). PHP: pseudo hyper phosphorylated hTau, NP: non-phosphorylated 
hTau. The labeling distribution and intensity was evaluated in a blinded fashion with 
respect to genotype and semi quantitatively described by two observers using the 
following abbreviations: pan = pan-neuronal, cords = ventral or dorsal nerve cords 
without apparent labelling of somata, with the modifier ++ indicating a stronger 
labelling over +, single cells = sparse labelling of individual neurons only.
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Table 10: Anti-Tau Antibodies and Dilutions
Table 11: IHC of Published C. elegans Models of Tauopathies
Tau IHC of adult worms, three days after synchronization using phosphorylation-
independent antibody HT7 (top row), and phosphorylation-dependent antibodies AT8 
(middle row) and AT100 (bottom row). Longitudinal sections through the head were 
selected to demonstrate the extent of hTau labelling, wild type (N2) was used as 
negative control. Strains are described in Table 11. Scale bar = 50 µm for all images 
(bottom right). The strain FX10519 (Miyasaka et al., 2005) expresses hTau mainly in 
the six touch neurons, whose somata are not located within the head ganglia and 
therefore not visible in the sections presented.
One of the defining histopathological hallmarks of tauopathies is aggregated tau, which can 
be  demonstrated  with  Gallyas  silver  impregnation.  Figure  19 shows  Gallyas  silver 
impregnation of one of the published strains. 
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Automated Gallyas silver impregnation to demonstrate fibrillary hTau aggregates, a 
pathological hallmark of tauopathies. Mouse (P301S): sagittal section through brain 
stem of a 6 month old hTau (0N4R, P301S) expressing mouse (positive control), 
CK10 (Kraemer et al., 2003) mixed population of hTau (1N4R, V337M) expressing 
worms, N2: mixed population of wild type worms (negative control). Top row: 
incubation time optimized for positive control, bottom row: prolonged incubation time. 
Note that even the fibrin clot from the worm block has accumulated metallic silver. 
Scale bar = 50 µm for all images (bottom right). 
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3.3 Modelling Tauopathy in C. elegans
3.3.1 Replication of a Published Model
Since one of the reported models showed progressive paralysis, insoluble tau aggregation 
and structural alterations indicating neurodegeneration (Kraemer et al., 2003), we replicated 
the hTau construct used in this study to generate independent hTau lines and assess their 
locomotor performance using RAPID. We generated six lines expressing hTau (1N4R, wt), 
four lines expressing hTau (1N4R, P301S), and 14 lines expressing hTau (1N4R, V337M). 
Expression  is  driven  by  the  promoter  region  1.3  kb  upstream  of  aex-3 and  2.2  kb 
downstream of  unc-86 was inserted to serve as three prime untranslated region (3’-UTR). 
After backcrossing the integrated lines with N2, all lines were crossed with the strain SS104 
carrying the glp-4(bn2) allele, rendering the worms sterile at assay conditions (> 25 °C). In 
addition, the strain CK10  (Kraemer et al., 2003) was crossed with SS104 resulting in the 
strain IFP134. This strain served as positive control in all IHC experiments. We created worm 
blocks of synchronized populations to check the expression and phosphorylation status of 
hTau  in  all  our  lines.  The  IHC  results  from  adult  worms  grown  for  three  days  after 
synchronization are listed in Table 12.
Antibodies
Genotype Strain HT7 AT8 AT100
Positive Control IFP134 pan++ cords+ cords+
Negative Control SS104 - - -
hTau (1N4R, wt) IFP141 pan++ pan+ -
IFP142 pan++ pan+ -
IFP144 pan++ pan+ -
IFP148 pan+ single cells -
IFP224 pan++ single cells few cords
IFP225 pan++ single cells few cords
hTau (1N4R, P301S) IFP195 single cells - -
IFP199 single cells - -
IFP222 single cells - -
IFP223 - - -
hTau (1N4R, V337M) IFP187 pan+ single cells -
IFP191 pan++ pan+ -
IFP196 pan+ single cells -
IFP197 pan++ single cells -
IFP200 pan++ single cells -
IFP208 single cells - -
IFP211 pan+ - -
IFP212 pan+ single cells -
IFP213 pan+ - -
IFP214 single cells - -
IFP217 pan++ pan+ -
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Antibodies
Genotype Strain HT7 AT8 AT100
hTau (1N4R, V337M) IFP218 pan++ pan+ -
IFP220 pan+ single cells -
Three day old worms (day 0 = day of synchronization) from synchronized worm 
cultures were formalin-fixed and paraffin-embedded for subsequent histology. The 
phosphorylation-independent antibody HT7 was used to assess the expression of 
total hTau as well as phosphorylation-dependent antibodies AT8 and AT100 to check 
the phosphorylation status of hTau as indicated in Table 10. Strain SS104 served as 
negative control while IFP134, a cross of CK10 (Kraemer et al., 2003) with SS104, 
served as positive control in all IHC experiments. The labelling distribution and 
intensity was evaluated blind to the genotype and semi quantitatively described using 
the following abbreviations: pan = pan-neuronal, cords = ventral or dorsal nerve cords 
without apparent labelling of somata with the modifier ++ indicating a stronger 
labelling over +, single cells = only sparse labelling of individual neurons, see Figure 
20 for examples of labelling intensities and Figure 21 for representative examples of 
each genotype.
Labelling intensities demonstrated with HT7 IHC. The strains shown are IFP134 
(pan++), IFP187 (pan+), IFP195 (single cells), and SS104 (negaitve). Pan++, pan+, 
and negative show sections through the pharynx to demonstrate labelling of the nerve 
ring, ventral and dorsal nerve cords recorded using the same exposure settings. The 
image “single cells” was recorded using a longer exposure and does not show the 
pharynx, arrow head points at the single positive cell. Scale bar = 50 µm for all 
images (bottom right). 
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Table 12: IHC on Generated Strains
Tau IHC of selected strains summarized in Table 12. Sections through the pharynx 
were chosen to demonstrate labelling of the nerve ring, ventral and dorsal nerve 
cords; heads are oriented to the left. Exposure and scale are the same for all images, 
scale bar = 50 µm (bottom right).
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3.3.2 Longitudinally Measuring Stimulated Locomotor Performance of 
hTau-Expressing Strains Using RAPID
An often reported phenotype in hTau-expressing worm strains is uncoordinated locomotion. 
In order to objectively measure the lifelong locomotor performance of our newly generated 
hTau strains, we employed our Robot-Assisted Plate Imaging Device (RAPID) described in 
section “Manuscript: RAPID - High-throughput standardized health modelling in C. elegans”. 
Figure 22 shows an overview of all measured strains.
Figure 22: Strains Recorded Using RAPID
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Plots of area [px] vs. chronological age [days] of all strains grouped by strain name 
and run (numbers above strain name, 2-9), recorded using RAPID. Runs 2-7 and 9 
consisted of four strains with 70 worms per strain, while run 8 consisted of two strains 
with 140 worms each. Due to a technical failure during the recording of set 3, data 
between day 4 and 5 are missing. Colour indicates the hTau construct / genotype. 
The full list of genotypes can be found in Table 24. Table 13 summarizes the number 
of worms per strain per run shown in Figure 22. 
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Run No. Strain Number of 
Worms
Mean Temperature [°C]
2 IFP134 65 26.56
IFP143 65 26.61
IFP177 69 26.61
SS104 68 26.6
3 IFP141 68 26.58
IFP142 67 26.56
IFP144 70 26.53
IFP148 58 26.59
4 IFP211 65 26.86
IFP212 63 26.87
IFP213 65 26.88
IFP214 70 26.89
5 IFP187 64 26.6
IFP195 69 26.65
IFP199 69 26.62
IFP200 57 26.63
6 IFP191 67 26.59
IFP217 69 26.58
IFP218 64 26.59
IFP222 67 26.57
7 IFP196 58 26.48
IFP197 66 26.54
IFP208 69 26.4
IFP223 69 26.36
8 IFP224 138 26
IFP225 134 26.09
9 IFP134 67 25.53
IFP147 62 25.62
IFP220 63 25.64
SS104 69 25.65
Sum 8 28 2114
Summary of the number of worms assessed per strain per run. Sum indicates the 
number of runs, number of unique strains and number of worms. Worms which were 
censored are excluded from this list. Mean temperature indicates the mean 
temperature of all non-zero measurements for each given strain.
The  strains  SS104  and  IFP134  were  assessed  in  duplicate.  Strains  having  a  unique 
genotype  (IFP134,  IFP143,  IFP147  and  IFP177)  were  excluded  from  the  analysis,  see 
section  “Generation  of  Transgenic C.  elegans“.  RAPID data were arranged by genotype 
(Figure 23) and all strains with the same genotype can be combined (Figure 24). 
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Table 13: Strains Recorded Using RAPID
Figure 23: Selected Strains Recorded Using RAPID
Same plots as in Figure 22 but limited to the strains included in statistical analysis, 
ordered by genotype. See Table 24 for complete list of genotypes and alleles. 
87
Figure  24: Selected Strains Recorded Using RAPID Combined According to hTau  
Genotype
Area vs. age plots, all strains of a given genotype are combined, see Figure 23 and 
Table 12 for list of strains and genotypes.
Although all strains of the same hTau genotype were generated in the same way using the 
same DNA construct for injection, IHC revealed varying expression of hTau. Figure 25 shows 
the strains arranged according to hTau expression level as listed in Table 12.
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Figure 25: Strains Recorded Using RAPID Arranged by hTau Labelling
Area vs. age of hTau expressing strains, ordered according to hTau labelling using 
IHC with HT7 as listed in Table 12. Full list of genotypes can be found in Table 24.
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Comparing the Effect of hTau Genotype on Stimulated Locomotor Performance
The effect of hTau genotype on locomotor performance was assessed using linear mixed-
effect models as established in section “Manuscript: RAPID - High-throughput standardized
health modelling in C. elegans”. Linear mixed-effect models are similar to multiple regression 
models.  Coefficients of  several predictor variables are estimated to best fit  the observed 
measurements  while  taking  the  hierarchical  structure  of  the  data,  i.e.  longitudinal 
measurements, into account. The coefficients of those predictor variables are called the fixed 
effects. The predictors are age, genotype, and temperature during the measurement and the 
dependent variable is area. In order to test the effect of the predictor or fixed effect genotype, 
we constructed the following model:  
area∼age+age: genotype+genotype+age²+temperature (1)
In equation (1), area is predicted by the coefficients of the fixed effects on the right hand side 
which are: age, the slope of the reference genotype, the interaction age:genotype describes 
relative  changes  in  slope  for  a  given  genotype,  and  genotype,  relative  changes  in  the 
intercept for a given genotype. Furthermore, there are genotype-independent fixed effects: a 
quadratic term for age2 and temperature indicates changes in area for a given temperature 
during the measurement.
Since individual strains are only a sample of all infinite, theoretically possible strains of a 
given genotype, they were included as random effects, nested in genotype, nested in runs, 
with  random  slopes  and  random  intercepts  per  worm  (section  “Statistical  Evaluation  of
RAPID Data” for full model descriptions). The predictions of this model are shown in Figure
26 and the estimated fixed effects of the model are listed in Table 14.
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Figure 26: Predictions of Model 1
A linear mixed-effect model was fitted to determine the effect of genotype on 
locomotor performance. The data of all strains with a common genotype are pooled 
and shown as one plot to illustrate what was fitted. The line shows the prediction for 
each genotype. The strain SS104 with the genotype “no Tau” (top left) was used as 
reference to which the other genotypes are compared. The estimated fixed effects for 
the model are listed in Table 14.
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Fixed Effect [per Unit] Area [px] Std. Error [px] p-value
no Tau 28169 2837 <0.001
hTau (1N4R, wt) -5371 3716 0.199
hTau (1N4R, P301S) -6134 3360 0.088
hTau (1N4R, V337M) -5023 2985 0.113
temperature [°C] 210 16 <0.001
age [day] -3860 205 <0.001
age [day2] 108 1 <0.001
age:hTau (1N4R, wt) [day] 395 262 0.132
age:hTau (1N4R, P301S) [day] 199 247 0.42
age:hTau (1N4R, V337M) [day] 243 218 0.265
Fitted fixed effects of the model described by equation (1). Fixed effects for age and 
the interaction age:genotype are indicated as changes per day, temperature is 
indicated as change in area per 1 °C, while fixed effects without unit indicate a 
change in intercept. The reference strain is SS104 with genotype “no Tau”. The p-
value indicates the probability of obtaining the coefficient as listed, under the 
assumption that the fixed effect does not predict the outcome.
Comparing the Effect of Tau Expression Levels on Stimulated Locomotor 
Performance
In  order  to  test  the  effect  of  hTau  expression  levels  on  locomotor  performance,  we 
constructed a linear mixed effect model which contains a fixed effect for labelling of hTau 
using anti-hTau antibody HT7 and IHC, according to equation (2).  
area∼age+age: labelling+labelling+age ²+genotype+ temperature (2)
Since the evaluation of IHC labelling as listed in Table 12 was performed semi-quantitatively, 
the distinction between pan+ and pan++ is ambiguous. Therefore, the labelling was grouped 
into “tau positive” or labelling (i.e. pan+ and pan++) and "tau negative" or no labelling (i.e.  
single cells and no labelling). 
Again, the coefficients of the right hand side of equation (2) are the fixed effects which are 
fitted to predict the area on a given age (in days). The fixed effect  age, is the slope of the 
reference  SS104  (“no  Tau”,  “no  labelling”).  If  labelling  is  detected,  the  interaction 
age:labelling describes relative changes in slope, and labelling indicates relative changes in 
intercept.  The  amount  of  change  in  slope  per  day2 is  given  by  age2,  and  temperature 
indicates changes in area for a given temperature during the measurement.
The predictions of this model are shown in Figure 27 and the estimated fixed effects of the 
model are listed in Table 15.
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Table 14: Estimated Fixed Effects of Model 1
A linear mixed-effect model was fitted to determine the effect of hTau expression on 
locomotor performance as determined by HT7 IHC. Predictions of the linear model (2) 
are shown to illustrate what the model fits. The plot “no Tau labelling” on the left side 
shows pooled data of all strains in which no or only single cells were detected with 
HT7 anti-hTau antibody, while the plot “Tau labelling” on the right side shows pooled 
data from all strains in which HT7 was pan-neuronally detected according to the Table
12. Line colours indicate genotype as listed in the legend. The fitted coefficients for 
the model are listed in Table 15. Note: all theoretically possible combinations of 
labelling and genotype are shown even if they did not occur experimentally.
Fixed Effect [per Unit] Area [px] Std. Error [px] p-value
no Tau, no labelling 27010 1752 <0.001
labelling -1479 1570 0.362
hTau (1N4R, wt) -1615 1558 0.34
hTau (1N4R, P301S) -3692 1200 0.008
hTau (1N4R, V337M) -3239 1336 0.029
temperature [°C] 210 16 <0.001
age [day] -3768 102 <0.001
age [day2] 108 1 <0.001
age:labelling [day] 228 101 0.025
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Table 15: Estimated Fixed Effects of Model 2
Fitted fixed effects of the model described in equation (2). Fixed effects for age and 
the interaction age:labelling are indicated as changes per day, temperature is 
indicated as change in area per 1 °C, while fixed effects without unit indicate change 
in intercept. The reference was the strain SS104 with genotype “no Tau” and labelling 
“no labelling”. The p-value indicates the probability of obtaining the coefficient as 
listed, under the assumption that the fixed effect does not predict the outcome.
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3.4 Additional Recordings Using RAPID
3.4.1 Recordings from Run 11 and 13
To  check  the  sensitivity  of  RAPID,  we  recorded  three  different  strains  under  various 
conditions. The results from these recordings are shown in  Figure 28 and the number of 
worms used in each run is shown in Table 16. 
Figure 28: Additional Recordings Using RAPID
Recordings of the strains wild type (N2), SS104 and CK10, FUdR indicates the strain 
was recorded on NGM plates containing 10 µg/ml FUdR, FUdR old indicates, the 
strain was recorded on FUdR plates which were stored for more than 2 weeks. 
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Strain / Condition Run 11 Run 13
N2, FUdR 37 65
SS104 37 69
SS104, FUdR 38 67
N2, FUdR old 38 -
CK10, FUdR - 62
Temperature 25.7 26.7
Number of worms used per strain and run. N2, FUdR, SS104, FUdR and CK10, 
FUdR were recorded on NGM plates containing 10 µg/ml FUdR. N2, FUdR old 
indicates, the strain was recorded on FUdR plates which were stored for more than 2 
weeks. SS104 was recorded on standard NGM plates. Temperature indicates the 
average temperature during the respective run.
Since N2, and SS104 with and without FUdR was recorded in both runs, we can assess the 
variability between the runs. A linear mixed model was fitted as described in equation (1), 
treating each strain/condition per run as individual fixed effect for comparison. 
Figure 29 shows the combined data from run 11 and run 13 as well as the predictions from 
the fitted model. The fixed effect coefficients are shown in Figure 29.
Figure 29: Comparison of Independent Runs
Three different strains/conditions were recorded in two independent runs. Run 13 was 
started almost 3 months after run 11. N2, FUdR and SS104, FUdR were recorded on 
NGM plates containing 10 µg/ml FUdR, while SS104 was recorded on regular NGM 
plates.
A linear mixed effect model was fitted to combined data obtained in run 11 and 13. Area is 
predicted by the fixed effects age, the interaction age:strain,  strain, a quadratic fixed effect 
for age2, and temperature. Strains from each run were treated independently. The lines show 
the predictions from the fitted model using the value of the fixed effects listed in Table 17. 
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Table 16: Additonal Strains Recorded Using RAPID
Fixed Effect [per Unit] Value [px] Std.Error [px] p-value
N2, FUdR (Run 11) 14761 1274 <0.001
N2, FUdR (Run 13) 1461 1023 0.154
SS104 (Run 11) 21931 1163 <0.001
SS104 (Run 13) 12388 1007 <0.001
SS104, FUdR (Run 11) -677 1119 0.546
SS104, FUdR (Run 13) 2945 1006 0.004
temperature [°C] 394 38 <0.001
age [day] -2963 93 <0.001
age [day2] 83 3 <0.001
age:N2, FUdR (Run 13) [day] -319 107 0.003
age:SS104 (Run 11) [day] -1633 121 <0.001
age:SS104 (Run 13) [day] -841 104 <0.001
age:SS104, FUdR (Run 11) [day] 224 113 0.048
age:SS104, FUdR (Run 13) [day] -108 103 0.294
Fixed effects fitted to data of Figure 29 for the combined data of run 11 and run 13. 
Each strain per run was treated as independent strain to enable comparison between 
the runs. The values of the fixed effects are listed in changes of area in pixels. N2, 
FUdR (Run 11) was chosen as reference (common intercept), to which the fixed 
effect of strain are added. Fixed effects age, temperature and the interaction 
age:strain indicate change in area per unit. The p-value indicates the probability of 
obtaining the coefficient as listed, under the assumption that the fixed effect does not 
predict the outcome.
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Table 17: Estimated Fixed Effects for Comparison Between Runs
Since  FUdR is  known  to  have  an  effect  on  body  size  when  applied  before  maturation 
(Gandhi et al., 1980), we measured the width of 10 worms of each strain of run 11, using the 
images recorded with RAPID. The measurements are listed in Table 18.
Run 11 N2, FUdR [px] SS104 [px] SS104, FUdR [px]
15.12 19.68 15.14
14.76 16 14.54
13.88 17.87 14.78
14.43 20.13 13.9
14.87 17.76 14.58
13.2 17.9 14.63
14.94 17.46 16.6
15.79 18.5 15.76
14.74 17.14 15.12
15.73 18.88 14.75
mean [px] 14.75 18.13 14.98
SD [px] 0.78 1.22 0.75
The width of 10 worms of each strain used in run 11 was measured. The values 
indicated are the width in pixel, mean: mean value of all measurements, SD: standard 
deviation. 
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Table 18: Effect of FUdR on Body Width
3.5 Attempts to Create an Aggregation and Spreading Model
One  of  the  defining  hallmarks  of  tauopathies  is  the  appearance  of  intraneuronal  tau 
aggregates. As described in section “Induction of Tau Aggregation by Expression of Mutated
Tau”, these tau aggregates can be induced in mice by expression of mutated hTau as well as 
by injection of preformed fibrils. In analogy to the mouse models expressing mutated hTau in 
restricted brain regions  (de Calignon et al., 2012; Harris et al., 2012; Liu et al., 2012), we 
created worm strains expressing mutated hTau (1N4R, V337M) in the touch neurons, and 
strains expressing hTau (1N4R, wt) pan-neuronally. By crossing these lines and performing 
IHC at different timepoints, we investigated the possible seeding effect of the mutated hTau. 
Figure 30 shows epifluorescence images of the mutated hTau, wt hTau, and the crossbred 
double-homozygous transgenic animals. 
 
Spreading model of hTau in C. elegans, epifluorescence images of worms on day 2 
after hatching. IFP48 expresses hTau (1N4R, V337M) and DsRed in the touch 
neurons, while IFP42 expresses hTau (1N4R, wt) and GFP pan-neuronally. 
IFP48xIFP42 inidcates the cross of both lines, thereby leading to expression of 
mutated hTau in the touch neurons and wt hTau in all neurons. DIC: differential 
interference contrast, DsRed: filter set for DsRed, GFP: filter set for GFP. Scale bar = 
100 µm for all images (bottom right).
The IHC results of different time points are partially shown in  Figure 31 and fully listed in 
Table 19.
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IHC of synchronized worm cultures from the hTau (1N4R, wt) and GFP expressing 
strain IFP42 at different time points indicated as chronological age in days since 
synchronization. Timepoints day 2 to day 5 are grown on standard NGM plates while 
day 14 were grown on NGM plates containing 125 µg/ml EtBr which leads to arrested 
larval development at stage L3 and therefore sterile worms. GFP: anti-GFP antibody, 
hTau antibodies used as listed in Table 10. The labelling intensity is comparable 
between the different timepoints, indicating stable expression of hTau and GFP. Scale 
bar = 50 µm for all images (bottom right).
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Age Strain HT7 AT8 AT100 RFP GFP
Day 2 IFP48 single cells+ - - single cells+ -
IFP42 pan++ single cords+ - - pan++
IFP48 x IFP42 pan++ pan++ single cells+ single cells+ pan++
Day 3 IFP48 - - - single cells+ -
IFP42 pan+ single cells+ - - pan++
IFP48 x IFP42 pan++ pan+ - single cells+ pan++
Day 4 IFP48 - - - single cells+ -
IFP42 pan++ pan+ - - pan++
IFP48 x IFP42 pan++ pan++ cords+ single cells+ pan++
Day 5 IFP48 - - - - -
IFP42 pan+ pan++ single cords+ - pan++
IFP48 x IFP42 pan++ pan++ single cords+ single cells+ pan++
Day 14 IFP48 - - - NA -
IFP42 pan++ pan+ cords+ NA pan+
IFP48 x IFP42 pan++ pan+ cords+ NA pan+
Synchronized worm blocks of IFP48 (mutated hTau in touch neurons), IFP42 (wt hTau 
in all neurons) and the cross IFP48 x IFP42 at different timepoints; all transgenes in 
homozygous state. Timepoints day 2 to day 5 are grown on standard NGM plates 
while day 14 were grown on NGM plates containing 125 µg/ml EtBr which leads to 
arrested larval development at stage L3 and therefore sterile worms. The labeling 
distribution and intensity was evaluated in a blinded fashion in regard to strain or 
genotype and semi-quantitatively determined by comparison with the positive control 
CK10. Pan: pan-neuronal, cords: only processes, no labelling of somata, single cells: 
single cells in some of the worms, NA: not assessed. 
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Table 19: IHC of  hTau Spreading Model in C. elegans
3.5.1 Combining Gallyas and IHC to Locate Neurons
Since mutated hTau is co-expressed with DsRed and wt hTau is co-expressed with GFP, we 
used anti-GFP and anti-DsRed antibodies to locate these neurons. We combined IHC and 
Gallyas silver impregnation as shown in Figure 32.
Anti-GFP (red) and Gallyas silver impregnation were successively applied to worm 
sections in order to locate neurons. AD: confirmed AD patient (positive control), IFP42 
x IFP46: cross of pan-neuronal hTau (1N4R, wt) and touch neuronal hTau (1N4R, 
V337M) expressing strains, IFP42: pan-neuronal hTau (1N4R, wt), N2: wild type 
(negative control). All worm blocks were made from mixed populations of worms, 
scale bar = 50 µm for all images (bottom right). 
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3.6 Contributions to Manuscripts
3.6.1 Automated Quantification of Gallyas Silver Impregnation 
To quantify the extent of tau aggregation as detected by Gallyas silver impregnation after 
intraperitoneal injection of brain homogenates from 6 month old homozygous hTau (0N4R, 
P301S) expressing mice into heterozygous hTau (0N4R, P301) expressing mice (Clavaguera 
et al., 2014), we developed an automated imaging pipeline and analysis tools. A microscope 
with a motorized x-y stage was equipped with a motorized focus to scan whole brain mouse 
sections.  A  predefined  region  of  interest  (ROI)  was  scanned  with  20x  magnification, 
recording a movie shifting the focus through the section from top to bottom. The stage is 
moved to the next field of view and the focus is shifted back up again. After the whole ROI is 
scanned, the sharpest image of each field of view is determined and the ROI is stitched to 
create an overview image. The overview image is used to annotate predefined anatomical 
landmarks and brain regions to be analysed. The original images are processed using colour 
deconvolution and thresholding of black, i.e. Gallyas-positive, and blue, i.e. nuclei structures 
for  quantification.  The  images  are  coloured  according  to  the  ratio  of  Gallyas-positive 
structures to nuclei  (G/N).  All  brain sections of  the non-injected control  and the injected 
experimental  groups  are  superimposed  using  the  defined  anatomical  landmarks.  The 
average G/N ratio between the two groups are compared using a pixel-wise Student’s t-test. 
The p-values of this t-test are plotted on a schematic representation of the mouse brain to 
reveal brain regions with significant differences in G/N ratio. Figure 33 shows an overview of 
a scanned brain section as well as the averages for the non-injected and the injected group 
and their comparison.
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Automated brain scanning and comparison of tau aggregation in heterozygous hTau 
(0N4R, P301S) mice injected with brain homogenates from homozygous hTau (0N4R, 
P301S) mice, modified from (Clavaguera et al., 2014). The Gallyas stained whole 
brain sections are automatically scanned and stitched to create an overview for 
annotation of anatomical landmarks and brain regions for analysis (a). The ratio 
between Gallyas positive particles and nuclei (G/N) is determined using image 
processing and the image in (a) is coloured according to the G/N ratio (b) of the 
respective image tile. All brain sections of the non-injected control and injected 
experimental groups are superimposed and the average calculated (c). A pixel-wise 
Student’s t-test reveals significant differences in the G/N ratios at specific brain 
regions between the two groups (d). 
3.6.2 Correlative Light- and Electron Microscopy
A  common  problem  in  electron  microscopy  (EM)  of  tissue  sections  is  unambiguous 
identification of the structure of interest. In our case, we intended to analyse tau aggregates 
ultrastructurally  in  the  neurons  of  C.  elegans.  To  identify  the  neurons  before  EM,  we 
established IHC on epon embedded tissue as described in  (Vidal et al., 1995). In addition, 
we successfully performed Gallyas silver impregnation on epon-embedded semithin sections 
of post mortem human tissue from an AD patient, see Figure 34.
104
Comparison of Gallyas silver impregnation on a human hippocampus. 1 µm thick 
epon sections, on which the epon was removed using a saturated solution of KOH in 
absolute EtOH to make the tissue permeable, stained with Gallyas silver impregnation 
(a). 4 µm thick sections from an adjacent slice of the same hippocampus, formalin-
fixed, paraffin-embedded, and stained with Gallyas silver impregnation for comparison 
(b). Scale bar = 20 µm for all images (bottom right). 
A region from the epon block shown in Figure 34 was trimmed for ultrathin sectioning size to 
include  a  tangle  bearing  neuron.  Figure  35 shows  an  electron  microscopy  image  of 
structures resembling PHFs.
Transmission electron microscopy images of tissue section from AD patients. Biopsy 
of a patient showing clinical signs of AD, adapted from (Gray, 1987) (a). Ultrathin 
sections of an autopsy derived sample from a confirmed AD patient (b), same block 
as shown in Figure 34 (top). Arrowheads: structures resembling PHFs. Scale bar = 1 
µm for both images (bottom right). 
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Although our correlative light- and electron microscopy protocol was ultimately not used to 
study tau aggregates in C. elegans, we instead applied this technique to locate Lewy bodies 
in post mortem tissue of a patients who had suffered from Parkinson’s disease, see Figure
36. 
 
Semithin section of epon embedded human Parkinson's disease tissue. The epon 
was removed and IHC for -synuclein was performed to locate the Lewy bodies ɑ
(arrows) and Lewy neurites (arrowheads) within the section. By alternating semithin 
with ultrathin sections, the adjacent ultrathin section were used to image the located 
structures using EM. Scale bar = 25 µm.
The located Lewy bodies were then ultrastructurally  examined by our  collaborators.  The 
results from these and other experiments were submitted for publication and are available as 
a preprint  (Shahmoradian et  al.,  2017).  In  short,  unambiguous distinction between Lewy 
bodies, Lewy neurites, and the more numerous Corpora amylacea which are easily mistaken 
as Lewy bodies, was facilitated.
3.6.3 Sample Preparation for Micro-Computed Tomography of Formalin-
Fixed Brain Tissue
Histology is the gold standard for tissue examination and offers high lateral resolution but is 
usually limited to thin sections of several µm. To study larger volumes of tissue in all three 
dimensions, new imaging modalities are being developed. A method which offers sufficiently 
high resolution of  low absorbing biological material  without the use of  contrast  agents is 
micro-computed tomography (µCT). We introduced an FFPE sample preparation protocol for 
µCT imaging of human brain tissue and subsequently validated µCT data histologically. This 
preparation method was used to study the distribution of Purkinje cells in human cerebellum 
using hard  X-ray  phase tomography  (Hieber  et  al.,  2016) as  well  as  to  virtually  extend 
histology to three dimensions using absorption-contrast µCT (Khimchenko et al., 2016).
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4 Discussion
4.1 Reviewer Comments on RAPID Manuscript
As  mentioned  in  section  “Manuscript:  RAPID  -  High-throughput  standardized  health
modelling  in  C.  elegans”,  we  received  feedback  from  two  reviewers  concerning  our 
manuscript “RAPID - High-throughput standardized health modelling in C. elegans” which is 
summarised and addressed in this section.
We were asked to compare RAPID with the Multi-Worm Tracker (MWT) (Swierczek, Giles, 
Rankin, & Kerr, 2011) and a more recent report  (Podshivalova, Kerr, & Kenyon, 2017) in 
which two daf-2 mutants were examined using the MWT. In general, we will need to provide 
more measurements obtained from long-lived mutants since the focus of our manuscript is 
centered around RAPID applied as a tool to study locomotor performance during ageing. We 
should address how the decline patterns of long-lived mutants compare with wild type and if 
this  pattern  was  shared  among long-lived  mutants.  By  performing  these experiments  in 
replicates,  we were asked to assess if  RAPID was suitable for  robust  and standardized 
compound evaluation  and  therefore  a  useful  addition  to  the  Caenorhabditis Intervention 
Testing Program (CITP) (Lucanic et al., 2017). Lastly, a simultaneous conventional lifespan 
assay should be performed in parallel to validate automated lifespan determination based on 
RAPID datasets. 
In  contrast  to  MWT,  RAPID  allows  longitudinal,  high-throughput  recordings  of  individual 
worms where each measurement can be unambiguously attributed to a particular animal. 
This sets RAPID apart from the majority of worm-tracking approaches including MWT, which 
was built to record and track up to 120 worms in parallel on the same plate (Swierczek et al., 
2011), thereby prohibiting longitudinal studies. In order to make a direct comparison between 
the imaging performance of RAPID and the MWT, we might record video data with RAPID 
instead of series of still images and then use the MWTs image analysis module to extract 
locomotion parameters. Alternatively, we could integrate the tracking algorithm of MWT in our 
analysis pipeline. Similar to RAPID, MWT uses image subtraction to detect moving objects, 
i.e. worms, but then differs from our approach by using the detected pixels as starting point 
for a flood-fill operation to segment a worm. It remains to be evaluated how well the MWT 
algorithm performs under  RAPID imaging conditions on standard NGM plates with living 
bacteria. Importantly, the subsequent statistical analysis of RAPID data is independent of the 
track extraction method and could be directly applied to longitudinal data recorded using 
another system such as the MWT.
For  the  proof-of-principle  experiment  outlined  in  the  manuscript  we  chose  worm strains 
displaying a variety of  locomotor phenotypes. We discovered the true potential of RAPID in 
the study of ageing and health assessment and therefore acquired more long-lived mutants 
from the Caenorhabditis Genetics Center including strains with mutations in the insulin/IGF-1 
pathway. This will enable a more in depth study of decline patterns of long-lived strains and 
compare how these different mutants age.
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As discussed in the manuscript, we are aware of the fact that we underestimate the time of 
death of worms recorded using RAPID. Instead of performing a manual ageing assay in 
parallel by hand, we can inspect the recorded tracks visually and determine the time of death 
retrospectively.  This  would  allow  additional  censoring  of  worms that  “got  lost”  and  died 
outside the field of view. However, accurate lifespan determination is not the aim of RAPID, 
since a more appropriate automated system was developed for this purpose (Stroustrup et 
al., 2013).
A more technical point of concern was the recreation of RAPID by other labs. Undoubtedly, 
RAPID is a complex system with different subsystems performing in concert. The three main 
subsystems are: the imaging platforms, the analysis software and a mechanism to switch the 
plates,  in  our  case  an  industrial  robotic  arm.  Importantly,  these  subsystems  are 
interchangeable and RAPID is only one possible implementation. The value of RAPID is the 
general idea of recording single worms on standard NGM plates, increasing the throughput 
by multiplexing of the imaging platforms and using an automated system to load and unload 
the plates. This enables acquisition of longitudinal data which otherwise can not be easily 
obtained.
We designed RAPID based on open source software and all our soft- and hardware designs 
are released to the public on github (https://github.com/gabe0815/RAPID). 
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4.2 Histology of hTau-Expressing C. elegans
The generation of worm blocks using the cell  block technique has proven to be an ideal 
method to study hTau expression and the phosphorylation state of tau. In theory, a worm 
block with 3 mm of tissue will yield 750 sections of 4 µm thickness, facilitating retrospective 
comparison of different worm blocks over a long period of time. No special equipment is 
needed and worm blocks can be generated with consistent quality. Induction of sterility by 
crossing worm strains with sterile mutants such as glp-4(bn2) or by using chemicals such as 
ethidium bromide or FUdR greatly facilitates the culture of synchronized worm populations 
past the onset of reproduction. The number of adult worms in a synchronized population is 
quickly outnumbered by the large amount of progeny which can not always be distinguished 
from the older adults.  Generation of  synchronized worm blocks from 1 day old adults is 
unaffected by these problems and can be obtained using fertile hermaphrodites.
Expression of  hTau  of  the  newly  generated worm strains  is  similar  to  the  worm strains 
obtained from Kraemer et  al.  (Kraemer et  al.,  2003) and Brandt  et  al.  (Brandt,  Gergou, 
Wacker, Fath, & Hutter, 2009) (see Figure 18 and Figure 21). Human tau is stably expressed 
throughout  the  nervous  system,  and  is  phosphorylated  at  the  AT8  and  AT100  epitope, 
indicating  the  presence  of  hTau  phosphorylating  kinases.  Expression  of  hTau  and  its 
phosphorylation can be detected throughout life (Figure 30).
AT8 and AT100 labelling seems to be dependent on expression level of  hTau, since the 
labelling intensities follow the form HT7 > AT8 > AT100. If we test this assumption for HT7 
and AT8 we find a significant positive correlation (Figure 37). 
Figure  37:  Corrleation  Between  AT8  and  HT7  
Labelling  
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AT8 labelling versus HT7 as summarized in Table 12 reveals a positive correlation 
between HT7 labelling and AT8 phosphorylation. The Spearman’s rank correlation 
coefficient is 0.85. Individual points were scattered and linear regression was fitted for 
illustration purposes only.  
This labelling pattern is also observed in mice expressing hTau (0N4R, P301S), where AT8-
positive  cells  outnumber  AT100-positive  ones  (Allen  et  al.,  2002).  The  reason  for  this 
observation could be a lower detection sensitivity of AT8 and AT100 compared to HT7. 
AT100 labelling does not seem to be dependent on the hTau construct expressed, since it is 
present in strains expressing hTau (1N4R, wt) as well as in the positive control expressing 
hTau (1N4R, V337M). None of the hTau (1N4R, P301S) strains were positive for AT8 nor 
AT100 labelling, again possibly due to the to the lower detection sensitivity. The strain VH254 
listed in Table 11 indicates, that AT100 phosphorylation is not dependent on phosphorylation 
of AT8 epitope, since the respective transgene has a mutated AT8 epitope and is therefore 
AT8-negative. Hence, hTau phosphorylation in C. elegans differs from hTau phosphorylation 
in vitro (Zheng‐Fischhöfer, 1998).
Diagnostic criteria common to tauopathies are neuronal inclusions of tau protein most of 
which can be demonstrated using various physical silver stains. Gallyas silver impregnation 
is one of the most sensitive silver staining methods for NFTs and able to detect filamentous 
tau made up of isoforms with four MT binding repeats (0N4R, 1N4R, and 2N4R) (Uchihara, 
2007).  Silver  staining  methods  share  a  common  principle:  silver  ions  (Ag+)  in  solution 
penetrate  the  tissue  and  selectively  attach  to  specific  structures  building  silver-ion 
complexes. In a second step, often called developing, these attached silver ions are reduced 
to  metallic  silver  in  situ,  rendering the structures  opaque,  appearing black  under  a  light 
microscope. Once mixed, the developer solution contains silver ions as well as the reducing 
agent.  The time between mixing the developer solution and immersion of the sections is 
critical,  as the developer starts reacting by itself,  continuously decreasing the amount of 
available silver ions and reducing agent. Hence the developing step is usually performed by 
hand under continuous visual inspection of a positive control slide for the staining intensity 
and stopped once the neurofibrillary tangles become evident.  If  the slides remain in the 
developed solution beyond this state, the entire tissue will be rendered black.
In order to systematically test Gallyas silver impregnation on sections of hTau-expressing C. 
elegans worm blocks, the staining procedure was standardized using a modified autostainer 
which allows consistent  timing between automated mixing of  the developer  components, 
immersion, and stopping of the developing process.
No silver positive inclusions could be unambiguously demonstrated in the worm (Figure 19). 
If the developing step was intentionally prolonged, the worm sections were rendered black, 
still  without  apparent  filamentous  inclusions.  To  corroborate  these  findings,  IHC  was 
combined with Gallyas silver impregnation to localize the neurons based on detection of 
GFP, and although NFTs remained detectable in human control tissue after IHC, there were 
no silver-positive structures detectable within worm neurons (Figure 32).
Gallyas  silver  impregnation  may  fail  due  to  some  inherent  differences  of  worm  tissue; 
alternatively, hTau in C. elegans may actually not form silver-positive inclusions. Although the 
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size difference between  C. elegans and mammalian neurons is considerable, Gallyas silver 
impregnation does stain the fine NTs in murine and human neurons which are similar in size 
to C. elegans neurites (Figure 19 and Figure 32).
Tau  aggregation  was  observed  ultrastructurally  by  electron  microscopy,  however  the 
aggregates do not appear to be filamentous in nature (Kraemer et al., 2003). The reports on 
hTau-expressing  worms  summarized  in  section  “C.  elegans  as  Model  System  for
Tauopathies” and  Table 2 mostly focused on sequential extraction and western blotting to 
determine the solubility of tau. 
As  silver-positive  tau  inclusions  were  undetectable  (or  do  not  exist)  in  hTau-expressing 
worms, C. elegans seems rather unsuited to model and study the spreading phenomena of 
tau aggregates or the induction thereof. In sum our attempts failed to establish a C. elegans 
spreading model system expressing mutant hTau (1N4R,  V337M) in a subset of neurons in 
a background where a pan-neuronal promoter drives hTau (1N4R, wt). 
Instead of focussing on surrogate markers of  tau aggregation and neurodegeneration as 
described  in  section  “Surrogate  Markers  for  Neurodegeneration”,  we  shifted  our  focus 
towards  quantification  of  the  functional  consequences  induced  by  expression  of  wt  and 
mutated hTau in C. elegans.
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4.3 Measuring Locomotor Decline Using RAPID
4.3.1 RAPID Sensitivity and Variation Between Runs
In order to assess the sensitivity of RAPID measurements, we recorded additional data from 
wild type N2 with FUdR and from the temperature-sensitive sterile mutant SS104 with and 
without FUdR in two different runs (Figure 28 and Figure 29).
Although the trajectory of a given strain between the two runs shows similarity, all of the 
estimated fixed effects  for  strain and the interaction  age:strain are  significantly  different, 
except for the change in intercept for N2, FUdR (Run 13), SS104, FUdR (Run 11) and the 
interaction age:SS104, FUdR (Run 13). The differences in change of intercept in SS104 are 
almost twice as high in run 11 compared to run 13. The interaction age:strain is lower for run 
13 than for run 11. Since the standard errors of fixed effects are comparable between the 
runs,  we  speculate  that  there  are  more fixed effects  which  could  explain  the difference 
between runs than we currently include in the model. Variation between the runs could arise 
due  to  differences  in  the  assay  plates,  bacteria  and  bacterial  density  on  the  plates, 
temperature, temperature fluctuations, and epigenetic drift of the strains. These factors are 
known to have an effect  on lifespan  (Gruber  et  al.,  2009) and hence might  also impact 
locomotor performance. 
The temperature during assay recording is not constant and therefore continuously recorded. 
By treating temperature as a fixed effect  in  our models,  we can correct  for  temperature 
induced differences of performance at a given time point. However, we can not correct for 
the  “cumulative”  temperature  the  worm  has  experienced  up  until  this  point,  since  this 
parameter will differ between individuals. Although we adhere to the protocol described in 
section “Preparation of Worms for RAPID Assay”, some variation can not be excluded. As an 
exaggerated example, we performed and assay with N2 kept on NGM plates with FUdR 
which were stored longer than 2 weeks (Figure 28). The locomotor performance of these 
worms is appreciably different than N2 recorded on freshly prepared NGM plates containing 
FUdR. In sum, these experiments demonstrates, that the sensitivity of RAPID is sufficient to 
systematically investigate the effects of some of those factors.
Different genotypes recorded with RAPID were distributed across individual runs (Figure 22). 
This averages potential systematic effects of each run, leading to less biased data.
In runs 11 and 13 it can be appreciated that SS104 growing on FUdR plates perform worse 
than on regular NGM. FUdR decreases the body width of SS104 animals by almost 20 % 
which  will  also  decrease  the  measured  track  area  by  at  least  the  same  amount.  The 
apparent difference in locomotor performance measured by RAPID is therefore in part due 
the change in body width. A tracking method with worm segmentation and centroid speed 
extraction is unsusceptible to changes in body size and could be employed to determine the 
effect of FUdR on locomotor performance. Nonetheless, smaller worms will have different 
biomechanics of locomotion and centroid speed may not completely compensate for these 
differences.
To characterize the direct effect of FUdR on locomotor performance using RAPID, we will 
have to repeat the experiments with various concentrations of FUdR on SS104. We have 
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performed this experiment on wild type (N2) worms and did not observe an effect of FUdR 
concentration on locomotor performance (Figure 5). 
4.3.2 Variation Within a Strain and the Rate of Ageing
From the broad distribution of measurements (Figure 23) we recognize that besides inter-
strain differences variation can also be found between individual recordings of  the same 
strain.
To determine how this distribution arises, we plotted individual worm trajectories. Since we 
are able to determine the lifespan of each worm, we can sort the individuals according to this 
parameter. Figure 38 shows all individuals of SS104 recorded in run 9.
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Figure 38: Individual Trajectories of SS104
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Individual trajectories of SS104 recorded in run 9, arranged according to their 
individual lifespan from left to right and top to bottom. The longest-lived individuals 
appear top left and the shortest-lived ones bottom right. The colour of each 
measurement indicates whether a worm is still alive (black) or if a particular 
measurement was determined to represent the time of death (red) as described in 
section “Modelling and statistical tests”. No additional censoring was applied, 
therefore the time of death may potentially be underestimated. 
To compare the different rates of decline, we can fit each individual worm trajectory with a 
linear regression and colour the graphs according to lifespan (Figure 39).
Figure 39: Rate of Ageing of SS104
Rate of ageing from SS104 recorded in run 9. Each line represents the linear 
regression through all the measurements of a single worm, same data as in Figure 
38. Colour indicates the lifespan of the respective worm.
From Figure 38 and Figure 39 it can be appreciated that the long-lived lived individuals have 
a slower decline in locomotor performance and an extended period of poor performance later 
in life, whereas the short lived individuals show a faster decline without an extended period 
of poor performance. This notion is consistent with previous findings  (Zhang et al., 2016). 
The rate of ageing was studied in an isogenic culture of wild type worms using longitudinal 
recordings of several physiological biomarkers of ageing, including locomotion. The authors 
report that short-lived individuals do not simply die prematurely and in fact undergo the same 
changes as the long lived individuals, but within a shorter period of time. They noted different 
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trajectories even among long-lived individuals,  indicating that the ageing process itself  is 
highly stochastic. Recently, a necropsy study on isogenic wild type worms was performed 
(Zhao et al., 2017). The reason for the early death of some individuals was attributed to a 
swelling of the pharynx due to bacterial infection. Interestingly, resistance to colonization of 
the pharynx by E. coli was also discovered as one mechanism for an extended state of poor 
performance late in life of long-lived daf-2 mutants (Podshivalova et al., 2017). If infections 
are  prevented  by  feeding  dead  bacteria,  wild  type  worms  live  longer  and  also  show a 
prolonged state of poor performance similar to the daf-2 mutants (Podshivalova et al., 2017). 
To further test this hypothesis, we could employ RAPID on worms grown on dead bacteria 
and examine if these distinct rate of ageing trajectories still exist.
4.3.3 Effect of hTau Genotype on Stimulated Locomotor Performance
In order to compare the locomotor performance of hTau-expressing strains, we subjected 23 
newly generated strains expressing hTau (1N4R, wt), hTau (1N4R, P301S), and hTau (1N4R, 
V337M) as well as a non transgenic control to a lifelong locomotor assessment using RAPID. 
Figure 23 shows all measurements per strain, coloured according to genotype.  Figure 24 
combines  all  measurements  of  each  strain  according  to  their  hTau  genotype.  The  plots 
reveal no obvious systematic differences between the hTau transgenic strains and the non 
transgenic  control.  Within  each  genotype  there  is  a  broad  range  of  locomotor  decline 
patterns.
Due to a technical failure during the recording of set 3, data are missing between day 4 and 
5. Since the data are missing at random timepoints and not due to a biological trait of the 
strains recorded, the recordings remain valid for statistical evaluation.
To compare locomotor  decline  throughout  life,  we applied  linear  mixed-effect  models  as 
described in section “Manuscript: RAPID - High-throughput standardized health modelling in
C. elegans”, and hereby estimated the effect of genotype on locomotor performance. 
Model 1 was constructed to contain fixed effects for age, interaction age:genotype, genotype, 
age2, and temperature. The model predicts the measured area at a given time by estimating 
an overall intercept and the fixed effects. The fixed effect age indicates the change in area 
per day, age:genotype additional change per day for a given genotype, genotype the change 
of area for a given genotype, age2 changes in area per day2, and temperature the change in 
area for a given temperature during the recording. 
The  model  was  fit  to  the  data  presented  (Figure  23)  with  SS104  as  reference.  The 
predictions for the model are plotted in Figure 24.
To visualize how well the model predicts the measurements, we plotted the measured area 
against the predicted area per genotype (Figure 40). 
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Measured area vs. predicted area for model 1 per genotype. Each circle in the plot 
corresponds to one measurement and is plotted on the y-axis. The parameters for this 
particular measurement are applied to the model and the resulting prediction is 
plotted on the x-axis. The black line indicates the case for which the measured area 
corresponds to the predicted area (y = x).
This plot emphasizes, that the model describes all genotypes equally well and that there is 
quite some deviation from the ideal case (y = x). Furthermore, we can acknowledge outliers, 
possibly  artifacts  which  were  not  detected  during  visual  inspection.  The  estimated  fixed 
effects for this model are listed in Table 14. Of the fixed effects of model 1, only temperature, 
as well as age, and age2 are significant. A rise in temperature by 1 °C leads to an increase in 
area by 210 px, while each day decreases the area by 3860 px and increases the area by 
108 px per day2. Neither the fixed effects  genotype nor the interactions  age:genotype are 
significant, indicating hTau genotype does not have an effect on the locomotor performance 
nor its rate of decline.
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4.3.4 Effect of hTau Expression Status on Stimulated Locomotor 
Performance
We verified hTau expression and phosphorylation state by immunohistochemical staining in 
each of the worm strains recorded by RAPID. The results are summarized in Table 12 and 
representative histological image examples are shown in Figure 21. Since the effect of hTau 
phosphorylation  on  neurodegeneration  remains  unclear,  especially  in  the  context  of 
transgene overexpression,  we focused our  analysis  on hTau expression detected by the 
phosphorylation-independent  antibody  HT7.  For  this  experiment,  analysis  was  only 
performed at one time point in life, since we previously determined that the hTau expression 
with these constructs is stable throughout life (Figure 30).
 
Each  transgenic  strain  is  expected  to  have  a  different  expression  level  of  hTau,  since 
integration of extrachromosomal arrays leads to formation of multicopy arrays with different 
copy numbers (Mello, Kramer, Stinchcomb, & Ambros, 1991). To test whether the expression 
level of hTau has an effect on locomotor performance, we constructed a linear mixed-effect 
model. Model 2 contains fixed effects for age, interaction age:labelling, a fixed effect for hTau 
expression level which we termed  labelling,  age2,  genotype, and  temperature. This model 
estimates an overall  intercept  for  the reference condition SS104, which has the  labelling 
state “no labelling” and the genotype “no Tau”. The interpretation of the fixed effects is the 
same  as  described  for  model  1,  with  the  exceptions  that  if  labelling  is  detected,  the 
interaction  age:labelling estimates relative changes in area per day and  labelling relative 
changes of the intercept. 
The labelling intensities were assessed in a semi-quantitative manner and the distinction 
between pan++ and pan+ is not always as pronounced as depicted in Figure 20. Therefore 
we have grouped pan++ and pan+ together as tau-positive or labelling and single cells and 
negative as tau-negative or no labelling for the labelling status in model 2.
Figure 27 shows the predictions from the fitted model 2, grouped by the labelling status and 
coloured according to the hTau genotype using the fixed effects listed in Table 15. To check 
how well model 2 predicts the measured data, we plotted the measured values against the 
prediction (Figure 41). 
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Measured area vs. predicted area of model 2 for all combinations of labelling (no HT7 
or pan-neuronal HT7 labelling) and genotype. Since not all combinations exist, the 
respective plots are omitted. Each circle corresponds to one measurement and is 
plotted on the y-axis. The parameters for this particular measurement are applied to 
the model and the resulting prediction is plotted on the x-axis. The black line indicates 
the case for which the measured area corresponds to the predicted area (y = x).
The model describes all strains reasonably well, and as with model 1, there is a high amount 
of deviation from the ideal line (y = x) in all the strains.
Estimated fixed effects are compared with the reference SS104, which has the  labelling 
status “no labelling” and genotype “no Tau”. Fixed effects for temperature, age, and age2 are 
significant. Raising the temperature by 1 °C increases the measured area by 210 px, each 
day decreases the area by 3768 px and increases it by 108 px for each day2. The genotypes 
hTau  (1N4R,  P301S)  decreases  the  intercept  by  3692  px  and  hTau  (1N4R,  V337M) 
decreases the intercept by 3239 px, while the change in intercept for the  genotype hTau 
(1N4R, wt) is not significant. This indicates that the genotypes hTau (1N4R, P301S) and 
hTau (1N4R, V337M) perform worse than the reference SS104, which has the genotype “no 
Tau”. The fixed effect labelling significantly increases the area by 228 px per day, indicating 
tau has an unexpected small, but positive effect on the rate of decline, irrespective of the 
actual hTau genotype.
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4.3.5 Comparison of Model 1 and Model 2
In model 1, the fixed effect genotype is not significantly different from the reference in any of 
the genotypes, while in model 2 genotype is significantly different for hTau (1N4R, P301S) 
and hTau (1N4R, V337M). We recorded all  strains generated for  this study without prior 
screening for hTau expression and used GFP expression as surrogate marker for integration 
of both constructs. This did not result in all possible combinations of genotype and labelling 
(Figure 41, Table 12). After applying a classification that defines tau-positive as pan-neuronal 
staining and less prominent immunoreactivity as tau negative, all four hTau (1N4R, P301S) 
strains  are  tau-negative  and  all  six  of  the  hTau  (1N4R,  wt)  strains  are  tau-positive. 
Interestingly,  the  performance  of  the  labelling  negative  hTau  (1N4R,  P301S)  strains  is 
marginally worse than the reference and worse than the labelling positive hTau (1N4R, wt) 
strains (Figure 23). 
Given  our  data,  model  2  predicts  that  transgenic  hTau  expression  ameliorates  the 
performance decline during ageing. An alternative explanation is, that the model attributes 
the differences between the genotypes hTau (1N4R, wt) and hTau (1N4R, P301S) to the 
fixed effect labelling since it coincidentally defines the two groups. The reason for the lack of 
high expressing hTau (1N4R, P301S) worms might be due to a toxic effect of this construct. 
This  would  lead  to  a  bias  towards  low-expressing  lines.  Nonetheless,  we  successfully 
generated  high-expressing  lines  of  a  different  mutant  hTau  (1N4R,  V337M)  and  others 
(Kraemer  et  al.,  2003) generated  a  strain  expressing  hTau  (1N4R,  P301L).  If  such  a 
selection towards low expression of hTau (1N4R, P301S) existed, this would imply a unique, 
strong toxic effect of P301S hTau mutation in C. elegans. To investigate this further, we could 
crossbreed  two  of  the  low  expressing  strains  with  integration  sites  located  on  different 
chromosomes. Alternatively, we could generate more independent integrated strains, from a 
different non-integrated strain. All the hTau (1N4R, P301S) strains were integrated from the 
same progenitor strain, therefore it is possible, that the extrachromosomal array in this strain 
had fewer copies of the transgene than the other hTau construct variants.
If we ignore hTau expression levels as detected by IHC, we arrive at model 1. This model 
attributes all  differences in performance and performance decline to the genotype alone. 
Model 1 tells us, that none of the hTau genotypes significantly alters locomotor performance 
compared to the sterile mutant SS104 which does not express hTau.
4.3.6 Comparison of our Data with Published Work
As summarized in section “C. elegans Models of Tauopathies“ and Table 2, four of the seven 
reviewed publications assessed the locomotor phenotypes in thrashing assays. Worms are 
placed in a drop of liquid and the number of body bends are counted during a defined period 
of time by an observer. The results from each thrashing assay can not be directly compared 
due to varying assay conditions such as temperature, time until the assay was performed, 
definition of body bends etc., but we can compare the strains within each report  to their 
respective control and each other. Thrashing rates were extracted as numerical values from 
published figures and then plotted accordingly (Figure 42). 
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Thrashing assay data published by Kraemer et al. (Kraemer et al., 2003) (a), Brandt 
et al. (Brandt et al., 2009) (b), Miyasaka et al. (Miyasaka et al., 2016) (c), and Pir et al. 
(Pir, Choudhary, Mandelkow, & Mandelkow, 2016) (d). The data were provided as 
graphs only, therefore the points were extracted using PlotDigitizer 
(http://plotdigitizer.sourceforge.net) and replotted. Thrashing rates of all strains were 
adjusted to thrashes per 30 s, day indicates days since hatching. The genotype of the 
strains is shown in the legend of the respective plot, non-Tg: non transgenic, Mock-
Tg: integrated empty vector, H: high expression levels, L: low expression levels.
The published data are  in  part  contradictory.  The hTau (0N3R,  wt)  expressing strain  by 
Brandt et al.  (Brandt et al., 2009) performs worse than the non-Tg control while the high 
expressing hTau (0N3R, wt) strain performs better than the mock-Tg strain by Miyasaka et 
al.  (Miyasaka  et  al.,  2016).  Furthermore,  low  expression  of  hTau  (0N4R,  wt)  improves 
thrashing rates over the control  whereas high expression of the same wt hTau construct 
results in reduced performance, being worse than in the mutant hTau-expressing strains. In 
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Pir et al. (Pir et al., 2016), low expression of hTau (2N4R, wt) thrashes less frequent than the 
control and high expressing hTau (2N4R, wt) perform worse than low-expressing strains. The 
effect of 4R hTau expression is reported to depend on expression levels but the functional 
effect largely differs between the studies. The toxic effect of wt hTau was attributed to an 
overstabilization of MTs  (Brandt et al., 2009). If this is the case, then wt hTau expressing 
worms should be more tolerant towards MT-destabilizing drugs such as colchicine (Margolis 
& Wilson, 1977). Wether hTau exerts a stabilizing function on MTs in  C. elegans  was not 
assessed in vivo nor in vitro.
Mutated  hTau  was  reported  to  have  a  pronounced  negative  impact  on  thrashing 
performance,  even at  low expression levels  and independent  of  the mutation  itself.  The 
mutations P301S/L and V337M lie within the MT binding domains and R406W lies outside 
the MT repeats. All of these mutant forms were shown to exhibit a decreased MT binding 
affinity and a decreased MT stabilization ability  in vitro (Hong, 1998) indicating a possible 
loss-of-function  in  carriers  of  this  mutation.  Since  C.  elegans does  not  have  a  close 
homologue to hTau,  a  phenotypic  effect  of  a  loss-of-function  due to  a  hTau mutation  is 
unlikely.
The published (Brandt et al., 2009; Kraemer et al., 2003; Miyasaka et al., 2005, 2016; Pir et 
al., 2016; Xie et al., 2014) as well as our IHC experiments agree, that the phosphorylation 
profiles of mutated and wt hTau are congruent. Hence, the phosphorylation status is not a 
distinctive feature of mutated hTau. Furthermore, neither Miyasaka et al.  (Miyasaka et al., 
2016) nor  Pir  et  al.  (Pir  et  al.,  2016) detected  detergent  insoluble  hTau.  To  date,  no 
pathomechanism of  any  of  these rare  familial  hTau  mutations  is  known in  humans and 
therefore a possible gain of toxicity of mutated hTau in C. elegans remains elusive. 
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4.3.7 RAPID Recordings of a Published hTau Strain
One  of  the  preexisting  mutant  strains  (Kraemer  et  al.,  2003) expressing  hTau  (1N4R, 
V337M) was assessed in two independent RAPID runs (Figure 22).  Figure 43 shows the 
data plotted from both runs.
Figure 43: RAPID Recordings of IFP134
Measurements from the strain IFP134 by run. This strain a cross of CK10 (Kraemer et 
al., 2003) hTau (1N4R, V337M) with SS104 glp-4(bn2), the same strain which is 
shown in Figure 42 (a). 
There is  a  significant  difference between the locomotor  performance of  the  same strain 
recorded in two different runs, 8 month apart. The differences between the two runs also 
apparent in their survival curves (Figure 44). 
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Figure 44: Survival Curves of IFP134
Survival curves of IFP134 recorded in run 2 and in run 9, indicated by colour, dashed 
line indicates the median survival, which is 14.4 days for run 2 and 6.9 days for run 9.
The observed difference between the two runs of  IFP134 is  much larger  than what  we 
observed  otherwise  (Figure  29)  and  therefore  might  be  caused  by  other  factors  than 
discussed  before  (section  “RAPID  Sensitivity  and  Variation  Between  Runs”).  The  strain 
IFP134 recorded in run 2 might have experienced an (epi)genetic drift while in culture before 
the  assay  was  performed.  Epigenetic  imprinting  was  shown  to  alter  the  expression  of 
transgenes over several generations  (Sha & Fire, 2005). Although we did not generated a 
worm block for IHC from this particular batch of IFP134, we never observed a reduction in 
hTau  expression  in  this  strain  before.  To  exclude  a  possible  phenotype  caused  by  a 
bystander mutation due to integration, we could backcross IFP134 several times with N2 wild 
type. The outcrossed line could then be subjected to a RAPID assay and worm blocks for 
IHC generated to examine hTau expression levels.  
IFP134 recorded in run 2 contains more long-lived individuals which show a slower decline 
compared to IFP134 recorded in run 9 which primarily consist of short-lived, fast declining 
individuals. The decline rate observed in run 9 are in agreement with the reported decline in 
thrashing  rates  (Figure  42 (a)),  although  the initial  performance  is  higher  than  reported 
(Kraemer et al., 2003). 
Furthermore,  we  recorded  the  original  CK10  strain  kindly  provided  by  Kraemer  et  al. 
(Kraemer et al., 2003) on plates containing 10 µg/ml FUdR (Figure 28). This strain shows a 
distinct locomotor performance trajectory, with a steep decline between day 3 and 5 followed 
by a recovery and a final decrease. Figure 45 shows the individual trajectories of this strain. 
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Figure 45: Individual Trajectories of CK10  
Individual trajectories of CK10 recorded during run 13 on NGM plates containing 10 
µg/ml FUdR. 
Some of the individuals show the same behaviour as observed in CK10 as a group (Figure
28). An initial decline, followed by a recovery and a final decline until death. This particular 
pattern does not seem to be an artifact, since the measurements span several days and 
worms from different strains recorded in the same run do not show this behaviour (Figure
46). Long-term retention of habituation is only achieved in distributed trainings with blocks of 
repeated stimuli and interstimulus intervals of 60 s (Rose, Kaun, & Rankin, 2002).
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Since our measurements are 6.2 h apart, habituation is unlikely and was never observed in 
any other strain. To test this hypothesis, we could adapt RAPID for habituation experiments. 
Figure 46: Individual Trajectories from N2
Individual worm plots of the wild type (N2) recorded in run 13 on NGM plates 
containing 10 µg/ml FUdR.
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4.3.8 Generation of Transgenic C. elegans
Generation of stable transgenic  C. elegans strains usually involves the induction of DNA 
double-strand breaks by UV, X-ray, or -ray irradiation. This does not only lead to the desiredɣ  
integration  of  the  extrachromosomal  array,  but  also  induces  mutations  and  complex 
rearrangements  of  the  chromosomes  (Rosenbluth,  Cuddeford,  &  Baillie,  1985;  Stewart, 
Rosenbluth, & Baillie, 1991). Some of these rearrangements can be removed by outcrossing 
the  integrated  strain  with  wild  type.  However,  mutations  and  rearrangements  of  the 
chromosome affected by the integration can only be removed by recombination with a wild 
type  chromosome  during  meiosis.  Lastly,  the  site  of  integration  will  most  likely  remain 
disturbed by the integration of the transgene, which can have a deleterious effect on the 
resulting strain regardless of the transgene expression itself.  Since the integration site is 
random, the effects of the disruption will conceivably be different for each created strain. To 
exclude phenotypes caused by the integration event, several independent transgenic strains 
of  the  same  construct  should  be  studied.  We  therefore  excluded  genotypes  from  the 
statistical analysis if only one strain was available. 
Previously published thrashing assays were mostly conducted on a single transgenic strain 
per hTau construct, with 10 - 60 worms each (Table 20).
Construct Integrated Publication Strains Worms Observations
Observed 
Time [s]
0N3R, NP no 1 1 20 3 600
0N3R, PHP no 1 1 20 3 600
0N3R, wt no 1 1 20 3 600
0N3R, wt yes 2 1 60 2 3600
0N4R, P301L yes 2 1 60 2 3600
0N4R, R406W yes 2 1 60 2 3600
0N4R, wt yes 2 2 60 2 7200
1N4R, P301L yes 3 1 10 4 1200
1N4R, V337M yes 3 1 10 4 1200
1N4R, wt yes 3 1 10 4 1200
2N4R, A152T yes 4 2 30 1 1800
2N4R, wt yes 4 2 30 1 1800
Total 390 31 27000
Number of examined worms per hTau construct, number of observations and total 
observation time from the published thrashing assays. Multiplying the number of 
worms with the number of observations and the assay duration (10 - 30 s) results in 
the total observed time. Publications: 1 = (Brandt et al., 2009), 2 = (Miyasaka et al., 
2016), 3 = (Kraemer et al., 2003), 4 = (Pir et al., 2016).
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Table 20: Summary of Published Observations on hTau-Expressing C. elegans
As  summarized  in  Table  21,  RAPID  enabled  us  to  record  functional  data  of  4  to  13 
independent strains per hTau construct, with an unprecedented number of hTau-expressing 
worms assayed and a total observation time two orders of magnitude larger than what was 
reported before. 
Construct Strains Worms Observations Observed Time [s]
1N4R, P301S 4 274 5543 166290
1N4R, V337M 13 839 22864 685920
1N4R, wt 6 531 13062 391860
Total 1644 41469 1244070
Number of assayed worms per construct, number of observations and total observed 
time recorded using RAPID. Multiplying the number of worms with the number of 
observations and the assay duration (30 s) results in the total observed time. 
As  an  alternative  to  genomic  integration  via  random  double-strand  breaks,  site-directed 
integration techniques could be employed such as MosTIC/MosSCI (Frøkjær-Jensen et al., 
2008; Robert, Katic,  & Bessereau, 2009). Mobilization of a transposon generates double-
strand breaks at defined loci and enables integration of the transgene through homologous 
repair.  More  recently,  locus-specific  integration  of  transgenes  was  achieved  through  the 
powerful  CRISPR/Cas9  system  (Yoshina,  Suehiro,  Kage-Nakadai,  &  Mitani,  2016).  To 
exclude  phenotypes  due  to  developmental  defects  caused  by  transgene  overexpression 
during embryogenesis, inducible transgenes could be employed. Temporal control of tissue 
specific transgene expression was achieved using the FLP recombinase driven by a heat-
shock  promoter  (Davis,  Morton,  Carroll,  &  Jorgensen,  2008;  Voutev  &  Hubbard,  2008). 
Expression of the FLP recombinase excises a transcriptional terminator sequence, leading to 
permanent  expression  of  the  transgene.  These  newer  techniques  may  help  to  attribute 
phenotypes  with  higher  confidence  to  transgene  expression  than  the  traditional  method 
which can be very disruptive. 
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Table 21: Summary of  Observations Recorded Using RAPID
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5 Conclusion
5.1 RAPID - A Novel Tool to Study Neurodegeneration, Ageing, 
and Health
With RAPID we developed a novel tool to study lifelong stimulated locomotor performance of 
single worms, enabling longitudinal studies of worm health under various conditions. RAPID 
consists of a series of independent imaging platforms with script-enabled consumer-grade 
cameras, a software pipeline for the extraction of locomotor data, a statistical framework for 
analysis and a robotic plate changing mechanism. Our modular design entirely relies on 
open source software enabling other researchers to adapt and extend the RAPID platform 
for their purposes. Archival of the imaging data enables retrospective analysis and extraction 
of additional locomotor parameters. 
In  contrast  to  existing  worm  trackers,  RAPID  enables  high-throughput,  single  worm 
recordings on standard NGM plates. Measuring stimulated locomotor performance allows 
assessment of worm health instead of focussing on time to death or lifespan as a read-out. 
Lifespan-extending interventions are not desireable if  they do not increase the amount of 
time that is spent in good health. In a proof-of-principle experiment we demonstrated that 
RAPID is  able  to  determine  the locomotor  performance of  long-lived  and  uncoordinated 
worm strains and how they compare to the wild type strain. None of the long-lived strains 
showed a better performance than the wild type, indicating that this kind of life extension 
does not improve healthy ageing.
5.2 C. elegans as Model of Tauopathy
We generated 23 genomically integrated  C. elegans strains expressing either wild type or 
mutated  hTau  in  the  nervous  system  to  evaluate  the  possible  toxic  effect  of  hTau  and 
neurodegeneration.  To estimate the expression levels and determine the phosphorylation 
status of  hTau,  we developed a synthetic  tissue which we termed worm block,  enabling 
conventional histology and immunohistochemistry on a large number of synchronized worm 
populations.  Worm blocks  allow the use of  automated tissue processing techniques and 
autostainer platforms for high throughput histology which also ensure reproducibility across 
replicates.
IHC on our newly generated worm strains demonstrated, that the expression levels vary. In 
accordance with published work,  phosphorylation at  the two epitopes examined is  not  a 
unique  feature  of  mutated  hTau  but  is  also  found  in  wild  type  hTau-expressing  strains. 
Phosphorylation of one epitope correlates with the amount of total hTau expression.
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To test whether hTau expression in C. elegans is neurotoxic, we examined our strains in a 
lifelong stimulated locomotor performance test using RAPID. The data show considerable 
variation among individual animals within any given strain. This variation is in part caused by 
the  stochastic  nature  of  the  ageing  process  itself.  All  strains  show  distinct  decline 
trajectories, but there is no acknowledgeable difference between the hTau genotypes and the 
non-transgenic control. For statistical evaluation, we constructed a linear mixed-effect model 
which contains hTau genotype as a fixed effect. All strains with a given genotype are grouped 
and compared to the reference strain. The fixed effect for  genotype does not significantly 
change the baseline performance nor does it affect the rate of decline, indicating that hTau 
does not have an effect on stimulated locomotor performance.
Since our IHC experiments revealed different expression levels among the hTau-expressing 
strains, we classified them into hTau positive (labelling), and hTau negative (no labelling). In 
analogy to the first model, we grouped all strains with labelling and compared them to the 
group with no labelling. The fixed effect labelling does not significantly change the baseline 
performance. However, the effect of hTau labelling on the rate of decline is significant but 
small, leading to a slightly slower decline in hTau positive worms. The model also includes a 
fixed effect for genotype, which decreases the baseline performance of the two mutant hTau 
constructs, but not of the wild type hTau. This outcome can be partially attributed to how the 
groups are composed. One mutant hTau genotype contains lower performing strains with no 
labelling, while the wild type hTau genotype consists of strains with labelling. To definitely 
determine  how  expression  levels  affect  the  locomotor  performance  of  different  hTau 
genotypes, all combinations of labelling and genotype need to be available for testing. 
Our data disagrees with the published literature on the reported deleterious effects of hTau 
expression in C. elegans. In contrast to earlier reports, we generated and analysed 4, 6, and 
13 independent  strains  per  hTau genotype and examined several  hundred worms using 
lifelong longitudinal recordings, outnumbering all previous observations combined. Our data 
indicate that neither mutant nor wild type hTau expression leads to a pronounced locomotor 
phenotype, arguing against a previously postulated, toxic effect of neuronal hTau expression.
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6 Outlook
6.1 RAPID - Improvements and Additions
RAPID is a stable and reliable platform on which experiments can run for  several  week 
without experimenter interventions. Nonetheless, RAPID consists of mechanical parts which 
are in constant use and therefore will wear out over time. These parts include the camera’s 
moving  lenses,  a  relay  switching  the  vacuum  pump,  the  pump  itself  and  the  attached 
electromagnetic valve. Failure of one camera will lead to missing data on 1/4 of the plates 
recorded. Once the faulty camera is identified, it can be easily replaced with only a short 
interruption. Due to missing redundancy, failures in the vacuum system are more critical. 
Plates can be dropped, flipped and switched in position. Since each plate is labelled with a 
unique identifier and plate position, the plates can always be put back to their designated 
position. Possible switching of plates can be detected and in most cases also corrected, 
since each plate has unique track patterns in the E. coli lawn, produced by the moving worm. 
If unambiguous identification is not possible, the corresponding data sets are censored. In 
the current implementation, RAPID does not have sensors to detect plate pick up errors due 
to a failure in the vacuum pick-up system. A sensor at the calibration position could be used 
to detect the presence of a plate and report it back to the host computer. In case of a missing 
plate, the assay could be interrupted and the operator notified to prevent error propagation 
due to switched plates etc.
The  light  sources  are  conventional  incandescent  halogen  light  bulbs  due  to  a  constant 
brightness  and  homogeneity  of  the  illumination.  Recently,  we  switched  to  LEDs  with 
comparable light characteristics which we are currently evaluating. LEDs are desirable since 
they emit less heat. To improve the imaging quality of RAPID further, we could replace the 
magnifying lens assembly with an achromatic lens. As discussed in section “Discussion”, the 
current lenses have spherical- and chromatic aberrations, which leads to blurred tracks near 
the edge of the field of view. Furthermore, the construction material used for the frame which 
holds the imaging platforms,  diffuser and light  sources is  made of  plywood and wooden 
boards, since it is easy to work with and does not require specialized tools. Ideally, the next 
version of the frame will be made of extruded aluminium to make the structure more rigid. 
To improve the temperature stability during our experiments, we should separate the heat 
generating components such as the robot controller from the assay compartment. Additional 
installation of a small air conditioning unit may stabilize the temperature at 25 °C. Due to the 
arrangement  of  the  imaging  platforms  and  the  plate  storage  array,  it  is  not  possible  to 
enclose the plates of the storage array in a temperature controlled cabinet. 
For optogenetics experiments, a secondary light source could be coupled to the imaging 
system using a dichroic  mirror/beamsplitter.  Alternatively,  a  second excitation illumination 
ring could be installed around the light source. Since stimulation with the vibratory stimulus 
worked reliably, we have not yet tested any of these potential implementations.
As with the hardware, our software was designed to work robustly with our assay conditions. 
For this reason we compare the area covered by the worm. Ideally, we would like to compare 
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the track length instead which is independent of the worm body size and changes therein 
during life. Skeletonization is the operation which reduces a given area/contour to a line of 
one pixel width. Counting the number of pixels results in the length of the track. In addition, 
the  general  shape  of  the  track  is  preserved.  Initial  tests  using  skeletonization  were  not 
satisfactory, since it  produced artifacts such as branching, falsely increasing track length. 
This can be improved by employing pruning to remove branches. An attractive contestant to 
skeletonization would be to fit  a B-spline along the medial  axis  of  a track area,  thereby 
avoiding the possibility of branching. Having a line representation of a track would further 
enable the extraction of  features beside length,  such as amplitude,  wavelength,  bending 
angles etc.,  which are currently not quantifiable. We aim to evaluate the worm detection 
algorithm employed by the Multi-Worm Tracker, combining image subtraction with flood-fill  
operation  to  detect  worm outlines.  Since  RAPID preserves  all  raw image data,  we  can 
evaluate new tracking algorithms on our  large data set  and compare their  performance. 
However, extracting additional locomotor parameters will require different means of statistical 
analyses. It is not apparent, how parameters such as bending angles can be compared, or 
even become meaningless once sinusoidal movement ceases.
6.2 RAPID - Additional Experiments
We will continue to use RAPID in the study of ageing, performing more experiments on long-
lived mutants and life prolonging interventions. Moreover, we will address the issues raised 
by the reviewers and revise our manuscript on RAPID accordingly. RAPID can furthermore 
be employed to study the effect of compounds on health and ageing. Since the system is 
capable  to  deal  with  NGM plates  containing  living  bacteria,  we  might  test  the  system's 
capability as a platform for functional RNAi screening by feeding RNAi expressing bacteria.
6.3 Worm Blocks as Synthetic Reference Tissue
We envisage the use of our worm block technique for use in routine diagnostics as reference 
tissue for IHC and molecular pathology. Proteins or short  peptides containing an epitope 
could be expressed in the pharynx, a structure which can be readily identified in longitudinal- 
and transversal sections. By generating several strains with varying expression levels, the 
reference tissue can be selected to optimally cover the detection range of a given diagnostic 
test. Similar attempts were made by creating artificial tissues from cell cultures. However, C. 
elegans is less challenging in cultivation, and requires no special equipment nor expensive 
culturing  media.  The  use  of  worm  blocks  as  reference  tissue  is  not  limited  to  antigen 
expression, but can also be used for DNA-based assays by incorporation of specific DNA 
sequences. In particular, distribution of engineered reference  C. elegans strains is simpler 
than  distribution  of  cell  cultures,  which  could  aid  in  standardization  across  molecular 
diagnostic pathology laboratories.
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6.4 C. elegans as Model System of Tauopathies
To further study the effect of  expression of  hTau on locomotor performance,  it  would be 
helpful to create new sets of hTau expressing strains with all combinations of hTau genotype 
and expression levels. Instead of focusing on overall performance, more subtle change in 
locomotion  could  be  detected  by  extracting  additional  locomotor  parameters.  To  avoid 
bystander  mutations  and  phenotypes  due  to  random  integration,  site-directed  insertion 
method should be employed. This would make strains with different hTau genotypes more 
comparable as with conventional genomic integration, since they would have a more uniform 
genetic background. To avoid phenotypes, hTau expression could also be made inducible. 
Instead of using non-transgenic worms as control, strains with a scrambled copy of the hTau 
constructs  should  be  employed.  Lastly,  phenotypic  scoring  should  be  carried  out  using 
automated systems, allowing unbiased and experimenter-independent observations. 
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7 Appendix
7.1 List of Primers and Constructs
Region Name Sequence (5’ - 3’)
Promoter mec-7p_fwd GAGCTTTCAACACCCCGCAC
mec-7p_MAPT_rev tcctggcggggctcagcCATGTTGCTTGAAATTTGGACCCGA
aex-3p-.1.3_fwd TGCCGCTTCAATTCTCCATGTG
aex-3p_MAPT_rev tcctggcggggctcagcCATTTTTTATTAGGATAGGTACATTGGTGCA
aex-3p_GFP_rev ctccagtgaaaagttcttctcctttactCATTTTTTATTAGGATAGGTACATTGGTGC
mec-7p_DsRed2_rev gatgacgttctcggaggaggcCATGTTGCTTGAAATTTGGACCCGA
3'-UTR MAPT_unc-86-UTR_fwd tggccaagcagggtttgtgaTTTCGTTTTCGTGAACACATTTTCCC
unc-86-UTR_fwd GGCGGGTTAACAAGCAGGTC
unc-86_nested_rev ACACTATGCAAGCATCAATCGCC
GFP_unc-86_fwd cacatggcatggatgaactatacaaatagTTTCGTTTTCGTGAACACATTTTCCC
DsRed2_unc-86_fwd cgccaccacctgttcctgtagTTTCGTTTTCGTGAACACATTTTCCC
MAPT MAPT_fwd gctgagccccgccagga
MAPT_rev tcacaaaccctgcttggcca
GFP GFP_fwd agtaaaggagaagaacttttcactggag
GFP_rev ctatttgtatagttcatccatgccatgtg
DsRed2 DsRed2_fwd gcctcctccgagaacgtcatc
DsRed2_rev ctacaggaacaggtggtggcg
Sequencing MAPT_nested_fwd TGCCCATGCCAGACCTGAA
mec-7p_150bp_upstream_fwd GATGGGGCACCGAGATGTG
aex-3p_200bp_upstream_fwd TTGTAATCTATCATGTAAACAGTTACAC
unc-
86_150bp_downstream_rev
CTTGTCGCTAAAAATGTTGAGGAAC
MAPT_mid_rev TGTGGCGATCTTCGTTTTACCAT
Mutagenesis V337M_fwd GAGGTGGCCAGATGGAAGTAAA
V337M_rev TTTACTTCCATCTGGCCACCTC
V337M_no1_fwd GGTGGCCAGATGGAAGTAAAATCTGAGAA
V337M_no1_rev ACTTCCATCTGGCCACCTCCTGGTTTAT
P301S_no1_fwd CAAACACGTCTCGGGAGGCGGC
P301S_no1_rev CCTCCCGAGACGTGTTTGATATTATCCTTTGAG
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Table 22: Primer Seqeunces
Primer 1 Primer 2 Template Product
mec-7p_fwd mec-7p_MAPT_rev N2 genomic mec-7p_MAPT
mec-7p_fwd mec-7p_DsRed2_rev N2 genomic mec-7p_DsRed2
aex-3p-.1.3_fwd aex-3p_MAPT_rev N2 genomic aex-3p_MAPT
aex-3p-.1.3_fwd aex-3p_GFP_rev N2 genomic aex-3p_GFP
MAPT_fwd MAPT_rev prk172 (1N4R) MAPT
MAPT_fwd V337M_rev prk172 (1N4R) V337M(5')
V337M_fwd MAPT_rev prk172 (1N4R) V337M(3')
GFP_fwd GFP_unc-86_fwd OH4134 genomic GFP_unc-86-UTR
DsRed2_fwd DsRed2_unc-86_fwd OH4134 genomic DsRed2_unc-86-UTR
MAPT_unc-86-UTR_fwd unc-86_nested_rev N2 genomic MAPT_unc-86-UTR
GFP_unc-86_fwd unc-86_nested_rev N2 genomic GFP_unc-86-UTR
DsRed2_unc-86_fwd unc-86_nested_rev N2 genomic DsRed2_unc-86-UTR
aex-3p-1.3_fwd MAPT_rev aex-3p_MAPT + MAPT aex-3p::MAPT
aex-3p-1.3_fwd GFP_rev aex-3p_GFP + GFP aex-3p::GFP
mec-7p_fwd DsRed2_rev mec-7p_GFP + DsRed2 mec-7p::DsRed2
mec-7p_fwd V337M_rev mec-7p_MAPT + V377M(5') mec-7p::V337M(5')
MAPT_fwd unc-86_nested_rev MAPT + MAPT_unc-86-UTR MAPT::unc-86_UTR
GFP_fwd unc-86_nested_rev GFP + GFP_unc-86-UTR GFP::unc-86-UTR
DsRed2_fwd unc-86_nested_rev DsRed2 + DsRed2_unc-86-UTR DsRed2::unc-86-UTR
V337M_fwd unc-86_nested_rev V337M(3') + MAPT_unc-86-UTR V337M(3')::unc-86-UTR
aex-3p-1.3_fwd unc-86_nested_rev aex-3p::MAPT + MAPT::unc-86_UTR aex-3p::MAPT::unc-
86_UTR
aex-3p-1.3_fwd unc-86_nested_rev aex-3p::GFP + GFP::unc-86-UTR aex-3p::GFP::unc-
86_UTR
mec-7p_fwd unc-86_nested_rev mec-7p::V337M(5')  +  V337M(3')::unc-
86-UTR
mec-7p::V337M::unc-
86_UTR
mec-7p_fwd unc-86_nested_rev mec-7p::DsRed2  +  DsRed2::unc-86-
UTR
mec-7p::DsRed2::unc-
86_UTR
Combination of primers and templates used to generate the constructs. The final 
amplicons were ligated into the pCR 2.1-TOPO TA vector as described in section 
“Plasmid Construction and Generation of Transgenic Worm Lines”.
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Table 23: Amplifications for DNA constructs
7.2 List of Strains and Genotypes
Strain Allele(s) Tau Construct Genotype Source
N2 no Tau CGC
SS104 bn2 glp-4(bn2) CGC
IFP177 bn2; juIs76 unc-25p::gfp + lin-15(+); glp-4(bn2)
IFP147 npbIs12 aex-3p::gfp::unc-86UTR  +  mec-
7p::dsRed::unc-86UTR
IFP42 npbIs1 hTau (1N4R, wt) aex-3p::gfp::unc-86UTR + aex-3p::hTau(1N4R, 
wt)::unc-86UTR
IFP141 npbIs16; bn2 aex-3p::gfp::unc-86UTR + aex-3p::hTau(1N4R, 
wt)::unc-86UTR; glp-4(bn2)
IFP142 npbIs18; bn2
IFP144 npbIs19; bn2
IFP148 npbIs15; bn2
IFP224 npbIs2; bn2
IFP225 npbIs1; bn2
IFP195 npbIs24; bn2 hTau (1N4R, P301S) aex-3p::gfp::unc-86UTR + aex-3p::hTau(1N4R, 
P301S)::unc-86UTR
IFP199 npbIs31; bn2
IFP222 npbIs43; bn2
IFP223 npbIs42; bn2
IFP134 bkIs10; bn2 hTau (1N4R, V337M) aex-3p::hTau(1N4R,  V337M)::unc-54UTR  + 
myo-2p::gfp; glp-4(bn2)
IFP143 bkIs10;  bn2; 
juIs76
aex-3p::hTau(1N4R,  V337M)::unc-54UTR  + 
myo-2p::gfp;  glp-4(bn2);  unc-25p::gfp  +  lin-
15(+)
IFP187 npbIs28; bn2 hTau (1N4R, V337M) aex-3p::gfp::unc-86UTR + aex-3p::hTau(1N4R, 
V337M)::unc-86UTR; glp-4(bn2)
IFP191 npbIs26; bn2
IFP196 npbIs30; bn2
IFP197 npbIs33; bn2
IFP200 npbIs25; bn2
IFP208 npbIs27; bn2
IFP211 npbIs23; bn2
IFP212 npbIs29; bn2
IFP213 npbIs37; bn2
IFP214 npbIs39; bn2
IFP217 npbIs32; bn2
IFP218 npbIs35; bn2
IFP220 npbIs36; bn2
CK10 bkIs10 hTau (1N4R, V337M) aex-3p::hTau(1N4R, V337M)::unc-54UTR Kraemer et al.
FX10646 tmIs110; 
su1006
hTau (0N3R, wt) mec-7p::hTau(0N3R,  wt)::unc-86UTR;  rol-
6(su1006)
Mitani et al.
FX10519 tmIs82; su1006 hTau (0N4R, wt) mec-7p::hTau(0N4R,  wt)::unc-86UTR;  rol-
6(su1006)
FX11152 tmIs81; su1006 hTau (0N4R, P301L) mec-7p::hTau(0N4R, P301L)::unc-86UTR;  rol-
6(su1006)
FX12012 tmIs146; 
su1006
hTau (0N4R, R406W) mec-7p::hTau(0N4R,  R406W)::unc-86UTR; 
rol-6(su1006)
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Strain Allele(s) Tau Construct Genotype Source
VH255 hdEx82; e2123 hTau (0N3R, wt) rgef-1p::hTau(0N3R,  wt)  +  pha-1(+);  pha-
1(e2123)
Hutter et al.
VH254 hdEx81; e2123 hTau (0N3R, PHP) rgef-1p::hTau(0N3R,  PHP)  +  pha-1(+);  pha-
1(e2123)
VH420 hdEx180; 
e2123
hTau (0N3R, NP) rgef-1p::hTau(0N3R,  NP)  +  pha-1(+);  pha-
1(e2123)
List of all the strains and genotypes used in this work. Duplicate hTau constructs and 
genotypes are omitted, strains without source reference were created by us. 
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Table 24: Strains, Allels and Genotypes
7.3 Diagnostic Plots of Models 1 and 2
Diagnostic plots of all strains recorded using RAPID. Measured vs. predicted area (a) same as in 
Figure 26, Tukey-Anscombe plot (b), histogram of residuals (c), and normal Q-Q- plot of residuals (d).
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Diagnostic plots of all strains recorded using RAPID. Measured vs. predicted area (a) same as in 
Figure 27, Tukey-Anscombe plot (b), histogram of residuals (c), and normal Q-Q- plot of residuals (d).
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7.4 RAPID - Image Processing and Censoring
Once the imaging of a plate is complete, the images are downloaded to the host computer 
and compressed into a video. Data from each recording is saved into a folder together with 
additional metadata. A demon running in the background constantly checks for new videos 
and performs the image processing with track extraction. Figure 49 shows the results of the 
image subtraction and track extraction. 
Image processing of RAPID data. Image subtraction of images recorded before (a), 
and after the vibratory stimulus (b) leads to an image showing only pixel which have 
changed, i.e. the worm track. The track area is extracted from these images using 
adaptive thresholding. The result is overlaid onto the first image of the series along 
with indication of the period, before (b) or after the stimulus (d). The area in pixels 
(bottom left), track is censored due to the worm being too close to the edge of the 
image (middle), and the version of the image processing pipeline (bottom right corner) 
are indicated. All timepoints of a given worm are compiled into a mosaic, visually 
inspected and censored if the thresholding failed. For this work we only analysed the 
track area recorded after the vibratory stimulus. 
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After  the  track  area  has  been  extracted  and  the  overlays  generated,  all  timepoints  are 
assembled into a large mosaic for each worm. These mosaics are then visually inspected 
and individual timepoints are censored (Figure 50).
Figure 50: Manual Censoring of RAPID Data
ImageJ is used to display the mosaic assemblies of all time points of each worm and 
visually inspected. Thresholding artifacts are identified and censored, which is 
indicated with a purple rectangular overlay. After censoring is complete, ImageJ will 
write the censoring state for each time point in a text file within the folder of this 
particular timepoint. In this example, only the first 16 time points of >100 timepoints 
recorded for this worm are visible. The mosaics are presented in a scrollable window 
and censoring is performed interactively by pointing at a given time point and pressing 
a key.
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After processing and censoring, the folder contains the following files:
dl1449254930_1_1_3
├── camera.txt
├── imgseries_h264.AVI_2fps.AVI
├── imgseries_h264.AVI_2fps.AVI_0_25_before.jpg
├── imgseries_h264.AVI_2fps.AVI_0.jpg_before_overlay.jpg_tracklength.jpg
├── imgseries_h264.AVI_2fps.AVI_27_55_after.jpg
├── imgseries_h264.AVI_2fps.AVI_27.jpg_after_overlay.jpg_tracklength.jpg
├── imgseries_h264.AVI_metadata.txt
├── sampleID.txt
├── temperature.txt
├── timestamp.txt
├── trackLength.tsv
└── version.txt
The .AVI file contains the compressed raw image data, the .jpg files result from the image 
processing, track area, number of contours and edge indication are summarized in the .tsv 
file.  The .txt  files contain various meta data relating to the recording conditions such as 
sample id, current time, temperature, camera serial number, imaging platform etc. Once a 
run has finished and image processing and censoring are complete, all  data is gathered 
using R and compiled in a single data frame. The data frames of each run can be combined 
for statistical evaluation and modeling. The structure and information contained in this data 
frame is shown in Table 25. 
Column Type Example
sampleID factor SS104_143
birthTimestamp num 1449086400
currentTimestamp num 1449427804
trackVersion factor trackVersion.v13
beforeLength num 0
beforeArea num 5210
beforeEdge num 0
beforeContours num 140
afterLength num 0
afterArea num 20398
afterEdge num 0
afterContours num 46
trackCensoredBefore factor NA
trackCensoredAfter factor NA
cameraSerial factor 860869D768724772A766819D1BAD8411
cameraVersion factor 0.9
device factor 3
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Column Type Example
temperatureAssay num 28.75
temperatureTable num 27.5
setID factor 2
days num 3.950845
groupID factor SS104
date num 06.12.15 19:49
genotype factor no Tau
HT7 factor no HT7
Columns of the R data frame in which all assay data is collected for visualization and 
statistical analysis. Each row of the data frame contains all information for a specific 
measurement. Factor indicates a categorical variable with distinct levels, while num 
stands for continuous variables, NA indicates a missing entry. Certain columns such 
as beforeLength and afterLength are placeholder and not yet populated. Columns 
below temperatureTable are constructed from other columns or added by the user. 
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Table 25: Data Frame Structure and Examples
7.5 Development of RAPID
The development of RAPID has gone through various design stages before we arrived at the 
current implementation (Figure 51).
Evolution of the imaging platforms for stimulated locomotor assessment. The first 
prototype (a) was operated manually by putting plates on to the plate holder and the 
assay was performed recording videos through a magnifying glass and the vibration 
motor was directly controlled by a computer. This version was used to evaluate 
provoked locomotion using vibratory stimuli. The next version (b) was constructed 
from a stereo microscope with camera adapter and plates were handled by a robotic 
arm (Figure 53) to load and unload plates from the stereo microscope, allowing 
longitudinal recordings for the first time. The vibration motor was switched by the 
robot controller and the setup was limited to one imaging device. Current version of 
the imaging platform (c) termed RAPID. The vibration motor is directly controlled by 
the camera, enabling multiplexing of the imaging stages and independent operation.
The first version of the imaging platform was used to evaluate the effectiveness of a vibratory 
stimuli to provoke locomotion of the worms (Figure 52). 
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Early version of track extraction using image subtraction on videos recorded using the 
first imaging platform (Figure 51 a). Track area before (a) and track area after 
stimulus (b) are compared (c). From these experiments we concluded to switch to 
locomotor assessment on single worms, since the number of worms can not be 
reliably determined due to overlapping tracks.
Switching to single worm recordings prompted us to develop an automated plate switching 
device. The solution was the use of a robotic arm in combination with a stereo microscope 
(Figure 53). 
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Figure 53: Prototype of Automated Locomotion Assessment
First version of an automated locomotion assessment capable of recording 70 plates 
using the same camera as the current version of RAPID in combination with a stereo 
microscope. This enabled longitudinal locomotor performance recordings. Since the 
capacity was limited to 70 plates, we developed a more compact imaging platform, 
enabling parallel recordings of several plates at the time. 
While this version worked well, the plate capacity was limited to 70 plates per run. In order to 
record all  the generated strains in a reasonable amount of time, we had to increase the 
capacity and multiplex the image acquisition. Since we did not have four identical stereo 
microscopes and only limited space, we developed a more compact imaging platform from 
generally available components (Figure 51 c).
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